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The focus of this work is on mechanically interlocked molecules (MIMs), which
have unusual physicochemical and mechanical properties with potential applications in
nano-scale/molecular devices and high strength materials.
Rotaxanes, for example, consist of an axle-like molecule threaded through a
wheel-like molecule, with bulky groups at the two ends of the axle preventing the wheel
from dissociating.

The position of the wheel along the axle can be switched in a

controllable and reversible manner by applying external stimuli, a feature that might lead
to the next generation of computers. Molecularly woven materials (MWMs), another
example of molecules with mechanically interlocked features, are predicted to be
unprecedentedly strong while being lightweight and flexible.
With the ultimate goal of achieving control over the functioning of molecular
devices in the solid state, a variety of pseudorotaxane building blocks were prepared and
characterized, including a novel, rare blue-colored motif. The temperature-dependent
assembly/disassembly of pseudorotaxanes was exploited for the construction of singlewavelength colorimetric temperature sensors over a 100 °C window. Pseudorotaxanes
based on aromatic crown ether wheels and disubstituted 4,4-bipyridinium axles were

converted into rotaxanes upon binding to metal complexes (zinc, cadmium, mercury,
copper, cobalt), and the formation of ordered crystalline arrays was studied in the solid
state. The columnar organization of pseudorotaxanes by Hg2X62– complexes (X = Cl, Br,
I), leading to unprecedented dichroic (blue/red) rotaxane crystals, was demonstrated for
the first time. From the crystal structures studied it became apparent that negatively
charged metal complexes are needed for successful assembly with the positively charged
pseudorotaxane units. To be able to use the more common, positively charged metal ions
for rotaxane framework construction, neutral and negatively charged pseudorotaxanes
were synthesized, by attaching anionic substituents (carboxylates, sulfonates) to either the
wheel or the axle component. It was found that pseudorotaxane formation also enabled
resolution of two sulfonated crown ether isomers, which were inseparable by
conventional methods.
Organic ligands for MWM precursors were designed and synthesized according to
multi-step schemes. Helical metal-complexes based on these ligands were prepared and
characterized.
Chromatography, Nuclear Magnetic Resonance and UV-Visible spectroscopy,
Mass

spectrometry,

Electrochemistry,

Thermogravimetric

Analysis

and

X-ray

crystallography were used in identification, purification and characterization of the
compounds involved.
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CHAPTER 1

INTRODUCTION
1.1. Mechanically interlocked molecules (MIMs)
MIMs contain components which are held together by a mechanical bond. To separate
the components, at least one covalent bond has to be broken. Therefore, MIMs are
considered to be molecules rather than complexes or supramolecular entities.1,2
Catenanes, rotaxanes, pretzelanes, molecular knots, and molecular Borromean rings are
examples of MIMs (Figure 1.1).3,4

Figure 1.1: Schematics (from left to right) of a catenane, rotaxane, pretzelane, pentafoil
knot and Borromean ring.
1.1.1. Pseudorotaxanes and rotaxanes
Pseudorotaxanes consist of an axle–like molecule threaded through a wheel–like
molecule (Figure 1.2A). These two components interact with each other via non-covalent
intermolecular interactions such as  stacking,1,5,6 hydrogen bonding,2

and

electrostatic interactions.7,8 In pseudorotaxanes, the wheel-like molecule can dissociate
from the axle due to threading/dethreading equilibrium between the two components. By
attaching bulky groups at both ends of the axle of a pseudorotaxane, the wheel is
1

mechanically locked onto the axle. The resulting assembly is called a rotaxane (Figure
1.2B). In both pseudorotaxanes and rotaxanes, the wheel-like molecule can slide along or
pirouette around the axle.3,9–12

Figure 1.2: Schematics of A) a pseudorotaxane and B) a rotaxane.
The most commonly used axles for the construction of pseudorotaxanes and rotaxanes
contain one of the following cores: 4,4′-bipyridinium,13 1,2-bis(pyridinium) ethane,14
perylenediimide,15,16 naphthalenediimide15,16 or diaminoalkane (Figure 1.3).17,18

Figure 1.3: Commonly used axle cores for pseudorotaxane construction A) 4,4′bipyridinium, B) 1,2-bis(pyridinium) ethane, C) perylenediimide, D) naphthalenediimide
and E) diaminoalkane.

Crown ethers, 13,14,19 cucurbiturils, 17,18 cyclodextrins, 11,13 cyclo[2](2,6-di(1H-imidazol-1yl)pyridine)[2](1,4-dimethylenebenzene) (‘Texas sized’ molecular box – [TSMB]4+),20
cyclobis-(paraquat-p-phenylene) ([CBPQT]4+)13,21 and pillarenes22,23 have been most
often used as wheel components for pseudorotaxanes (Figure 1.4).

2

Figure 1.4: Commonly used wheel-like molecules for pseudorotaxane construction A)
crown ethers, B) cucurbiturils, C) pillarenes, D) cyclodextrins, E) cyclobis(paraquat-pphenylene
and
F)
(cyclo[2](2,6-di(1H-imidazol-1-yl)pyridine)[2](1,4dimethylenebenzene).

The first generation of pseudorotaxanes reported by J. Fraser Stoddart, a pioneer in
MIMs, and his coworkers consist of [CBPQT]4+ (wheel E) and aromatic axles (Figure
1.5A), or aromatic crown ethers and 4,4′-bipyridinium core.13,24 The pseudorotaxanes
reported by Harry W. Gibson et. al consist of 1,3-dibenzo crown ethers and 4,4′bipyridinium core containing axles.10 The self assembly processes of these systems are
driven by the  stacking– and charge transfer (CT)– interactions between the -

3

electron rich, -donor units and the -electron deficient, acceptors units. In addition,
N+∙∙∙O electrostatic interactions and C–H∙∙∙O hydrogen bonds between two components
contribute to the robustness of the assembly.
Jeremy K. M. Sanders and coworkers proposed a number of neutral pseudorotaxane
systems which consist of

neutral crown ethers and naphthalenediimide or

perylenediimide core containing axles (Figure 1.5B).15,16 Since both axle and wheel
components are neutral,  stacking interactions between two components are the main
driving force for pseudorotaxane formation.
To amplify the interactions between the axle and the wheel and obtain highly stable
pseudorotaxanes, Stephen J. Loeb’s and Donald Fitzmaurice’s groups synthesized
[2]pseudorotaxanes with (+2) positively charged axles and (–2) negatively charged
disulphonated aromatic crown ether wheels (Figure 1.5C).7,8 Feihe Huang’s research
group in China has reported the pillarene wheel and the 4,4′-bipyridinium core containing
pseudorotaxanes (Figure 1.5D).22,23

Figure 1.5: Representative examples of [2]pseudorotaxanes.
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A number of synthetic approaches have been employed to lock the wheel onto the axle to
form a rotaxane. The first reported rotaxane synthesis attempts were based on statistical
approaches which provided very low yields.25–28 Later on, a covalent bond directed
approach was employed, which consists of multi-step organic synthesis, and again
resulted in a low overall yield.29–31 To overcome these drawbacks, in 1983 Jean-Pierre
Sauvage and his coworkers reported a ground breaking approach called the metal-ligand
coordination directed molecular recognition approach.32 This approach has been widely
used not only for rotaxane synthesis but also for a wide variety of other MIMs.33
Among the rotaxanes synthesized according to the above mentioned methods and
reported in the literature, two major types of bulky stoppers can be recognized.3 One type
consist of bulky organic moieties, such as tris(1-methylethyl)silyl,34 anthracenyl,35 3,5bis(dimethylethyl)phenyl,33

1,3-dicarboxyphenyl,33,36

3,5-bis(4-carboxypheyl)phenyl,

tris(4-tert-butylphenyl)-4-phenoxy33 (Figure 1.6A–F) while the other type consist of
bulky metal complexes, such as a ruthenium polypyridine complex 37 or metal (Zn(II),
Au(II), Rh(II), Ru(II)) porphyrins (Figure 1.6G–J).38,39 The two bulky stoppers used in
rotaxane synthesis can be identical or different.

5

Figure 1.6: Representative examples of bulky organic stoppers (A-F), metal complex
stoppers (G-J).

Two examples of rotaxanes with bulky organic stopper and the metal complex are given
in Figure 1.7.39,40

M = Zn(II), Ru(CO), RhI
Figure 1.7: [2]rotaxane with a) bulky organic group– and b) metal complex– as a
stopper.
6

1.1.2. Bistable (two station) rotaxanes
Bistable rotaxanes are rotaxanes which have axles with two different accommodation
sites for the wheel molecule or wheels with two different accommodation sites for the
axle molecule.16,34,41 By applying external stimuli such as a chemical (pH, metal ions),
photochemical or electrochemical changes, the wheel can move along the axle, from one
station to the other or pirouette around the axle.42 This molecular level movement is a
result of changing the binding affinity of one component (axle or wheel) of the rotaxane
towards the first or second station on the other component and it has been very useful
property in constructing artificial molecular machines (AMMs).42
Stoddart and coworkers reported a pH-driven bistable rotaxane based molecular machine
in 1994, the axle of which has two recognition sites for the tetra cationic wheel molecule
(dibenzidine and biphenol) (Figure 1.8).34 In one conformation, the wheel molecule is
located on stays in the dibenzidine site. The addition of trifluoroacetic acid leads to the
protonation of the dibenzidine site, which then repels the cationic wheel. Subsequently,
the wheel moves along the axle to the biphenyl site. Upon addition of pyridine (base), the
dibenzidine site is regenerated and the wheel molecule moves back to the original
position. The wheel molecule can therefore move back and forth as a shuttle, driven by
changes of the medium is pH.34

7

Figure 1.8: a) Schematics of a bistable rotaxane which has two recognition sites on the
axle. b) A representative example of pH driven bistable rotaxanes. Figure (b) was
reproduced with permission from reference 34. Copyright 1994 Nature Publishing Group.

In 2004, Jean Pierre Sauvage and coworkers reported a redox driven molecular machine
based on a bistable rotaxane. The wheel molecule was designed to have two metal
binding sites: 1,10–phenanthroline and 2,6-bis(2-pyridyl)pyridine (terpyridine). The axle
molecule contains a 2,2′–bipyridinium core (Figure 1.9). In the presence of Cu(I) ions,
the bidentate 1,10–phenanthroline group of the wheel together with the 2,2′–bipyridinium
group of the axle chelate to the Cu(I) ion in a tetrahedral coordination geometry. Upon
oxidation of Cu(I) to Cu(II) electrochemically, the terpyridine group of the wheel
coordinates to the Cu(II) ion, replacing 1,10-phenanthroline to provide the preferred
trigonal bipyramidal conformation around the Cu(II) ion. A pirouetting motion of the
wheel around the axle can therefore be induced by altering the redox stimuli of the
medium. 41
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Figure 1.9: a) Schematics of a bistable rotaxane possessing two recognition sites on the
wheel and b) A representative example of a redox driven bistable rotaxane. The figure (b)
was reproduced with permission from reference 41. Copyright 2004 the Royal Society of
Chemistry (RSC).
1.1.3. Metal-organic rotaxane frameworks (MORFs)
1.1.3.1. Metal-organic frameworks
Organic ligand molecules can bind to metal ions or complex nodes via metal–ligand
coordination bonds to form extended one–, two– or three– dimensional networks called
metal-organic frameworks (MOFs).43

Figure 1.10: Schematic representation of extended 1D, 2D and 3D MOFs.
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The dimensionality of MOFs is determined by the coordination geometry of the metal
ion/ cluster and the denticity of the ligand (Figure 1.10). Ligands containing carboxylate,
pyridyl and nitrile functional groups are widely used in the MOFs’ construction.43 Both
pyridine and nitrile ligands bind to the metal ions in a monodentate fashion while
carboxylate ligands bind in a monodentate, bis-monodentate or bidentate pattern (Figure
1.11). The high porosity and the organic-inorganic hybrid nature of the MOFs make
them very useful in a vast range of applications.43 The porous nature of MOFs utilized in
selective separation of compounds, catalytic reactions, guest exchange and gas storage
applications. The organic component of the MOFs provides tunable cavity sizes and
shapes based on the shape (ligand coordinating angle), size and the functionality of the
ligand, while inorganic component provides the optical, electronic and magnetic
properties.43
a)
b)
c)

Figure 1.11: Coordination geometries of a) pyridine based ligands, b) nitrile based
ligands and c) carboxylate based ligands. (M = metal ion).

A sub class of MOFs consists of (pseudo)rotaxanes as linkers between metal ions called
metal-organic rotaxane frameworks (MORFs) (Figure 1.12).44 The MORFs are not as
widely explored as MOFs. Kimoon Kim, Stephen J. Loeb, Jonathan Sessler, J. Fraser
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Stoddart and their coworkers reported the known examples of MORFs. According to the
dimensionality of the structure, MORFs can be divided into three groups: 1D, 2D and 3D MORFs. Appropriate selection of coordinating groups at the two ends of the
(pseudo)rotaxane linkers, the nature of solvents (coordinating or non-coordinating), metal
ions and counter ions are very important factors that determine the final dimensionality of
MORFs.45

Figure 1.12: Schematic representation of extended 1D, 2D and 3D metal–organic
rotaxane frameworks.

1.1.3.2. 1D MORFs
A number of 1D MORFs with different shapes such as straight chain, zig–zag shaped,
square wave shaped or helical structure have been reported by pioneers in MORFs. They
have designed and synthesized pseudorotaxane linkers with pyridine or carboxylate
functionalities at the two ends, which are essential for the preparation of extended
structures.
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The very first 1D metal–organic rotaxane structure was reported by Kimoon Kim and his
co-workers in 1996.46 In their studies various combinations of diamino alkane derivatives
and cucurbit[6]uril (CB(6)) were used as the axle molecule and the wheel molecule,
respectively, to construct [2]pseudorotaxanes (Figure 1.13).17,18 The highly symmetric
nature of the (CB(6) wheel shows a higher affinity of forming pseudorotaxanes even in
the highly polar aqueous medium. Transition metal ions have been used as metal ion
nodes due to their relatively strong bond forming capacity and the large number of
preferred coordination geometries. All 1D MORFs reported by Kim’s laboratory were
grown at room temperature. 17,18

Figure 1.13: Various pseudorotaxanes used by Kim’s group for 1D and 2D MORFs.

Layering of a solution of Cu(NO3)2 in methanol over an aqueous solution of [P1][NO3]2
[2]pseudorotaxanes leads to crystals that contain a zig–zag shaped extended 1D metal–
organic rotaxane chain, MORF–1. The crystal structure of MORF–1 shows that each
Cu(II) ion has square pyramidal coordination geometry. The terminal pyridyl groups of
two P1 [2]pseudorotaxane linkers are coordinated to one equatorial and one axial position
of a Cu(II) ion in a cis geometry. The remaining three coordination sites of the Cu(II) ion
are occupied by three water molecules (Figure 1.14.a).46
12

The slow reaction of an aqueous solution of M(NO3)2 (M = Co(II) or Ni(II)) with the
same [2]pseudorotaxane linker in an aqueous medium produces iso-structural, square
wave shaped 1D MORFs, MORF–2 and MORF–3, respectively (Figure 1.14.b).18 In
contrast, layering an aqueous solution of Co(NO3)2 or Ni(NO3)2 with a solution of
[P2][NO3]2 [2]pseudorotaxanes (which have terminal 3-pyridyl groups instead of 4pyridyl) yields zig-zag shaped iso-structural 1D MORFs, MORF–4 and MORF–5,
respectively (Figure 1.14.c).18 In the last four cases, the metal ion centers are found in
octahedral coordination geometries. In the case of MORF–2 and MORF–3, four water
molecules coordinate to the equatorial positions of the metal ion, while axial positions are
occupied by the terminal pyridine group of the P1 [2]pseudorotaxane linker. This trans
binding geometry of two [2]pseudorotaxane ligands to the metal ion and the sigmoidal
shape of the P1 [2]pseudorotaxane unit give the square wave shape to MORF–2 and
MORF–3.18 In contrast, two sites of the metal centers of MORF–4 and MORF–5 are
coordinated by the 3–pyridine groups of two P2 [2]pseudorotaxane linkers in a cis
geometry, while the remaining sites are coordinated by water molecules to give a zig–zag
shaped 1D MORF.18

Kim and coworkers also reported a number of 1D MORFs with second row transition
metals such as Ag(I) and Cd(II). Layering a solution of Ag(CH3(C6H4)SO3) in methanol
over an aqueous solution of a [P1][NO3]2 [2]pseudorotaxane yields a 1D linear chain,
MORF–6 (Figure 1.14.d).47 In contrast, changing the metal salt from Ag(CH3(C6H4)SO3)
to AgNO3 and the [2]pseudorotaxane from [P1][NO3]2 to [P3][NO3]2 yields a 1D helical
structure, MORF–7 (Figure 1.14.e).48 Crystal structures of MORF–6 and MORF–7 both
show coordination of the Ag(I) ion node with two P1 or P3 [2]pseudorotaxane linkers,
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respectively, in a trans geomtry. The helical structure, MORF–7, contains two Ag(I) ions
and two P3 [2]pseudorotaxane linkers per one turn of the helix.48

The 1D helix of MORF–8 was obtained by layering an aqueous solution of Cd(NO3)2
over an aqueous solution of [P3][NO3]2 [2]pseudorotaxane. The crystal structure of
MORF–8 shows that each turn of the helix consists of four Cd(II) ions of two types and
four P3 [2]pseudorotaxane linkers (Figure 1.14.f). Both Cd(II) ion types show distorted
octahedral geometry. The first type of Cd(II) ions are coordinated in a cis geometry by 3pyridyl groups of two [2]pseudorotaxane linkers, while the other four coordination sites
are occupied by water molecules. The second type of Cd(II) ions are coordinated by the
[2]pseudorotaxane linkers in a trans geometry, while the remaining sites are occupied by
three water molecules and one nitrate ion. The MORF–7 and MORF–8 are racemic
mixtures, since the same crystal contains both left handed and right handed helixes.18

a)

b)

c)

d)

e)

Figure 1.14: Crystal structures (space filling representation) of 1D rotaxane coordination
polymers reported by Kim’s group: a) zig–zag shaped MORF–1; b) square wave shaped
MORF–2; c) zig–zag shaped MORF–5; d) straight chain MORF–6; e) helical
MORF–7.17 Solvent molecules and hydrogens are omitted for clarity. Color code: O, red;
N, light purple; C, grey, metal ions, green. This figure was reproduced with permission
from reference 18. Copyright 2002 John Wiley and Sons, Inc.
Stephen J. Loeb and coworkers used positively charged axles and neutral dibenzo-24crown-8 (DB24C8) or anionic disulphonated dibenzo-24-crown-8 (DSDB24C8) crown
14

ether wheels to construct [2]pseudorotaxanes (Figure 1.15). The axles (A4 and A5) have
two pyridine groups at the two ends that can coordinate to metal ions. All 1D MORFs
reported by Loeb’s group were grown at room temperature.

Figure 1.15: The various pseudorotaxanes used by Loeb’s group for 1D MORFs.

Loeb and coworkers reported a 1D metal–organic rotaxane structure which consists of 2+
charged P4 [2]pseudorotaxanes and Co(II) or Zn(II) metal ion centers. Evaporation of a
solution containing a 1:2:1 mixture of [A4][BF4]2, DB24C8 and [M(H2O)6][BF4]2 (M =
Co(II), Zn(II)) in acetonitrile yields the isomorphous 1D polyrotaxane chains MORF-9
and MORF-10, respectively (Figure 1.16a). Both Co(II) and Zn(II) metal ions possess
octahedral coordination geometry with two pyridyl

groups from two [P4]

[2]pseudorotaxane linkers bound in a trans geometry. The remaining coordination sites
are occupied by two trans water molecules and two trans acetonitrile (solvent)
molecules. Tetrafluoroborate anions in the crystal structures of MORF–9 and MORF–10
balance the positive charge of the P4 [2]pseudorotaxanes.49
Layering a solution of zinc tetrakis(carboxyphenyl)porphyrin in methanol over a solution
of P4 [2]pseudorotaxane in chloroform yields a 1D MORF, MORF–11 (Figure 1.16b).
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The crystal structure of MORF–11 shows that each Zn(II) ion acquires distorted
octahedral geometry. The four equatorial sites of the Zn(II) ion are chelated by the
porphyrin ring and the axial positions are occupied by the terminal pyridine groups of the
P4 [2]pseudorotaxane linkers.50
To eliminate the counterions and obtain neutral MORFs, Loeb et. al. used
[Me4N]2[DSDB24C8] crown ether wheel and [A4][BF4]2 axle molecule to form neutral
dizwitterionic P5 [2]pseudorotaxanes. Neutral, paddle wheel copper benzoate was used
as a metal ion node. A neutral MORF–12 was obtained by layering a solution of
[A4][BF4]2 and copper benzoate in dimethylformamide (DMF) with a methanolic
solution of [Me4N]2[DSDB24C8]. The axial coordination sites of the copper paddle
wheel structure was coordinated by terminal pyridyl groups of two neutral P5
[2]pseudorotaxane linkers to form a 1D linear chain of polyrotaxane (Figure 1.16c).51
An equimolar mixture of negatively charged P6 [2]pseudorotaxane and Zn(NO3)2∙4H2O
in methanol yielded a 1D coordinated polyrotaxane chain, MORF–13 (Figure 1.16d). Its
crystal structure shows that each Zn(II) ion has octahedral coordination geometry.
Terminal pyridyl groups of two P6 [2]pseudorotaxanes coordinate to the Zn(II) ion node
in a trans geomtry. In addition, three methanol molecules and the SO3¯ group from
DSDB24C8 of the neighboring pseudorotaxane chain coordinate to the Zn(II) ion node.
As a result, the parallel polyrotaxane chains in the crystal structure are arranged in a
head-to-tail fashion. The non-coordinating nitrate ions are present in the crystal structure
for charge balance.52
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a)

b)

c)

d)

Figure 1.16: Crystal structures (wire-frame representation) of 1D rotaxane coordination
polymers reported by Loeb’s group. a) MORF–9; b) MORF–11; c) MORF–12 and d)
MORF–13. Solvent molecules, hydrogen atoms and counter ions omitted for clarity.
Axle color code: O, red; C, black; N, blue; S, yellow, Co(II), light green; Cu(II), green;
Zn(II), silver. Wheel color code: DB24C8, red. This figure was reproduced with the
permission of the RSC from reference 45.
Jonathan L. Sessler and coworkers prepared on pseudorotaxanes which consist of a large
molecular box, [TSMB]4+, and a 1,6-naphthalene dicarboxylate anion axle.

The

positively charged (+4) wheel interacts with the negatively charged (–2) axle to form a
(+2) charged pseudorotaxane (Figure 1.17).

Figure 1.17: The [2]pseudorotaxane used by Sessler’s group to build 1D MORFs.

The addition of triethyl amine to a mixture of AgNO3 (or AgPF6), [TSMB][PF6]4 and the
acid form of NDC in a 1:1:1 mixture of dimethylformamide, acetonitrile and water
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forms a precipitate. Slow evaporation of the filtrate yields a 1D MORF, MORF–14. The
crystal structure of MORF–14 shows that each Ag(I) ion is coordinated by two
carboxylate groups, one from a [2]pseudorotaxane linker and one from a naked axle, in a
linear monodentate fashion (Figure 1.18). Naked axles and [2]pseudorotaxanes are
arranged in an alternative manner in the consecutive layers which facilitates strong
donor–acceptor–donor interactions between axles and wheels of neighboring chains.
Naked [NDC]2– molecules in the MORF–14 crystal structure balance the charge.53

Figure 1.18: Crystal structure (wire frame representation) of 1D MORF, MORF–14,
reported by Sessler’s group. Solvent molecules, hydrogens and counter ions are omitted
for clarity. Color code: C, black; O, red; Ag(I), golden yellow; [TSMB]4+, light green.

1.1.3.3. 2D MORFs
Binding of [2]pseudorotaxane linkers to more than two coordination sites on the same
metal ion in a trigonal planar or square planar geometry yields extended 2D MORFs. The
reported 2D MORFs have hexagonal or square shaped cavities.
Kimoon Kim and his coworkers have reported the first 2D MORF in 1997. Layering a
solution of AgNO3 in methanol with an aqueous solution of [P1][NO3]2
[2]pseudorotaxanes yields a 2D MORF, MORF-15, which contains large edge-sharing
chair-shaped hexagons (Figure 1.19a). Each corner of the lattice consist of a Ag(I) ion
with a distorted tetrahedral geometry. Three coordination sites of the Ag(I) ion are
coordinated by terminal pyridyl groups of P1 [2]pseudorotaxane linkers, while the
18

remaining site is coordinated by a nitrate ion. The void space of the hexagons are filled
with an interpenetrated 2D hexagonal shaped MORF, in an almost perpendicular
geometry.47
The [P2][NO3]2 [2]pseudorotaxanes react with AgCF3SO3 to form a 2D square grid,
MORF-16 (Figure 1.19b). Similarly, the reaction between Cu(NO3)2 and [P2][NO3]2
[2]pseudorotaxanes produces a 2D square grid, MORF-17. The Ag(I) ions in MORF-16
have distorted tetrahedral geometry with all their coordination sites occupied by the P2
[2]pseudorotaxane linkers. In contrast, the Cu(II) ion centers of MORF-17 have distorted
square pyramidal geometry with four sites coordinated by P2 [2]pseudorotaxanes and one
site coordinated by a water molecule.18

a)

b)

Figure 1.19: Crystal structures (space filling representation) of 2D MORFs reported by
Kim’s group. a) hexagonal shaped MORF-15 and b) square grid shaped MORF-16.
Solvent molecules, hydrogens and counter ions are omitted for clarity. Color code: O,
red; N, light purple; C, grey; Ag(I), green. Reproduced with permission from reference
18. Copyright 2002 John Wiley and Sons, Inc.

Since coordinating solvents such as water and acetonitrile coordinate to the metal ion
centers of 1D MORF-9 and MORF-10, Loeb et. al. used non-coordinating solvents
(nitromethane), anhydrous metal salts and high concentration of [2]pseudorotaxane to
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obtain MORFs with higher dimensionality. The 2D non-interpenetrated iso-structural
square grid shaped MORF-18, MORF-19 and MORF-20 were synthesized by diffusing
isopropyl ether into a 2:4:1 mixture of [A1][BF4]2 axle, DB24C8 and [M(H2O)6][BF4]
(M = Cu(II), Cd(II), Ni(II)), respectively in nitromethane (Figure 1.20a). Each metal ion
center shows octahedral coordination geometry with four square planar sites occupied by
four P1 [2]pseudorotaxane linkers, while the remaining coordination sites are occupied
by one water molecule and one BF4¯ anion (Figure 1.20a).44,49
a)

c)

b)

Figure 1:20: Crystal structures (wire frame representation) of 2D MORFs reported by
Loeb’s group. a) MORF-19; b) MORF-21; c) MORF-22. Solvent molecules and
counter ions are omitted for clarity. Color code: O, red; N, blue; C, black; Cd(II), orange;
crown ethers, red. Reproduced with permission of the RSC from reference 45.
Later on, Loeb’s group studied the effect of changing the axle or wheel on the MORFs’
synthesis and their dimensionality. The N-oxide analogue of A1 axle (1,2-bis(4,4′dipyridinium N-monoxide) ethane - A7) was used in MORF-21 instead of A1, while the
tetra-p-anisyl derivative of DB24C8 (TPDB24C8) wheel was used in MORF-22 instead
of DB24C8 under the same crystal growing conditions (Figure 1.21). In both cases, P8 or
P9 [2]pseudorotaxane linkers are connected via Cd(II) ion nodes in a trans geomtry to
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form 1D strands. The 1D strands are connected to each other via naked axles to produce a
2D square grid (Figure 1.20b and c).44,54

Figure 1.21. The various [2]pseudorotaxanes used by Loeb’s group for the construction
of 2D MORFs.
So far, these 2D MORFs reported by Loeb’s groups contain (+2) positively charged
[2]pseudorotaxanes (P4, P8 or P9). In an attempt to eliminate counter ions from the
MORFs’ structure, an interesting square grid shaped non-interpenetrated 2D MORF,
MORF-23 was obtained. It consists of negatively charged P6 [2]pseudorotaxanes and
Zn(II) ion nodes. After standing for 5 days at room temperature, a 2:1 mixture of P6
[2]pseudorotaxane and Zn(NO3)2·(H2O)6 in methanol yields a neutral 2D MORF,
MORF-23. The crystal structure of MORF-23 shows that four P6 [2]pseudorotaxanes
are coordinated to the Zn(II) ion in a square planar arrangement (Figure 1.22a). The
remaining two sites of the octahedral coordination sphere of Zn(II) ion are occupied by
two water molecules. Since DSDB24C8 is positioned in the same direction along the axle
within the same layer, each layer of the square grid is enantiomerically pure. The
DSDB24C8 wheels in the neighboring layers have an opposite chirality. The neighboring

21

layers form hydrogen bonds between the axial water molecules on the Zn(II) ions and the
SO3¯ groups of the DSDB24C8 crown ether to yield a racemic solid (Figure 1.22b).52

b)

a)

Figure 1.22: Crystal structure (wire frame representation) of a neutral 2D MORF
reported by Loeb’s group: a) square grids of MORF-23; b) side view showing hydrogen
bonding between two layers of MORF-23. Solvent molecules and hydrogens are omitted
for clarity. Color code: O, red; N, blue; C, black; S, yellow; Zn(II), silver; crown ethers,
red. Reproduced with the permission of the RSC from reference 45.

1.1.3.4. 3D MORFs
The coordination of [2]pseudorotaxane linkers to metal ions with tetrahedral, trigonal
bipyramidal, octahedral or square antiprismatic coordination geometry yields 3D
MORFs.
Kimoon Kim and coworkers have employed three strategies to obtain 3D MORFs.
Lanthanide metal ion nodes were used instead of transition metal ions since they have
larger ionic radii and higher coordination number compared to the transition metal ions.
[2]Pseudorotaxanes with terminal nitrile functional groups were used. The reactions were
carried out under hydrothermal conditions, because the nitrile groups are easily converted
into carboxylate groups under those conditions, which then react with Tb(III) ions to
22

produce 3D MORFs (Figure 1.23).

By employing the above mentioned strategies,

Kimoon Kim’s reported 3D MORFs in 2000.17,55

Figure 1.23: Various pseudorotaxanes used by Kim’s group for 3D MORFs construction.

A reaction of an aqueous mixture of [P10][NO3]2 [2]pseudorotaxanes, Tb(NO3)2·5H2O
and triethyl amine in a sealed container at 150 °C for three days, produces a 3D MORF,
MORF-24. The building block of the MORF-24 consists of a binuclear Tb(III) center
and six P12 [2]pseudorotaxane units. The crystal structure of MORF-24 shows that
the 3-phenylcarboxylate terminal functional groups of [2]pseudorotaxanes function both
as bridging ligand and chelating ligand. Each Tb(III) ion center shows distorted square
antiprismatic

coordination

geometry

with

coordination

by

four

bridging

[2]pseudorotaxanes, one chelating [2]pseudorotaxane and two water molecules (Figure
1.24).
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Figure 1.24: Crystal structure of 3D MORF-23, reported by Kim’s group. Solvent
molecules, hydrogens and counter ions are omitted for clarity. Color code: A10 axles
along the a, b and c axis in red, light blue and light purple, respectively. CB(6), white;
Tb(III), yellow. Reproduced with permission from reference 54. Copyright 2002 John
Wiley and Sons, Inc.

Stephen J. Loeb and coworkers’ attempt to obtain 3D MORFs with first row transition
metal ion nodes and P4 [2]pseudorotaxane linkers were unsuccessful due to the steric
hindrance arising from coordinating six bulky [2]pseudorotaxanes around one transition
metal ion node. To overcome this problem, they used [P8]2+ [2]pseudorotaxane which
has a longer axle (A7) than A1. In addition, lanthanide metal ions were employed, since
they are more oxophilic and prefer higher coordination numbers. The lanthanide ions are
hard acids while oxide groups are hard bases which drives the metal-ligand binding. A
mixture of 3:9:1 axle/wheel/lanthanide ion [M(OTf)3] (M = Sm(III) (MORF-25), Eu(III)
(MORF-26), Gd(III) (MORF-27), Tb(III) (MORF-28)) in acetonitrile yields
isomorphous series of interpenetrated 3D MORFs at room temperature (Figure 1.25a).
All lanthanide(III) ion nodes show distorted square antiprismatic coordination geometry.
Six out of eight coordination sites are occupied by P8 [2]pseudorotaxane linkers, while
the remaining sites are coordinated by one water molecule and one triflate anion.56
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a)

b)

c)

d)

Figure 1.25: Crystal structures (wire frame representation) of 3D MORFs reported by
Loeb’s group. a) MORF-25; b) MORF-29; c) square grid of MORF-30; d) side view of
MORF-30 showing pillaring between two layers. Solvent molecules, hydrogens and
counter ions are omitted for clarity. Color code: O, red; N, blue; C, black; S, yellow;
Zn(II), silver; Sm(III), lime green; Y(III), golden yellow; crown ethers, red. Reproduced
with the permission of the RSC from reference 45.

The second row transition metal ion, Y(III), which has slightly smaller radius than
lanthanides, produces a slightly different 3D MORF, MORF-29, at room temperature.
Slow diffusion of a solution of Yb(OTf)3 in acetonitrile into a solution of [P8][OTf]3
[2]pseudorotaxane in acetonitrile produces MORF-29. The coordination geometry
around the Y(III) is pentagonal bipyramidal. All equatorial sites are coordinated by five
P8 [2]pseudorotaxane linkers, while the axial sites coordinated by one [2]pseudorotaxane
linker and a triflate anion. The equatorial [2]pseudorotaxanes form an alternating
triangle- and square- shaped 2D network, while the axial [2]pseudorotaxanes act as
connectors to yield a 3D structure (Figure 1.25b). The square-shaped-cavities show
interpenetration, while the triangle shaped cavities do not, due to steric hindrance.56

Loeb and coworkers also obtained a 3D MORF, MORF-30, during the synthesis of
MORF-23. Similarly to MORF-23, MORF-30 consists of 2D square grids that contain
Zn(II) ions and P6 [2]pseudorotaxanes (Figure 1.25c). In contrast to MORF-23, in
MORF-30 the 2D layers are pillared by robust [Zn(CH3OH)2(H2O)2(SO4)2] instead of
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forming hydrogen bonding with water molecules (Figure 1.25d). As a result, the distance
between two layers in MORF-30 is larger than in MORF-23. Each layer of MORF-30 is
a racemic mixture, while MORF-23 has alternating enantiomeric layers.52
A groundbreaking 3D MORF with dynamic interlocked components was reported by
Loeb’s group in 2012. They used a compact and rigid [2]rotaxane linker instead of a
[2]pseudorotaxane as building block in the construction of 3D MORFs. The [2]rotaxane
unit consists of a 24-crown-6 [24C6] wheel, a benzyl aniline recognition site on the
crossbar and 3,5-benzene-dicarboxylic groups at the two ends of the axle, which function
as bulky stoppers as well as coordinating groups (Figure 1.26a). After heating, a 2:1
mixture of Cu(NO3)2·3H2O and R1 in a 3:2:2 mixture of DMF, EtOH and H2O with two
drops of HNO3 at 65 oC over 48 h, followed by slow cooling to room temperature
produces a 3D MORF, MORF-31 (Figure 1.26b), with a rare -phase NbO topology.
Each Cu(II) ion in MORF-31 forms a paddle-wheel structure. Upon binding to the Cu(II)
ion, the rotaxane building block (R1) are assembled into large polyhedra (Figure 1.26c).36
a)

b)

c)

Figure 1.26: a) Schematics of the [2]rotaxane used by Loeb’s group to synthesize 3D
MORFs with dynamic interlocked components; b) crystal structure of MORF-31; c)
polyhedron comprised of six paddle-wheel units and 24C6 wheels. Solvent molecules
omitted for the clarity. Color code: axle, blue; wheel, red; Cu(II), green. Reproduced with
permission from reference 36. Copyright 2012 Nature Publishing Group.
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In 2011, Jonathan L. Sessler and coworkers reported a 3D MORF, MORF-32. X-ray
quality crystals of MORF-32 were obtained from a mixture of P7 [2]pseudorotaxane,
Zn(NO3)2.(H2O)6 and triethylamine in a 1:1 mixture of diethylformamide (DEF) and
water. The crystal structure of MORF-32 shows each Zn(II) center coordinated by three
naked axles and one P7 [2]pseudorotaxane linker in a tetrahedral geometry, which form
an interpenetrated bicyclic adamantine-type network (Figure 1.27).57

Figure 1.27: Crystal structure of MORF–32, an adamantane type 3D MORF reported by
Sessler’s group. Solvent molecules and hydrogen atoms are omitted for clarity. Color
code: [TSMB]4+, blue; [NDC]¯, black; carboxylate O, red; Zn(II), silver. Reproduced
with the permission of the RSC from reference 45.

P14 [2]pseudorotaxanes (Figure 1.28) and lanthanide cations, Nd(III), Eu(III), Sm(III), or
Tb(III), yield luminescent 3DMORFs, MORF-33, MORF-34, MORF-35 and MORF36, respectively. These four different MORFs were obtained by slow diffusion of layered
solutions at room temperature. An aqueous solution of two equivalents of the nitrate salt
of the metal (M(NO3)2; M = Nd(III), Sm(III), Eu(III), or Tb(III)) was layered with a 1:1
mixture of DMF and water. The resulting solution was further layered with a 1:5:10
mixture of the [TSMB]4+ wheel, terephthalic acid and tetramethyl ammonium hydroxide
pentahydrate (Me4NOH·5H2O) in a 1:1 mixture of DMF and water.58

27

Figure 1.28: The [2]pseudorotaxane used by Sesslers’ group to construct 3D MORFs.

In MORF-33 to MORF-36, lanthanide(III) ions were found in two different coordination
environments. The coordination number of the Nb(III) ions in both environments is nine,
while the one of the Eu(III) ions is eight and nine.

Isostructural MORF-35 and

MORF-36 show two different types of Sm(III) and Tb(III) ions with the same
coordination number, eight. The monomeric unit of MORF-33 to MORF-36 is
comprised of two P14 [2]pseudorotaxane linkers, seven terephthalate anions and four
lanthanide(III) metal ions (Figure 29a). The carboxylate groups at the two ends of the
P14 [2]pseudorotaxanes are either chelated in a bidentate fashion or coordinated in a
monodentate fashion to lanthanide(III) nodes. In the crystal structures of MORF-33 to
MORF-36, terephthalate anions bridge the 1D monomeric units to form extended 2D
networks. The 2D networks are further connected via the oxygen atoms of the
terephthalate dianions to form a 3D network (Figure 1.29).58
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a)

b)

c)

d)

Figure 1.29: Crystal structures of 3DMORFs reported by Sessler’s group. a) the
monomeric unit of MORF-33; b) 3D structure of MORF-33; c) the monomeric unit of
MORF-35; d) 3D structure of MORF-35. Solvent molecules, hydrogens and counter
ions omitted for clarity. Color code: [TSMB]4+, yellow; [BDC]2¯, purple; blue, black
and green, O, red. Reproduced with the permission of the RSC from reference 58.

J. Fraser Stoddart, Jean-Pierre Sauvage and Omar M. Yaghi and coworkers reported the
incorporation of copper-coordinated pseudorotaxane linkers P15 into MOFs to obtain 3D
MORFs (Figure 1.30).59

Figure 1.30: Schematics of copper coordinated [P15]2+ [2]pseudorotaxane linker.
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A solution of [P13][PF6]2 and Zn(NO3)2·6H2O in diethylformamide (DEF) in a sealed
vessel

in an isothermal oven at 100 °C over 48 h followed by cooling to room

temperature yielded a 3D MORF, MORF-37. The crystal structure of MORF-37 shows
that each corner of the 3D MORF consists of the secondary building unit Zn 4O. Each
Zn(II) ion is coordinated by the terminal carboxylate group of the axle to form a 3D
structure (Figure 1.31).59

Figure 1.31: Crystal structure of copper complex rotaxane incorporated 3D MORF,
MORF-37. Solvent molecules and hydrogens omitted for clarity. Color code: O, red; N,
blue; C, black; Zn(II), grey; Cu(II), yellow, W1, lime green. Reproduced with the
permission of the RSC from reference 45.

1.1.4. Molecularly woven materials (MWMs)
Molecularly woven materials are organic polymers which consist of polymeric
interwoven molecular strands. Even though a number of interwoven structures have been
reported in the literature, they cannot be considered as actual MWMs since their organic
molecular strands are interconnected via metal-metal bonds or coordinative bonds or
other weak intermolecular interactions instead of covalent bonds.
Daryle H. Busch and Timothy J. Hubin have reported a ‘tile’ approach60,61 for the
synthesis of interwoven polymers, which is somewhat similar to our approach. Since four

30

ditopic ligand and four metal ion containing coordination complexes show an irreversibly
interlocked cross-over interwoven pattern,62,63 they are promising building blocks for the
synthesis of molecularly woven materials. Hubin’s and Busch’s ‘tile’ approach consists
of polymerization of building blocks (metal complex) via metal-ligand coordination
(Figure 1.32) or covalent bond formation to obtain the truly interlocked, ‘infinite’ size
molecularly interwoven material.

Ditopic ligands

Metal ion

Polymerization

Metal complex with
irreversibly interlocked
cross-over interwoven pattern

Interlocked infinite sized molecularly
interwoven material

Figure 1.32: Schematics of the ‘tile’ approach to molecularly interwoven polymers.

MWMs comprised of individual molecular strands that consist of metal-free, covalent
organic skeletons are expected to have a high strength and light weight. In addition,
demetallated cross-over interwoven strands are also expected to possess high flexibility.
MWMs could be utilized where there is a need for more durable materials for objects
subjected to heavy use, such as medical implants, stronger materials for airplane and
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automobile construction, improved body-armor or armored vehicles, longer lasting
bridges and roads, more resistant buildings in areas with frequent earthquakes.

1.1.5. Applications of MIMs
Since MIMs such as rotaxanes and catenanes can be used in artificial molecular machines
(AMMs) due to their precisely controllable motion at the molecular level, a number of
research groups studied the synthesis of MIMs as well as the fabrication of nano scale
devices/AMMs from MIMs over the last two decades. The reported nano-scale devices
have a number of applications in various fields including molecular electronics-based
random access memories, drug delivery methodologies, light harvesting devices and
molecular switches.
As discussed in section 1.1.1.1., bistable rotaxanes and catenanes have more than one
stable co-conformation, which can be accessed in a reversible manner by applying
external stimuli (chemical, photochemical or electrochemical). Most of the early research
on MIMs and AMMs was carried out in solution, where molecules move randomly. Later
on, several research groups explored a number of methods to obtain highly organized
MIMs on solid surfaces and to fabricate AMMs.
A few representative examples of applications of MIMs are explained in this section.
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1.1.5.1. Molecular electronics64,65
One of the very interesting examples of molecular electronics reported by Stoddart,
Heath and coworkers is a crossed bar memory circuit based on a bistable [2]rotaxane.
d)
a)

b)

c)

Figure 1.33: Scanning electron microscopy images of a) entire crossed bar memory
circuit; b) cross-point of top- (red) and bottom- (yellow) nanowire electrodes; c)
approximately 2500 junctions of crossed bar memory; d) the bistable [2]rotaxane used for
the fabrication of crossbar memory.64 Reproduced with permission from reference 64.
Copyright 2007 Nature Publishing Group.
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The molecular memory circuit was fabricated in such a way that a monolayer of bistable
[2]rotaxanes is sandwiched between the Ti top nano–wire electrode and the Si bottom
nano–wire electrode. Each bit of the crossed bar memory consists of Ti top wire, Si
bottom wire and approximately 100 bistable [2]rotaxane units (Figure 1.33a–c).64
The bistable [2]rotaxane consists of two recognition sites – tetrathiafulvalene (TTF green site) and dioxynapthalene site (DNP - red site) – for the tetracationic [CBPQT]4+
wheel (Figure 1.33d). In the fabricated device, the hydrophilic stopper (light blue) is in
contact with the Si bottom nano-wire, while the hydrophobic stopper (black) is in contact
with the Ti top nano-wire. In the ground state co-conformation the wheel molecules are
located on the TTF recognition site, which corresponds to the low conductance or ‘0’ coconformation. Upon oxidation of the TTF site to TTF1+ or TTF2+, the [CBPQT]4+ wheel
moves to the DNP site to form a meta-stable co-conformation, which corresponds to the
high-conductance or ‘1’ co-conformation. The reduction of TTF1+ back to the TTF0
allows the bistable [2]rotaxanes to return to the ground state co-conformation, which has
a half-life of about an hour.64
The bistability and the switching mechanism of the bistable [2]rotaxanes were studied by
determining the thermodynamic and kinetic parameters of the fabricated crossed bar
memory.64

1.1.5.2. Nano-scale drug delivery vehicles66–68
MIMs-based nano-scale drug delivery vehicles attracted considerable attention over the
last decade due to their promising potential of precise delivery of drugs and controlled
release. J. Fraser Stoddart, Jeffery I. Zink and coworkers explored the biomedical
applications of bistable rotaxane-coated mechanized silica nano-particles (MSNP) as
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nano-scale drug delivery vehicles. Most of the MIM-based drug delivery vehicles
reported so far consist of three main units: 1) a solid support, b) a payload of cargo (or
the therapeutics), and c) the molecular machinery (MIMs) (Figure 1.34a). Since in vivo
studies of MSNPs demonstrate a lack of cytotoxicity and a great extent of
biocompatibility, MSNPs have been used as a solid support for the MIMs. MSNPs are
uniform spheres ~ 100 nm in size, which have highly ordered pores with approximately
diameter of 2 nm. Typically, cargo molecules with easily detectable properties, such as
fluorescence, have been used, since the release of cargo molecules from nano-particles
can be easily detected. A monolayer of MIMs on the MSNPs is responsible for the
controlled delivery of the therapeutic molecules. One of the representative examples of
MIMs-based drug delivery methodologies and its mechanism are shown below.
a)

b)

Figure 1.34: Schematics of a) the structural formula of the bistable [2]rotaxanes and the
monolayered MSNPs and b) proposed mechanism for loading and releasing cycle of
cargo molecules. The silica particles are not drawn to scale, and only a few of the
ordered pores are shown.68,69 Reproduced with the permission of the RSC from reference
68.
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Similarly to the earlier molecular electronics example, a bistable [2]rotaxane consisting
of an axle with two recognition sites (TTF and DNP) and the tetracationic [CBPQT]4+
wheel were used as a MIM in this case. The [CBPQT]4+ wheel shuttles between the two
sites depending on the redox stimuli. In the ground state co-conformation of the bistable
rotaxane, the [CBPQT]4+ wheel is located on the TTF recognition site, leaving openings
as cylindrical pores on the MSNPs. Cargo molecules are loaded by diffusion in this
conformation. Upon oxidation, the [CBPQT]4+ wheels move to the DNP recognition sites
and the openings close. The addition of ascorbic acid reduces the TTF sites and the
[CBPQT]4+ wheels move back to the original ground state co-conformation, allowing the
cargo molecules to be released. In this conformation, the cylindrical pore is ready for
recharging. This representative example demonstrated that the cylindrical pore of the
MSNP can be closed and opened in a reversible manner for controlled drug release
purposes (Figure 1.34b).

1.1.5.3. Light harvesting AMMs70
In 2005, Stoddart and coworkers reported a pseudorotaxane-based light harvesting
device, which mimics the photosynthetic energy transduction process. Basically, it
consists of a molecular triad and a [2]pseudorotaxane unit. The triad was designed to
contain three different functional units: a) an electron-donating TTF unit, b) a
chromophoric porphyrin unit, and c) an electron-accepting C60 unit. The disulphide
terminal group on the triad was anchored on the gold working electrode to make a self
assembled monolayer (SAM) of triads. The [2]pseudorotaxane unit consists of the -
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electron-rich 1,5-bis[(2-hydroxyethoxy)ethoxy]naphthalene (BHEEN) axle and the
electron deficient [CBPQT]4+ wheel (Figure 1.35).
By applying an external photochemical stimulus (413 nm laser light) to a SAM of a triad
on gold electrode, the porphyrin unit undergoes a photoinduced electron transfer (PET)
process, which transfers electrons to the electron-accepting C60 unit. This process is
followed by the charge shift (CS) from the TTF unit to the cationic radical phorphyrin
unit. The resulting charge on the TTF1+ unit is then neutralized by the Au electrode in the
closed circuit. Subsequently, the electron generated from this molecular level energy
supply dethreads the [2]pseudorotaxane by reducing the wheel to a radical form of
[CBPQT]∙/3+ before its electron is passed onto the Pt counter electrode. In the meantime,
[CBPQT]∙/3+ undergoes oxidation and forms pseudorotaxane while the electrons transfer
via the Pt electrode to complete the circuit.70

Figure 1.35: Schematic representation of a light harvesting molecular machine and its
mechanism. The electron transfer processes are indicated by arrows.70 Reproduced with
permission from reference 70. Copyright 2005 John Wiley and Sons, Inc.
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1.1.5.4. Molecular switches71
Huang, Stoddart and coworkers reported surface plasmon-based reversible molecular
motions in molecular machineries such as bistable rotaxanes on a gold nanodisk (Figure
1.36a). Surface-plasmon-based nanophotonics or ‘plasmonics’ can potentially be applied
in future generation nanophotonics integrated circuits. Similarly to the examples in
chapters 1.1.5.1 and 1.1.5.2, the bistable [2]rotaxanes used in the molecular switch
explained below consist of an axle with TTF and DNP recognition sites and the
[CBPQT]4+ wheel. The disulfide terminal group at one end of the axle is anchored to the
gold nanodisk surface (Figure 1.36b).

a)

b)

Figure 1.36: a) Schematics of bistable [2]rotaxane-based molecular switches and b) the
bistable[2]rotaxane used for the fabrication of the molecular machine. Reproduced with
permission from reference 71. Copyright 2009 American Chemical Society.
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In this example, the oxidation state of the monolayer of bistable [2]rotaxanes
immobilized onto the gold nanodisks’ surface reversibly controls the localized surface
plasmon resonance (LSPR) of the Au nanodisk. In the ground state co-conformation of
the [2]rotaxanes, the wheel components are located on the TTF recognition site. Upon
oxidation, the TTF station converts into TTF2+, which repels the [CBPQT]4+
electrostatically. As a result, the [CBPQT]4+ wheel moves to the DNP recognition site to
form a metastable co-conformation of bistable rotaxane. Upon reduction, the [CBPQT]4+
wheel returns back to the TTF recognition site.
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1.2. Objectives and goals
1.2.1. MORFs
Our long term goal is to construct MORFs and supramolecular architectures using
pseudorotaxanes as building blocks and develop functional devices/molecular machines
(Figure 1.37) based on the chemical and physical properties of the incorporated materials.

Figure 1.37: Schematics of a 3D MORF built from [2]pseudorotaxane building blocks.
The two recognition sites on the axle have different binding affinities for the wheel.
External stimuli can drive the motion of the wheel from one station to the other resulting
in different properties of the MORF.

In working towards the long term goal, we have set a number of short term goals:
1) Synthesize and characterize various axle- and wheel- components.
2) Synthesize and crystallize pseudorotaxanes with different combinations of axles
and wheels.
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3) Characterize pseudorotaxanes in solution using UV-Vis,

1

H-NMR and

electrochemistry as well as in the solid state, by single crystal X-ray diffraction,
and study their stability.
4) Construct and characterize metal-organic rotaxane architectures using rigid-linear
pseudorotaxanes as building blocks
Even though supramolecules such as rotaxanes and catenanes are very useful for the
fabrication of nano-scale functional devices, the large amount of information about their
dynamic behavior and the switching properties was obtained from solution studies. In
solution, the molecules show random motion and the output of the individual molecular
machines is averaged out resulting in no net work. Therefore, it is essential to arrange
them in a higher order form and interlock the components. Strategies such as deposition
on a surface,72

tethering between two electrodes,65,73 incorporation into an organic

polymers10,11 or dendrimers,74,75 and incorporation into crystalline lattices (MORFs)17,45
have been used. All these strategies produce materials with higher degrees of ordering,
which have individually addressable and controllable components. The most promising
strategy is the linking of pseudorotaxane units via metal ions to obtain crystalline lattices,
since the synthesis and characterization of MOFs is a thoroughly studied field. In
addition, MOFs are potential candidates for improved gas storage, sensing, catalysis,
chemical separation and drug delivery applications.43,76 Compared to MOFs, MORFs
have a number of interesting features: the volume of the wheel molecules is useful in
avoiding interpenetration of crystalline lattices and in forming cavities with larger
capacity; 2) the ability to change the position of the wheel molecules without affecting
the basic skeleton of the crystalline lattice provides structural flexibility and allows
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control over cavity properties and function; 3) the movement of the wheel along or
around the axle is useful in designing addressable and controllable devices.49
The binding geometry of previously used axle molecules is unpredictable due to their
non-linear and non-rigid nature. Therefore, we used [2]pseudorotaxanes with rigid linear
axle molecules, which were unprecedented when this project began (Figure 1.38). We
have chosen aromatic crown ethers, such as bis-p-phenyl-34-crown-10 (BPP34C10), bisnaphtho-38-crown-10 (BN38C10) and the novel crown ether, bis-naphtho-32-crown-8
(BN32C8) as wheel components, and N,N′-bis(4-pyridyl)-4,4′-bipyridinium nitrate
([PyBP][NO3]2) and N,N′-bis(4-carboxyphenyl)-4,4′-bipyridinium chloride ([CpBP]Cl2)
as axle components, since the [4,4′-bipyridinium/ aromatic crown ether] motif produces
colored CT complexes which facilitate the visual monitoring of pseudorotaxane
formation.

Figure 1.38: Proposed axles and wheels for the linear, rigid [2]pseudorotaxanes.
In addition to forming colored complexes, the 4,4′-bipyridinium moiety of the axle is also
able to form

non-covalent interactions, such as

π–π stacking, N+∙∙∙O electrostatic

interactions and C–H∙∙∙O hydrogen bonding with aromatic crown ethers, which contribute
to the stability of the resulting pseudorotaxanes. Pyridine or carboxylate groups at the two
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ends of the axles have the ability to form metal-ligand coordination bonds, which is an
essential element in building MORFs.
1.2.2. MWMs
The long term goal of this research project is to synthesize and characterize molecularly
woven materials which are expected to have high strength, light weight and high
flexibility.
The short term goal is to develop and optimize a synthetic methodology for the
preparation of appropriate ligands, and their helical metal complexes, which can then be
polymerized to yield MWMs.
To prepare a material which combines high strength, lightweight and flexibility, we
proposed to polymerize double stranded, dinuclear helical building blocks, as illustrated
in Figure 1.39.

Figure 1.39: Proposed scheme for MWM synthesis.
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Double stranded helicates are metal-ligand coordination complexes in which two strands
of organic ligand molecules are arranged in a helical geometry around templating metal
ions. Single,77,78 double,79–81 triple,82–85 quadruple86–88 stranded and circular89–91 helicates
have been reported in the literature. The most commonly used ligands for helicates
contain 2,2′-bipyridine, 1,10-phenanthroline, catechol, thiocatechol, 1,3-dicarbonyl, ohydroxy-carbonyl, 8-hydroxyquinoline and hydroxamate moieties. Transition metal ions,
such as Ti(II), Ni(II), Cu(II), Zn(II), Ag(I), Co(II), Pd(II), Cd(II) and lanthanides, such as
Eu(III), have been used in metal helicate synthesis.92–96
We have designed a new ligand L1 (Figure 1.40a), as starting material for the double
stranded, dinuclear helicates, which has geometrical features that allow only for
intermolecular and no intramolecular polymerization (Figure 1.40b). The 2,2′bipyridinium core was used, because it is expected to form a helical core based on the
literature.2,94 The phenyl groups attached to the 2,2′-bipyridinium core are expected to
provide rigidity to the ligand skeleton, orienting the terminal allyl groups away from the
helical core. The allyl groups are far enough from each other so that they cannot undergo
intramolecular alkene metathesis. The –CH2–CH2– spacer group is expected to facilitate
double stranded helicate formation based on the literature.2,94
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a)

b)

Figure 1.40: Schematics of a) ligand L1, and b) the expected double stranded, dinuclear,
helical metal complex of L1.

The alkene metathesis reaction is a transition metal catalyzed organic reaction which
involves cleavage of two carbon-carbon double bonds and formation of a new carboncarbon double bond. Both Grubbs’ and Schrock’s catalyst can be used as the transition
metal catalyst for the alkene metathesis reaction.
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CHAPTER 2

EXPERIMENTAL
2.1. General procedures and instrumentation
General procedures: All commercially available chemicals were used as received.
Acetone and THF were dried using CaSO4 and sodium, respectively, and distilled under
N2 and stored over 4Å molecular sieves before use. Toluene was degassed by purging N2
over 20 min. DMF was dried using 3Å molecular sieves and vacuum distilled before use.
Thin layer chromatography (TLC) was performed on Sigma–Aldrich silica gel plates and
viewed under UV light (256 nm and/or 354 nm wavelengths) or an iodine bath. Column
chromatography was performed using flash silica gel from Dynamic Adsorbents.
Tri(ethylene glycol) ditosylate,97 tetra(ethylene glycol) ditosylate,97 bis-p-phenylene-34crown-10 (BPP34C10),98,99 bis-naphtho-38-crown-10 (BN38C10),100 bis-naphtho-32crown-8 (BN32C8),101 tetrabutylammonium bis-paraphenylene-34-crown-10-12,152disulfonate

([TBA]2DSBPP34C10),7

dichloride

([DNPBP]Cl2),102

N,N′-bis(2,4-dinitrophenyl)-4,4′-bipyridinium

[PyBP][NO3]2,103

[CpBP]Cl2,104

N,N′-bis[(4-

carboethoxy)propyl]-4,4′-bipyridinium hexafluorophosphate ([C4BP][PF6]2),105 S-4bromobutyl ethanethioate,106 tributyl dimethyl silyloxy (TBDMS) 4-bromophenol (2),107
2-tributyltin-6-methyl pyridine (5),108 6-bromo-6′-methyl-2,2′-bipyridine (7),109 2(methoxyphenyl)-1,10-phenanthroline (14),110–112 3-(4-pyridyl)pentane-2,4-dione,113,114
bis[3-(4-pyridyl)pentane-2,4-dionato] copper (II) (Cu(Pyacac)2),115
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and bis(3-phenyl

pentane-2,4-dionato) copper (II) (Cu(Phacac)2)116 were synthesized according to
modified literature procedures.
General Instrumentation: Melting points were measured using Mel–Temp II laboratory
devices. UV–Vis spectra were obtained on a Shimadzu UV 2101 PC spectrophotometer.
1

H–NMR and

13

C–NMR spectra were recorded on a Jeol JNM-ECP400 instrument

operating at 400 MHz at room temperature using deuterated solvents. Mass spectra were
recorded using a Waters–Synapse mass spectrometer using LC–MS grade solvents.
Electrochemistry measurements were performed using a Bioanalytical Systems (BAS)
CV–50W electrochemical workstation. X–ray diffraction data were collected on a Bruker
SMART APEX II diffractometer using graphite-monochromated Mo-K (= 0.71073
Å) radiation at 100 K.

2.2. Synthesis
2.2.1. Starting materials and ligands
2.2.1.1. BPP34C10: A solution of 1,4-dihydroxynaphthalene (20.92 g, 0.19 mol) in dry
acetone (500 mL) was added to a refluxing suspension of K2CO3 (89 g, 0.64 mol) in dry
acetone (250 mL). Tetraethylene glycol ditosylate (82.94 g, 0.165 mol) in dry acetone
(750 ml) was added and the resulted mixture was refluxed 5 days under N2. The mixture
was cooled to room temperature, filtered, and evaporated to dryness under reduced
pressure. The dark brown color viscous liquid (53.5 g) was purified using column
chromatography (column height-45 cm, diameter-10 cm) over 1887 g (a mixture of 70–
230 mesh 60 Å – 1675 g and 70–270 mesh 60 Å – 212 g) of silica gel using
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Et2O:CHCl3:CH3OH – 68:30:2 (9L) and Et2O:CHCl3:CH3OH – 68:30:2.5 (8L) as an
eluting solution. 620 fractions were collected into 20 ml test tubes.
Fractions number 341-531 were collected and evaporated under reduced pressure. The
resulting light pinkish orange powder was washed with Et2O (50 mL x 3) to obtain a
white solid (4.83 g, 10.9 %). The combined Et2O filtrate was evaporated under reduced
pressure and washed with Et2O to recover another crop of pure BPP34C10 (0.370 g, 0.97
%).
Fractions number 251–340 (which contained unreacted tetraethylene glycol ditosylate
and crown ether) and 532-591 (which contained crown ether and byproduct) were
combined and evaporated under reduced pressure. The resulting light brown colored
solid (1.1445 g) was purified by column chromatography over 20 g of silica gel (70–270
mesh 60 Å). 18 x 6 mL fractions were collected. Fractions number 6-15 were combined
and evaporated and washed with Et2O to obtain a third crop of pure BPP34C10 (1.1250
g, 2.54 %). Rf = 0.21 (Et2O:CHCl3:CH3OH – 68:30:2 ); m.p. 94-95 ºC. (Lit. 93-94 ºC)
1

H NMR (400 MHz, CDCl3); = 6.75 (s, 8H), 3.98 (t, 8H, J = 4.7 Hz), 3.83 (t, 8H, J =

4.7 Hz), 3.70 (m, 16H).

C-NMR (D2O, 400 MHz):  (ppm) = 153.16, 115.60, 70.95,

13

70.82, 69.88, 68.23. max (CH3OH:CHCl3 = 1:1) = 290 nm.

Scheme 2.1: Synthesis of bis-p-phenylene-34-crown-10 (BPP34C10).
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2.2.1.2. BN32C8
The synthetic procedure of BN32C8 was originally published in New J. Chem. 2010, 34,
2097–2100101 and reproduced by permission of The RSC on behalf of the Centre
National de la Recherche Scientifique (CNRS) and the RSC.
Step1 - 1,5-Bis[10-(p-toluenesulfonyl)-1,4,7,10-tetraoxadecyl]naphthalene: A solution of
1,5-dihydroxynaphthalene (9.20 g, 58 mmol) and triethylene glycol ditosylate (132.06 g,
288 mmol) in dry acetone (1.5 L) were added under N2 to a refluxing suspension of
K2CO3 (250 g, 1.8 mol) in dry acetone (1.5 L) over 2 h. After 6 days of refluxing, the
mixture was cooled to room temperature, filtered, and evaporated to dryness under
reduced pressure. The dark brown colored viscous liquid (129.6 g) was purified by
column chromatography (height-1.5’, diameter- 4”) over 1850 g of flash silica using 6:1
(6 L), 3:1 (4 L), 2:1(1.8 L) and 1:2 (20L) mixtures of hexane:EtOAc as eluent.
Fractions containing both unreacted triethylene glycol ditosylate and the product were
collected and evaporated using a rotary evaporator to obtain a brown-red viscous liquid
(57.7 g). It was purified by column chromatography (height-1.5’, diameter- 4”) over
1775 g of flash silica using 3:2 (23.5 L) and 1:1 (22.5 L) mixtures of hexane:EtOAc as
eluent.

1,5-Bis[10-(p-toluenesulfonyl)-1,4,7,10-tetraoxadecyl]naphthalene

containing

fractions were collected and evaporated under reduced pressure to obtain the pure product
(21.4 g, 50.3 %). Rf = 0.44 (EtOAc:Hexane – 3:2 );

1

H-NMR (400 MHz, CDCl3); =

7.84 (d, J = 8.40 Hz, 2H), 7.78 (d, J = 8.40 Hz, 4H), 7.33 (t, J = 8.40 Hz, 2H), 7.30 (d, J =
8.40 Hz, 4H), 6.83 (d, J= 7.70 Hz, 2H), 4.27 (t, J = 4.4 Hz, 4H), 4.14 (t, J = 4.76 Hz, 4H),
3.95 (t, J= 4.4 Hz, 4H), 3.71 (m, 8H), 3.62 (t, J = 4.4 Hz, 4H), 2.39 (s, 6H).
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Scheme 2.2: First step of BN32C10 synthesis: 1,5-Bis[10-(p-toluenesulfonyl)-1,4,7,10tetraoxadecyl]naphthalene.

Step 2 - BN32C8: A solution of 1,5-dihydroxynaphthalene (4.67 g, 29.2 mmol) and 1,5bis[p-toluenesulfonyl)-1,4,7,10-tetraoxadecyl]naphthalene (21.4 g, 29.2 mmol) in dry
acetone (1.0 L) was added under N2 to a refluxing suspension of K2CO3 (150 g, 1.08 mol)
in dry acetone (3 L) over 3 h.
The mixture was refluxed for 5 days under N2, cooled to room temperature, filtered, and
evaporated to dryness under reduced pressure. The dark brown colored viscous liquid
(26.9 g) was purified by column chromatography (height-1.5’, diameter- 4”) over 1850 g
of flash silica gel using a 1:1 (12 L) mixture of hexane:EtOAc as eluent. Fractions
containing only crown ether were collected and evaporated using a rotary evaporator. It
was treated with Et2O (150 mL) and filtered to obtain a yellowish brown product (2.1 g)
which was dissolved in CHCl3 (50 mL) and a maroon-brown solid was removed by
filtration. The filtrate was concentrated under N2 flow and Et2O (250 mL) was added. It
was kept in a refrigerator at –4 ˚C for a slow precipitation overnight. The precipitate was
filtered and dried to obtain pure BN32C8 (1.88 g, 11.7 %).
Fractions

containing

unreacted

1,5-bis[(p-toluenesulfonyl)-1,4,7,10-tetraoxadecyl]

naphthalene and the product were combined and evaporated under reduced pressure and
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treated with a 1:1 (150 mL) mixture of hexane:EtOAc and filtered. The residue was
dissolved in CHCl3 (100 mL). The maroon-brown solid was filtered out and the filtrate
was evaporated to 3/4 of the initial volume under N2 flow. Et2O (250 mL) was added to
the concentrated filtrate and kept it in a refrigerator at –4 ˚C overnight for slow
precipitation. The precipitate was filtered and a white colored BN32C8 (2.1 g, 13.1 %)
was obtained as a second crop. Rf = 0.60 (EtOAc:Hexane – 2:1); m.p. 163-164 °C. 1HNMR (400 MHz, CDCl3); = 7.60 (d, J = 8.44 Hz, 4H), 6.96(t, J = 8.44 Hz, 4H), 6.53(d,
J = 7.32 Hz, 4H), 4.12(t, J = 4.4 Hz, 8H), 3.92 (t, J = 4.4 Hz, 8H), 3.80(s, 8H).

13

C NMR

(400 MHz, CDCl3); = 154.11 (4C), 126.68 (4C), 124.84 (4C), 114.45 (4C), 105.75
(4C), 71.30 (4C), 69.89 (4C), 67.94 (4C). max (CH3OH:CHCl3 – 1:1) = 298 nm.

Scheme 2.3: Synthesis of BN32C8 (second step).
2.2.1.3. syn-DSBPP34C10 and anti-DSBPP34C10
Maroon-red colored crystals of [PyBP/syn-DSBPP34C10] and orange colored crystals of
[PyBP/anti-DSBPP34C10] were grown as explained in Section 2.2.2.11 and they were
separated manually.

The following procedure was carried out for both [PyBP/syn-

DSBPP34C10] and [PyBP/anti-DSBPP34C10] pseudorotaxane crystals separately to
isolate two isomers, syn- and anti-DSBPP34C10.
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Crystals were dissolved in H2O (4.0 mL) and treated with 65% aqueous HPF6. The white
precipitate ([PyBP][PF6]2) was filtered, washed with water (~1.50 mL) and the filtrate
was evaporated to dryness to obtain pure syn- or anti-DSBPP34C10 as a sticky colorless
solid.
In the case of [PyBP/syn-DSBPP34C10] crystals, 7.0 mg of crystals (0.007 mmol) was
treated with 20 L (0.14 mmol) of HPF6 solution to obtain syn-DSBPP34C10 (4.2 mg, 88
%). 1H-NMR (D2O, 400 MHz):  (ppm) = 7.04 (d, J = 2.56 Hz, 2H), 6.72 (m, 4H), 4.01
(t, J = 4.4 Hz, 4H), 3.95 (t, J = 4.2 Hz, 4H), 3.79 (t, 8H), 3.66 (s, 16H).
In the case of [PyBP/anti-DSBPP34C10] crystals, 8.0 mg of crystals (0.008 mmol) was
treated with 23 L (0.16 mmol) of HPF6 solution to obtain anti-DSBPP34C10 (6.4 mg,
88 %). 1H-NMR (MeOD, 400 MHz):  (ppm) = 7.43 (d, J = 2.92 Hz, 2H), 7.01 (d, J =
8.8 Hz, 2H), 6.88 (dd, J = 3.10 Hz, J = 9.00 Hz, 2H), 4.16 (t, J = 5.08 Hz, 4H), 3.99 (t, J =
4.58 Hz, 4H), 3.86 (t, J = 4.96, 4H), 3.80 ( t, J = 4.4 Hz, 4H), 3.71 (t, J = 3.3 Hz, 4H),
3.65 (s, 12H).
2.2.1.4. N,N′-bis(4-carboxyphenyl)-4,4′-bipyridinium chloride ([CpBP]Cl2): An aqueous
solution (15.40 mL) of 1,1′-bis(2,4-dinitrophenyl)-4,4′-bipyridinium chloride (2.15 g,
3.83 mmol) was added dropwise over 25 min to a refluxing aqueous solution (10.40 mL)
of 4-aminobenzoic acid (2.62 g, 19.1 mmol). After refluxing for 1 h at 105 oC, it was
cooled down to room temperature and transferred to acetone (154 mL). The resulting
yellowish-orange colored precipitate was filtered and washed with a 1:6 mixture of H2O:
acetone (40 mL). The residue was redissolved in water and treated with activated carbon.
The mixture was boiled for 5 min and was filtered. The filtrate was concentrated using a
rotary evaporator to obtain a light yellow solid (0.340 g, 19 %). 1H-NMR (CD3OD, 400
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MHz):  (ppm) = 9.62 (d, J = 6.96 Hz, 4H), 8.95 (d, J = 6.96 Hz, 4H), 8.38 (d, J = 8.40
Hz, 4H), 8.01 (d, J = 8.40 Hz, 4H).

13

C-NMR (CD3OD, 400 MHz):  (ppm) =

145.93,131.58, 127.15, 124.49. max (CH3OH:CHCl3 = 1:1) = 310 nm.

Scheme 2.4: Synthesis of [CpBP]Cl2.

2.3.1.5.

N,N'-bis[3-(carboethoxy)propyl]-4,4'-bipyridinium

hexafluorophosphate

([C4BP][PF6]2): The synthetic procedure of [C4BP][PF6]2 was originally published in
New J. Chem. 2010, 34, 2097–2100101 and reproduced by permission of The RSC on
behalf of the CNRS and the RSC.
A solution of N,N'-bis[3-(carboethoxy)propyl]-4,4'-bipyridinium bromide (2.32 g, 4.23
mmol) in H2O (6.5 ml) was treated with a solution of NH4PF6 (2.79 g, 17.1 mmol) in
H2O (10 ml). The resulting white precipitate was filtered off, washed with an aqueous
solution of NH4PF6 (2.79 g, 17.1 mmol, 10 mL) and then with ice-cold water (10 mL).
Recrystallization from hot H2O followed by washing with Et2O and drying in vacuum
yielded pure [C4BP][PF6]2 (2.64 g, 92 %). m.p. 225-227 C. 1H-NMR (400 MHz,
DMSO-d6): 9.37 (d, 4H, 6.6 Hz), 8.78 (d, 4H, 6.6 Hz), 4.71 (t, 4H, 7.1Hz), 4.05 (q, 4H,
7.1 Hz), 2.46 (t, 4H, 7.5 Hz), 2.25 (m, 4H), 1.17 (t, 6H, 7.1 Hz) ppm.
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2.2.1.6. Multi-step synthesis of 1-(4-thiolbutyl)-1′-[4-(carboxy)butyl]-4,4′-bipyridinium
bromide (compound 5)
This synthetic procedure was originally published in Sensors and Actuators B, 2013, 176,
768-774117 and reproduced with permission. Copyright 2013 Elsevier B.V.

Scheme 2.5: Multi-step synthesis of compound 5.

2.2.1.6.1. N-(4-acetylthiolbutyl)-4,4′-bipyridinium bromide (compound 2): A solution of
compound 1 (500 mg, 2.368 mmol) in dried acetonitrile (4 mL) was added to the
refluxing solution of 4,4′-bipyridine (1.109 g, 7.104 mmol) in dried acetonitrile (8 mL)
under nitrogen. After refluxing for two days, the reaction mixture was added to Et 2O (60
mL). The solution was filtered and the residue was washed with a 1:5 mixture of
acetonitrile and Et2O (20 mL) to obtain a brown solid, compound 2 (653 mg, 75 %). 1HNMR (D2O, 400 MHz):  (ppm) = 8.95 (d, J = 6.24Hz, 2H), 8.76 (s, 2H), 8.40 (d, J =
6.20 Hz, 2H), 7.92 (d, J = 5.16 Hz, 2H), 4.67 (t, J = 7.32 Hz, 2H), 2.92 (t, J = 7.14 Hz,
2H), 2.33 (s, H), 2.10 (m, 2H), 1.67 (m, 2H).
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2.2.1.6.2.

1-(4-acetylthiolbutyl)-1′-[4-(carboethoxy)butyl]-4,4′-bipyridinium

bromide

(compound 4): Ethyl-4-bromobutyrate (1.039 g, 5.332 mmol) in dry acetonitrile (3.0 mL)
was transferred under nitrogen into a solution of compound 2 (653 mg, 1.77 mmol) in dry
acetonitrile (3 mL). After refluxing for two days it was cooled to room temperature. The
resulting yellow precipitate was collected by filtration and dissolved in a minimum
amount of methanol. A large excess of Et2O (CH3OH:Et2O ~ 1:10 ) was added to the
solution and filtration afforded a yellow solid (757 mg, 76 %).

1

H-NMR (D2O, 400

MHz):  (ppm) = 9.09 (m, 4H), 8.51 (m, 4H), 4.72 (m, 4H), 4.09 (q, J = 7.21 Hz, 2H),
2.90 (t, J = 7.14 Hz, 2H), 2.53 (t, J = 7.14 Hz, 2H), 2.33 (m, 5H), 2.11 (m, 2H), 1.64 (m,
2H), 1.88 (t, J = 7.14 Hz, 3H).

2.3.1.6.3. 1-(4-Thiolbutyl)-1′-[4-(carboxy)butyl]-4,4′-bipyridinium bromide (compound
5): A solution of 2 M HBr (0.88 mL) was added to the solid compound 4 (378 mg, 0.67
mmol). The resulting solution was evaporated at 100 oC using house vacuum to obtain a
yellow solid (297 mg, 90 %). 1H NMR (D2O, 400 MHz):  (ppm) = 9.10 (t, J = 6.78Hz,
4H), 8.52 (d, J = 3.62 Hz, 4H), 4.74 (m, 4H), 2.56 (m, 4H), 2.35 (m, 2H), 2.16 (m, 2H),
1.66 (m, 2H).
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2.2.1.7. Multi-step synthesis of ligand L1 for MWMs

Scheme 2.6: Multi- step synthesis of L1.
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2.2.1.7.1. Compound 8: nBuLi (23.95 mL, 38.32 mmol) was added drop wise under N2 to
a solution of TBDMS 4-bromophenol 7 (10.0 g, 34.8 mmol) in THF (83 mL) at -78 oC.
The reaction mixture was stirred for 90 min at the same temperature. After adding
Bu3SnCl (9.88 mL, 34.9 mmol), the reaction mixture was gradually warmed to room
temperature and was stirred. Then, it was filtered and the filtrate was concentrated under
reduced pressure to obtain a slightly yellow colored viscous liquid (18.9 g). GC-MS
analysis was carried out on a crude mixture (78.6 % of the crude is compound 8). The
crude mixture was used in the synthesis of compound 13 without further purification.
2.2.1.7.2. Compound 13 (6-[4-[[1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-6′-methyl2,2′-bipyridine): Degassed toluene (102 mL) was added to a mixture of compound 8
(14.5 g, 29 mmol), compound 12 (7.26 g, 29 mmol), LiCl (2.27 g, 53 mmol) and
Pd(PPh3)4 (0.526 g, 0.45 mmol) under N2.

After refluxing for 24 h at 120 oC, the

solution was cooled to room temperature and filtered. The evaporated filtrate was
recrystallized from methanol to obtain a white solid (5.6 g, 51 %), m.p. 98-100 °C. 1H
NMR (CDCl3, 400 MHz):  (ppm) = 8.39 (d, J = 7.68 Hz, 1H), 8.32 (d, J = 7.72 Hz, 1H),
8.04 (d, J = 8.80 Hz, 2H), 7.83 (t, J = 7.70 Hz, 1H), 7.70 (t, J = 7.94 Hz, 2H), 7.16 (d, J=
7.36 Hz, 1H), 6.95 (d, J = 8.76 Hz, 2H), 2.63 (s, 3H), 1.00 (s, 9H), 0.23 (s, 6H).

13

C-

NMR (CDCl3, 400 MHz):  (ppm) = 157.82 (1C), 156.87 (1C), 156.18 (1C), 155.96
(1C), 137.61 (1C), 137.06 (1C), 132.77 (1C), 128.24 (1C), 132.29 (1C), 120.44 (1C),
119.53 (1C), 118.75 (1C), 118.34 (1C), 25.81 (1C), 24.78 (1C), 18.38 (1C), –4.26 (1C).
2.2.1.7.3. Compound 14: LDA (1000 L, 2 mmol) was added into a solution of
compound 13 (500 mg, 1.32 mmol) in dried THF under N2 at -78 oC. After 4 h stirring at
-78 oC, a solution of dibromoethane (130 L, 1.5 mmol) in degassed THF (10 mL) was
57

transferred to it over 10 min. After 1 h it was warmed up to room temperature and stirred
overnight. The evaporated reaction mixture was purified by chromatography over silica
with a 5:1 mixture of hexane: EtOAc as an eluting mixture to obtain a white powder (130
mg, 26 %). m.p. 200-201 °C. 1H NMR (CDCl3, 400 MHz):  (ppm) = 8.42 (d, J = 8.00
Hz, 2H), 8.38 (d, J = 8.04 Hz, 2H), 8.04 (d, J = 8.80 Hz, 4H), 7.83 (t, J = 7.88 Hz, 2H),
7.70 (t, J = 7.70 Hz, 4H), 7.16 (d, J= 7.32 Hz, 2H), 6.95 (d, J = 8.80 Hz, 4H), 3.46 (s,
4H), 1.04 ( s, 18H), 0.23 (s, 12H).

13

C- NMR (CDCl3, 400 MHz):  (ppm) = 160.67

(2C), 156.85 (2C), 156.14 (2C), 156.07 (2C), 155.91 (2C), 137.58 (2C), 137.03 (2C),
132.80 (2C), 128.23 (4C), 123.08 (2C), 120.43 (4C), 119.52 (2C), 118.89 (2C), 118.62
(2C), 37.83 (2C), 25.81 (6C), 18.38 (2C), –4.25 (4C).
2.2.1.7.4. Compound 15: Tetrabutylammonium fluoride (TBAF) (154 mg, 0.59 mmol)
was added to a solution of compound 14 in dry THF (8 mL). After overnight stirring, the
resulting solid was filtered off and dissolved in CHCl3:CH3OH = 1:1 mixture (10 mL). It
was filtered through a silica bed and the filtrate was evaporated to obtain a white colored
powder (110 mg, 79 %).

1

H-NMR (DMSO-d6, 400 MHz):  (ppm) = 8.36 (d, J = 7.72

Hz, 2H), 8.27 (d, J = 7.32 Hz, 2H), 8.07 (d, J = 8.44 Hz, 4H), 7.90 (t+d+t, 6H), 7.38 (d, J
= 7.36 Hz, 2H), 6.90 (d, J = 8.80 Hz, 4H), (2.50, J = 1.64 Hz, 4H).

13

C- NMR (DMSO-

d6, 400 MHz):  (ppm) = 160.94 (2C), 159.25 (2C), 156.07 (2C), 155.47 (2C), 155.42
(2C), 138.60 (2C), 138.06 (2C), 129.99 (2C), 128.62 (4C), 123.85 (2C), 119.71 (4C),
118.61 (2C), 116.13 (2C), 37.32 (2C).
2.2.1.7.5. Compound 16 (L1): A solution of allyl bromide (36 L, 0.42 mmol) and
compound (15) (100 mg, 0.19 mmol) in dry DMF (85 mL) was added to Cs2CO3 under
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N2. After stirring for 3h at 80 oC, the solvent was vacuum distilled. The white residue
was dissolved in water (20 mL) and extracted into CH2Cl2 (3 x 20 mL). The combined
organic extracts were dried using MgSO4 and filtered through a silica bed.

The filtrate

was evaporated to obtain a white solid (100 mg, 86 %). m.p. 180-181 °C.

1

H-NMR

(CDCl3, 400 MHz):  (ppm) = 8.42 (d, J = 8.04 Hz, 2H), 8.38 (d, J = 7.72 Hz, 2H), 8.10
(d, J = 8.80 Hz, 4H), 7.83 (t, J = 7.88 Hz, 2H), 7.70 (t, J = 7.70 Hz, 4H), 7.16 (d, J= 7.72
Hz, 2H), 7.03 (d, J = 8.80 Hz, 4H), 6.09 (m, 2H), 5.45 (td, J = 17.24 Hz, 2H), 5.31 (td, J =
10.6Hz, 2H), 4.61 (d, J = 3.64 Hz, 4H), 3.44 (s, 4H).

13

C-NMR (CDCl3, 400 MHz): 

(ppm) = 160.68 (2C), 159.54 (2C), 156.09 (2C), 156.03 (2C), 155.90 (2C), 137.60 (2C),
137.04 (2C), 133.22 (2C), 132.36 (2C), 128.26 (2C), 123.09 (2C), 119.44 (2C), 118.89
(2C), 118.62 (2C), 117.95 (2C), 114.95 (2C), 77.74 (2C), 77.31 (2C), 68.96 (2C), 37.82
(2C).
2.2.1.8. Multi-step synthesis of Ligand L2 for MWMs
2.2.1.8.1. Compound 19: nBuLi (1.6 M in hexane, 35.00 mL, 56.00 mmol) was added
drop-wise under N2 over 10 min to a solution of 4-bromoanisole (17) (10.0 g, 53.46
mmol) in THF (80 mL) at -78 oC. After 90 min stirring at -78 oC, it was added under N2
using a cannula to a solution of 1,10-phenanthroline (8.00 g, 44.39 mmol) at -78 oC over
2 h. After 3 h stirring at -78 oC, the reaction mixture was gradually warmed up to room
temperature and stirred overnight.

The dark brown colored reaction mixture was

transferred to a beaker containing 200 cm3 of ice cubes. Organic and aqueous layers
were separated and the aqueous layer was extracted with CH2Cl2 (2 x 50 mL). The
combined organic layers were dried over MgSO4 and rearomatized by successive
addition of MnO2 (20g at a time, total of 90g). This oxidation reaction was monitored
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with TLC and the disappearance of the color of the solution. After stirring for 5 days, the
solution was filtered, and the solvent was evaporated using a rotary evaporator. The
resulting dark brown colored crude material (10.94 g) was chromatographed over silica
using an EtOAc:Hexane mixture as an eluent (EtOAc:Hexane (1/5) – 840 mL,
EtOAc:Hexane (1/4) – 750 mL, EtOAc:Hexane (1/3) – 240 mL, EtOAc:Hexane (1/1) –
200 mL, EtOAc:Hexane (2/1) – 900 mL, EtOAc – 1800 mL). The pinkish-yellow
colored compound (1.93 g) was washed with Et2O to yield very slightly pink colored
compound 3 (1.43 g, 11.2 %). 1H-NMR (CDCl3, 400 MHz):  (ppm) = 9.23 (dd, J = 4.40
Hz, 1H), 8.32 (d, J = 8.76 Hz, 2H), 8.26 (t, J = 8.06 Hz, 2H),8.06 (d, J = 8.44 Hz,
1H)7.76 (q, J = 9.88 Hz, 2H) 7.62 (q, J = 4.15 Hz, 1H), 7.06 (d, J = 8.80 Hz, 2H), 3.89
(s, 3H).

Scheme 2.7: Synthesis of compound 19.

2.2.2. Supramolecules and their metal complexes
2.2.2.1. [PyBP/BPP34C10][NO3]2 [2]pseudorotaxane: Maroon-red colored, X-ray
quality, single crystals of [PyBP /BPP34C10][NO3]2 [2]pseudorotaxanes (7.0 mg, 72 %)
were obtained from a 1:1 mixture of [PyBP][NO3]2

(4.0 mg, 0.009 mmol) and

BPP34C10 (5.0 mg, 0.009 mmol) in CH3OH (2.0 mL) by slow diffusion of iPr2O vapor at
–20 °C. 1H-NMR (CD3OD:CDCl3 = 1:1, 400 MHz):  (ppm) = 9.47 (d, J = 6.96 Hz, 4H),
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9.02 (d, J = 5.12 Hz, 4H), 8.68 (d, J = 6.96 Hz, 4H), 8.06 (d, J = 6.20 Hz, 4H), 6.55 (s,
8H), 3.84 (m, 8H), 3.74 (m, 8H), 3.61 (s, 16H). max (CH3OH:CHCl3 = 1:1) = 500 nm.
2.2.2.2. [PyBP/BN38C10][SbF6]2 [2]pseudorotaxane: Blue colored, X-ray quality, single
crystals of [PyBP/BN38C10][SbF6]2 [2]pseudorotaxanes (5.2 mg, 60 %) were obtained
by layering a solution of KSbF6 (3.8 mg, 0.014 mmol) in CH3OH (1.4 mL) over a
solution comprised of a 1:1 mixture of [PyBP][NO3]2 (3.0 mg, 0.007 mmol) and
BN38C10 (4.3 mg, 0.007 mmol) in a 1:1 mixture of CH3OH and CHCl3 (1.4 mL) at
room temperature.

1

H-NMR (CD3OD:CDCl3 = 1:1, 400 MHz):  (ppm) = 9.58 (d, J =

6.96 Hz, 4H), 9.35 (d, J = 6.24 Hz, 4H), 8.47 (d, J = 6.96 Hz, 4H), 8.39 (d, J = 6.24 Hz,
4H), 7.76 (d, J = 8.08 Hz, 4H), 7.40 (t, J = 8.06 Hz, 4H), 6.74 (d, J = 7.72 Hz, 4H), 4.28
(t, J = 4.22 Hz, 8H), 4.19 (t, d = 4.04 Hz, 8H), 4.01 (m, 16H). max (CH3OH:CHCl3 = 1:1)
= 590 nm.
2.2.2.3. [PyBP/BN32C8][NO3]2 [2]pseudorotaxane: Blue colored, X-ray quality, single
crystals of [PyBP/BN32C8][PF6]2 [2]pseudorotaxanes (5.0 mg, 62 %) were obtained by
layering a solution of KSbF6 (3.8 mg, 0.014 mmol) in CH3OH (1.2 mL) over a solution
comprised of a 1:1 mixture of [PyBP][NO3]2 (3.0 mg, 0.007 mmol) and BN32C8 (3.7
mg, 0.007 mmol) in a 1:1 mixture of CH3OH and CHCl3 (1.6 mL) at room temperature.
1

H-NMR (CD3OD:CDCl3 = 1:1, 400 MHz):  (ppm) = 9.43 (d, J = 6.60 Hz, 4H), 9.34 (d,

J = 5.88 Hz, 4H), 8.40 (d, J = 6.96 Hz, 4H), 8.29 (d, J = 6.24 Hz, 4H), 7.63 (d, J = 8.44
Hz, 4H), 7.20 (t, J = 8.06 Hz, 4H), 6.78 (d, J = 7.72 Hz, 4H), 4.37 (t, J = 4.40 Hz, 8H),
4.23 (t, J = 4.20 Hz, 8H), 4.13 (s, 8H). max (CH3OH:CHCl3 = 1:1) = 610 nm.
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2.2.2.4. [PyBP/DB24C8][NO3]2 [3]pseudorotaxane: Yellow colored, X-ray quality, single
crystals of [PyBP/DB24C8][NO3]2 [3]pseudorotaxanes (6.0 mg, 50 %) were obtained by
slow diffusion of iPr2O vapor into a 1:1 mixture of [PyBP][NO3]2 (4.0 mg, 0.009 mmol)
and DB24C8 (4.1 mg, 0.009 mmol) in a 1:1 mixture of CH3OH and CHCl3 (1.6 mL) at
–20 °C. 1H NMR (CD3OD:CDCl3 = 1:1, 400 MHz):  (ppm) = 9.77 (s, 4H), 8.98 (d, J =
5.12 Hz, 8H), 8.34 (s, 4H), 6.82 (m, 8H), 4.03 (m, 8H), 3.87 (m, 8H), 3.79 (m, 8H). max
(CH3OH:CHCl3 = 1:1) = 440 nm.
2.2.2.5. [CpBP-2H+/BPP34C10] [2]pseudorotaxane: Maroon-red colored, X-ray quality,
single crystals of [CpBP-2H+/BPP34C10] [2]pseudorotaxanes (4.0 mg, 37 %) were
obtained by slow diffusion of Et2O vapor into a 1:1 mixture of [CpBP]Cl2 (5.0 mg, 0.011
mmol) and BPP34C10 (5.7 mg, 0.011 mmol) in CH3OH (1.6 mL) at –20 °C.

1

H-NMR

(CD3OD:CDCl3 = 2:1, 400 MHz):  (ppm) = 9.48 (d, J = 6.60 Hz, 4H), 8.70 (d, J = 5.84
Hz, 4H), 8.40 (d, J = 8.40 Hz, 4H), 8.04 (d, J = 8.04 Hz, 4H), 6.54 (s, 8H), 3.83 (m, 8H),
3.73 (m, 8H), 3.59 (m, 16H). max (CH3OH:CHCl3 = 3:1) = 484 nm.
2.2.2.6.

[CpBP/BN38C10]Cl2

[2]pseudorotaxane:

A

blue

colored

powder

of

[CpBP/BN38C10]Cl2 [2]pseudorotaxanes (5.3 mg, 45 %) was obtained by slow diffusion
of iPr2O vapor into a 1:1 mixture of [CpBP]Cl2 (5.0 mg, 0.011 mmol) and BN38C10 (6.7
mg, 0.011 mmol) in a 3:1 mixture of CH3OH and CHCl3 (1.6 mL) at –20 °C. 1H-NMR
(CD3OD:CDCl3 = 2:1, 400 MHz):  (ppm) = 9.32 (d, J = 5.12 Hz, 4H), 8.44 ( d, J = 8.44
Hz, 4H), 8.26 (s, 4H), 8.07 ( d, J = 8.04 Hz, 4H), 7.41 ( d, J = 8.40 Hz, 4H), 7.08 ( t, J =
8.06 Hz, 4H), 6.46 ( t, J = 7.72 Hz, 4H), 3.91 (m, 8H), 3.85 (m, 8H), 3.70 (m, 16H). max
(CH3OH:CHCl3 = 3:1) = 550 nm.
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2.2.2.7. [CpBP-2H+/BN32C8] [2]pseudorotaxane: Bluish purple colored, X-ray quality,
single crystals of [CpBP-2H+/BN32C8] [2]pseudorotaxanes (6.6 mg, 60 %) were
obtained by slow diffusion of Et2O vapor into a 1:1 mixture of [CpBP]Cl2 (5.0 mg, 0.011
mmol) and BN32C8 (5.8 mg, 0.011 mmol) in a 3:1 mixture of CH3OH and CHCl3 (1.6
mL) at –20 °C. 1H-NMR (CD3OD:CDCl3 = 2:1, 400 MHz):  (ppm) = 9.23 (s, 4H), 8.44
(d, J = 8.04 Hz, 4H), 8.00 (d, J = 8.04 Hz, 8H), 7.24(s, 4H), 6.89 (t, J = 7.88 Hz, 4H),
6.49 (s, 4H), 4.05 (s, 8H), 3.94 (s, 8H), 3.84 (s, 8H). max (CH3OH:CHCl3 = 3:1) = 571
nm.
2.2.2.8. [C4BP/BPP34C10][PF6]2 [2]pseudorotaxane: Dark orange colored, X-ray
quality, single crystals of [C4BP/BPP34C10][PF6]2 [2]pseudorotaxanes (8.5 mg, 95 %)
were obtained by iPr2O vapor diffusion into a 1:1 mixture of [C4BP][PF6]2 (5.0 mg, 0.008
mmol) and BPP34C10 (4.0 mg, 0.008 mmol) in a 1:1 mixture of (CH3)2CO:CH3OH at
–20 °C. 1H-NMR (acetone-d6:CDCl3 = 2:1, 400 MHz):  (ppm) = 9.26 (d, J = 6.60 Hz,
4H,), 8.50 ( d, J = 6.60 Hz, 4H), 6.49 (s, 8H), 4.95 (t, 4H, J = 7.50 Hz), 4.10 (q, J = 7.20
Hz, 4H), 3.79 (m, 8H), 3.74 (m, 8H), 3.73 (s, 16H), 2.56 (t, J = 7.3 Hz, 4H), 2.47(m, 4H),
1.20 (t, J = 7.1 Hz, 6 H). max (CH3)2CO:CHCl3 = 2:1) = 448 nm.
2.2.2.9. [C4BP/BN38C10]Br2 [2]pseudorotaxane: Dark bright red colored, X-ray quality,
single crystals of [C4BP/BN38C10]Br2 [2]pseudorotaxane ( 1.0 mg, 10%) were obtained
by Et2O vapor diffusion into a 1:1 mixture of [C4BP]Br2 (5.0 mg, 0.009 mmol) and
BN38C10 (5.8 mg, 0.009 mmol) in a 1:1 mixture of CHCl3:CH3OH at –20 °C. 1H-NMR
(acetone-d6:CDCl3 = 2:1, 400 MHz):  (ppm) = 9.05 (d, J = 6.20 Hz, 4H), 7.99 (s, 4H),
7.22 (d, J = 8.4 Hz, 4H), 7.05 (t, J = 8.10 Hz, 4H), 6.54 (d, J = 7.70 Hz, 4H), 4.93 (t, J =
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7.40 Hz, 4H), 4.13 (q, J = 7.20 Hz, 4H), 3.99 (d, J = 4.40 Hz, 8H), 3.90 (d, J = 4.00 Hz,
8H), 3.80 (s, 16H), 2.60 (t, J = 7.3 Hz, 4H), 2.46 (m, 4H), 1.22 (t, J = 7.1 Hz, 6 H). max
(CH3)2CO:CHCl3 = 2:1) = 490 nm.
2.2.2.10. [C4BP/BN32C10][PF6]2 [2]pseudorotaxane: All crystallization attempts yielded
a light-pink colored solution and no crystals. 1H-NMR (acetone-d6: CDCl3 = 2:1, 400
MHz):  (ppm) = 9.13 (s, 4H), 8.16 (s, 4H), 7.30 (s, 4H), 6.94 (t, J = 8.10 Hz, 4H), 6.60
(d, J = 7.7 Hz, 4H), 4.90 (s, 4H), 4.12 (m, 4H), 4.02 (d, J = 4.4 Hz, 8H), 3.95 (d, J = 4.0
Hz, 8H), 3.85 (s, 4H), 2.56 (t, J = 7.3 Hz, 4H), 2.48(m, 4H), 1.21 (t, J = 7.10 Hz, 6H).
max (CH3)2CO:CHCl3 = 2:1) = 501 nm.
2.2.2.11. [PyBP/syn-DSBPP34C10] [2]pseudorotaxane and [PyBP/anti-DSBPP34C10]
[2]pseudorotaxane: Crystals were obtained by both diffusion and layering methods.
Diffusion method: iPr2O vapor was diffused into a solution of [PyBP][NO3]2 (20.0 mg,
0.045 mmol) and [TBA]2[DSBPP34C10] (54.0 mg, 0.046 mmol) in CH3OH (5.0 mL).
Maroon-red (10.0 mg, 22 %) and orange (8.0 mg, 17 %) colored, X-ray quality crystals
were obtained at –20 oC after one week.
Layering: A solution of [PyBP][NO3]2 (7.4 mg, 0.017 mmol) and [TBA]2[DSBPP34C10]
(20.0 mg, 0.017 mmol) in CH3OH (3.6 mL) was layered over iPr2O (2.0 mL). Maroonred (2.4 mg, 14 %) and orange (2.2 mg, 13 %) colored, X-ray quality crystals were
obtained at room temperature after one week.
Maroon-red colored crystals : 1H-NMR (CD3OD, 400 MHz):  (ppm) = 9.45 (d, J = 6.60
Hz, 4H), 9.03 (d, J = 6.24 Hz, 4H), 8.39 (d, J = 6.96 Hz, 4H), 8.31 (d, J = 6.20 Hz, 4H),
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6.99 (d, J = 3.28 Hz, 2H), 6.45 (d, J = 8.80 Hz, 2H), 6.24 (dd, J = 8.96, 3.12 Hz, 2H),
3.81 (t, J= 3.64 Hz, 4H), 3.75 (d, J = 4.04 Hz, 4H), 3.71 (m, 4H), 3.66 (m, 4H), 3.53 ( d,
J = 4.76 Hz, 4H), 3.49 (d, J = 5.48 Hz, 4H), 3.47 (s, 8H). max (CH3OH) = 461 nm.
Orange colored crystals: 1H-NMR (CD3OD, 400 MHz):  (ppm) = 9.45 (d, J = 6.60 Hz,
4H), 9.04 (dd, J = 4.38, 1.44 Hz, 4H), 8.40 (d, J = 6.56 Hz, 4H), 8.31 (dd, J = 4.72, 1.48
Hz, 4H), 6.98 (d, J = 3.28 Hz, 2H), 6.46 (d, J = 8.8 Hz, 2H), 6.24 (dd, J = 8.76, 2.94 Hz,
2H), 3.81 (t, J = 3.48 Hz, 4H), 3.76 (d, J = 4.40 Hz, 4H), 3.70 (m, 4H), 3.66 (m, 4H), 3.54
(d, J = 6.08 Hz, 4H), 3.51 (d, J = 5.76 Hz, 4H), 3.48 (s, 8H). max (CH3OH) = 458 nm.
2.2.2.12. [CpBP/syn-, anti- DSBPP34C10] [2]pseudorotaxane: A solution of [CpBP]Cl2
(20.0 mg, 0.043 mol) and [TBA]2DSBPP34C10 (50.0 mg, 0.043 mol) in CH3OH (3.0
mL) was layered over iPr2O (3.0 mL). A mixture of red and orange colored, X-ray
quality crystals of [CpBP/syn-, anti-DSBPP34C10] pseudorotaxanes (16.8 mg, 36.2 %)
were obtained at room temperature after one week.

1

H-NMR (CD3OD, 400 MHz): 

(ppm) = 9.43 (d, J = 6.96 Hz, 4H), 8.35 (d, J = 6.96 Hz, 4H), 8.40(d, J = 8.76 Hz, 4H),
8.30 (d, J = 8.30 Hz, 4H), 6.93(d+d, J = 3.14 Hz, 2H), 6.49, (d+d, J = 2.38 Hz, 2H),
6.37(dd+dd, J = 3.32, 6.40 Hz, 2H), 3.83(m, 4H), 3.77(m, 4H), 3.70(m, 8H), 3.59(m, 4H),
3.53(m, 8H), 3.46(m, 4H). max (CH3OH) = 436 nm.
2.2.2.13.

[C4BP/syn-,

anti-DSBPP34C10]

[2]pseudorotaxane:

A

solution

of

[C4BP][PF6]2 (5.0 mg, 0.0074 mmol) and [TBA]2DSBPP34C10 (8.7 mg, 0.0074 mol) in
a 1:1 mixture of CH3COCH3:CH3OH (3 mL) was layered over iPr2O (3 mL). A mixture
of yellow and orange colored, X-ray quality [C4BP/syn-, anti-DSBPP34C10]
[2]pseudorotaxanes crystals (5.1 mg, 64 %) were obtained at room temperature after one
week.

1

H-NMR (d6-acetone:CD3OD =1:1, 400 MHz):  (ppm) = 9.05 (d, J = 6.60 Hz,
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4H), 8.10 (d, J = 6.60 Hz, 4H), 6.75 (s, 2H), 6.23 (s, 4H), 4.84 (t, J = 7.70 Hz, 4H), 4.12
(q, J = 7.20 Hz, 4H), 3.74 (m, 24H), 3.71 (d, J = 4.04 Hz, 8H), 2.59 (t, J = 7.52 Hz, 4H),
2.45 (m, 4H), 1.22 (t, J = 7.14 Hz, 6H). max (CH3OH) = 407 nm.
2.2.2.14. [PyBP/BN38C10](ZnCl3)2: A solution of ZnCl2 (0.8 mg, 0.0057 mmol) in
CH3OH (1.5 mL) was layered over a solution of PyBP·[NO3]2 (2.5 mg, 0.0057 mmol)
and BN38C10 (3.2 mg, 0.0051 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5 mL). Dark
blue colored, rhombic shaped, X-ray quality crystals were obtained after two weeks.
2.2.2.15. [PyBP/BN32C8](ZnCl3)2: A solution of ZnCl2 (0.8 mg, 0.0057 mmol) in
CH3OH (1.8 mL) was layered over a solution of [PyBP][NO3]2 (5 mg, 0.011 mmol) and
BN32C8 (5.5 mg, 0.010 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.8 mL). Dark blue
colored, rhombic shaped, X-ray quality crystals were obtained after two weeks.
2.2.2.16. [PyBP/BN38C10](ZnBr3)2: A solution of ZnBr2 (1.3 mg, 0.0057 mmol) in
CH3OH (1.8 mL) was layered over a solution of [PyBP][NO3]2 (1.3 mg, 0.0028 mmol)
and BN38C10 (1.6 mg, 0.0025 mmol) in a 1:1 mixture of CH3OH:CHCl3 (0.75 mL).
Dark blue colored, rhombic shaped, X-ray quality crystals were obtained after two weeks.
2.2.2.17. [PyBP/BN32C8](ZnBr3)2: A solution of ZnBr2 (1.3 mg, 0.0057 mmol) in
CH3OH (1.5 mL) was layered over a solution of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol)
and BN32C8 (2.8 mg, 0.0050 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5 mL). Dark
blue colored, X-ray quality crystals (2.8 mg, 57 %) were obtained after two weeks.
2.2.2.18. [PyBP/BPP34C10][CdBr4]: A solution of CdBr2 (3.1 mg, 0.0091 mmol) in
CH3OH (1.5 mL) was layered over a 1:1 mixture of [PyBP][NO3]2 (2.0 mg, 0.0046
mmol) and BPP34C10 (2.0 mg, 0.0037 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5
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mL). Dark maroon-red colored, X-ray quality, needle shaped crystals were obtained after
two weeks.
2.2.2.19. [PyBP/BN38C10][CdBr4]: A solution of CdBr2 (3.9 mg, 0.0114 mmol) in
CH3OH (1.5 mL) was layered over a 1:1 mixture of [PyBP][NO3]2 (2.5 mg, 0.0057
mmol) and BN38C10 (3.2 mg, 0.0051 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5
mL). Dark blue colored, X-ray quality, rhombic shaped crystals were obtained after two
weeks.
2.2.2.20. [PyBP/BPP34C10][CdI4]: A solution of CdI2 (4.2 mg, 0.0114 mmol) in CH3OH
(1.5 mL) was layered over a solution of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol) and
BPP34C10 (2.5 mg, 4.7 mmol) in CH3OH (1.5 mL). X-ray quality, dark maroon-red
colored, needle shaped crystals were obtained after two weeks.
2.2.2.21. [PyBP/BN38C10][CdI4]: A solution of CdI2 (2.1 mg, 0.0057 mmol) in CH3OH
(1.5 mL) was layered over a solution of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol) and
BN38C10 (3.2 mg, 0.0051 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5 mL). Dark
maroon-red colored, X-ray quality, rhombic shaped crystals were obtained after one
month.
The same crystal was obtained by another method as follows. The solution of CdI2 (4.2
mg, 0.0114 mmol) in CH3OH (1.5 mL) was layered over a solution of [PyBP][NO3]2
(2.5 mg, 0.0057 mmol) and BN38C10 (3.2 mg, 0.0051 mmol) in a 1:1 mixture of
CH3OH:CHCl3 (1.5 mL).

X-ray quality, dark maroon-red colored, rhombic shaped

crystals were obtained after one month.
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2.2.2.22. [PyBP/BN32C8](CdI3)2: A solution of CdI2 (4.2 mg, 0.0114 mmol) in CH3OH
(1.5 mL) was layered over a 1:1 mixture of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol) and
BN32C8 (2.8 mg, 0.0057 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5 mL). After two
weeks, the resulting clear solution was layered over iPr2O to obtain X-ray quality, dark
maroon-red colored, needle shaped crystals.
2.2.2.23. [PyBP/BN38C10](Hg2Cl6)2: A solution of HgCl2 (3.2 mg, 0.0114 mmol) in
CH3OH (1.5 mL) was layered over a solution of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol)
and BN38C10 (3.2 mg, 0.0051 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5 mL). Xray quality, dark blue colored, rhombic shaped crystals were obtained after two weeks.
2.2.2.24. [PyBP/BN32C8](Hg2Cl6)2: A solution of HgCl2 (3.2 mg, 0.0114 mmol) in
CH3OH (1.5 mL) was layered over a solution of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol)
and BN32C10 (2.7 mg, 0.0051 mmol) in a 1:1 mixture of CH3OH:CHCl3 (1.5 mL). Xray quality, dark blue colored, rhombic shaped crystals were obtained after two weeks.
2.2.2.25. [PyBP/BN38C10](Hg2Br6)2: A solution of HgBr2 (4.2 mg, 0.0114 mmol) in
CH3OH (1.5 mL) was layered over a solution of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol)
and BN38C10 (3.2mg, 0.0051 mmol) in a 1:1 mixture of CHCl3:CH3OH (1.5 mL). Dark
blue color, rhombic shaped X-ray quality crystals resulted after three weeks.
2.2.2.26. [PyBP/BN32C8][Hg2Br6]: A solution of HgBr2 (4.2 mg, 0.0115 mmol) in
CH3OH (1.5 mL) was layered over a solution of [PyBP][NO3]2 (2.5 mg, 0.0057 mmol)
and BN32C8 (2.8mg, 0.0057 mmol) in a 1:1 mixture of CHCl3:CH3OH (1.5 mL).
Greenish-blue colored, very small crystals formed after one week. They were not high
enough quality for X-ray diffraction. Upon standing, the greenish-blue colored crystals
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disappeared. Dichroic (blue and red), rhombic shaped X-ray quality crystals were
obtained after five weeks.
2.2.2.27. [PyBP/BN38C10][ Hg2I6]: A 3:2 mixture of CHCl3:CH3OH was layered over a
solution of [PyBP][NO3]2 (2.5 mg, 5.7 mmol) and BN38C10 (3.2mg, 0.0051 mmol) in a
1:1 mixture of CHCl3:CH3OH (1.5 mL). After that the solution of HgI2 (5.2 mg, 0.0114
mmol) in CH3OH (1.5 mL) was layered over the resulted two layer solution. The vial
was kept in the freezer at –20 oC for one week. White, needle shaped crystalline material
were on the bottom of the vial. After warming it up to room temperature, the white
crystalline material disappeared within 30-40 min. Upon standing at room temperature it
gave dark blue rhombic shaped, X-ray quality crystals after two weeks.
2.2.2.28. [PyBP/BN32C8][Hg2I6]: A 3:2 mixture of CHCl3:CH3OH was layered over a
solution of [PyBP][NO3]2 (2.0 mg, 0.0046 mmol) and BN32C8 (2.8 mg, 0.0057 mmol) in
a 1:1 mixture of CHCl3:CH3OH (1.5 mL). After that the solution of HgBr2 (4.2 mg,
0.0092 mmol) in CH3OH (1.5 mL) was layered over the resulted two layer solution. The
vial was kept in the freezer at –20 oC for seven days. No crystals were obtained. It was
taken out from the freezer and kept at room temperature.

Upon standing at room

temperature dark blue rhombic shaped, X-ray quality crystals formed after two weeks.
2.2.2.29. Cu(II) complex-1 of L1: A solution of [Cu(CH3CN)4]PF6 (1.6 mg, 0.004 mmol)
in CH3CN:CH3OH = 1:1 (1.0 mL) was mixed with L1 (3.0 mg, 0.005 mmol) in CHCl3
(1.0 ml) to obtain a maroon-red colored solution. Slow evaporation of the resulting
mixture of [Cu(CH3CN)4]PF6: L1 provided dichroic (blue and purple), X-ray quality,
flake-like crystals.
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2.2.2.30. Cu(II) complex-2 of L1: Blue colored, X-ray quality single crystals were
obtained by iPr2O vapor diffusion into a 1:1 mixture of L1 (3.0 mg, 0.005 mmol) and
[Cu(CH3CN)4]PF6 (1.6 mg, 0.004 mmol) in a 1:1 mixture of CHCl3:CH3CN.
2.2.2.31. Cu(Pyacac)2 metallo-ligand (ML polymorph 1): iPr2O was layered over a
mixture of Cu(Pyacac)2 (5.0 mg, 0.012 mmol) and diaza-18-crown-6 (6.3 mg, 0.024
mmol) in a 1:1 mixture of CHCl3:CH3OH. Cubic shaped, green colored, X-ray quality
crystals of ML polymorph 1 were obtained after three days.
Another polymorph of Cu(Pyacac)2 metallo-ligand (ML polymorph 2) was obtained as
follows. iPr2O was layered over a solution of Cu(Pyacac)2 (5.0 mg, 0.012 mmol) and
diaza-18-crown-6 (6.3 mg, 0.024 mmol) in C2H5OH. Cubic shaped, green colored, X-ray
quality crystals of ML polymorph 2 were obtained after three days.
2.2.2.32. [diaza-18-crown-6][CuCl2] complex (ML3): Cubic shaped, dark blue colored,
X-ray quality crystals of ML3 were obtained from the same crystal growing vial of ML1
(2.2.2.31) after three weeks.
2.2.2.33. Cu(Phacac)2 and diaza-18-crown-6 complex (ML4): iPr2O vapor was diffused
into a 1:1 mixture of Cu(Phacac)2 (5.0 mg, 0.012 mmol) and diaza-18-crown-6 (3.2 mg,
0.008 mmol) in CHCl3 at room temperature. The resulting transparent light greenish-blue
solution was slowly evaporated to obtain blue colored, X-ray quality single crystals of
ML4 after one week.
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2.3. Solution preparation for UV-visible spectroscopy
The standard solutions of 3.000(± 0.006) x 10-3 M [PyBP][NO3]2, [CpBP]Cl2,
[C4BP][PF6]2, BPP34C10, BN38C10 and BN32C8 were prepared in 10.00(± 0.02) mL
volumetric flasks by dissolving 13.083(±0.001), 14.041(±0.001), 20.290(±0.001),
16.098(±0.001), 19.088(±0.001) and 16.459(±0.001) mg, respectively. In the case of a
syn- and anti- mixture of [TBA]2DSBPP34C10, the standard solutions were prepared in
5.00(±

0.01)

mL

volumetric

flasks

by

dissolving

17.687(±0.001)

mg

of

[TBA]2DSBPP34C10.
The standard solutions of 1.50(± 0.01) x 10-3 M [2]pseudorotaxanes were prepared by
mixing 1.50(± 0.01) mL of 3.000(± 0.006) x 10-3 M standard solutions of the axle and the
wheel using a micropipette.
A 1:1 mixture of CH3OH:CHCl3 was used as the solvent for [PyBP/wheel][NO3]2 and
[CpBP/wheel]Cl2 [2]pseudorotaxanes while 2:1 mixture of acetone:CH2Cl2 was used for
[C4BP/wheel]Cl2 [2]pseudorotaxanes. All [axle/DSBPP34C10] [2]pseudorotaxane
solutions were prepared in milli-Q H2O.
2.3.1. Variable temperature (VT) UV-Vis measurements for [C4BP/wheel][PF6]2
[2]pseudorotaxanes
The standard solutions of 1.0(± 0.1) x 10-3 M [C4BP/wheel] [PF6]2 [2]pseudorotaxane
solutions were prepared in 25.00(+ 0.03 mL) volumetric flasks by dissolving 16.9(+ 0.1)
mg of [C4BP][PF6]2 together with 13.4(+ 0.1) mg of BPP34C10 or 15.9(+ 0.1) mg of
BN38C10 or 13.7(+ 0.1) mg of BN32C8 respectively in a 2:1 mixture of acetone:
CH2Cl2.
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2.4. Solution preparation for 1H-NMR spectroscopy
2.4.1. [PyBP/neutral crown ether][NO3]2 [2]pseudorotaxanes
A 1:1 mixture of CD3OD:CDCl3 was used as a solvent mixture for NMR solution for
[PyBP/neutral crown ether][NO3]2 [2]pseudorotaxanes.
The solutions of 3.82(±0.01) x 10-3 M of the axle and wheel components were prepared
by dissolving 1.000(±0.001) mg of [PyBP][NO3]2, 1.230(±0.001) mg of BPP34C10,
1.460(±0.001) mg of BN38C10 and 1.258(±0.001) mg of BN32C8, respectively in
600(±1) μL of NMR solvent mixture.
The solutions of 3.82(±0.01) x 10-3 M of [PyBP/wheel] pseudorotaxanes were prepared
by mixing 1.000(±0.001) mg of [PyBP][NO3]2 together with either 1.230(±0.001) mg of
BPP34C10 or 1.460(±0.001) mg of BN38C10 or 1.258(±0.001) mg of BN32C8 in
600(±1) μL of the NMR solvent mixture.

2.4.2. [CpBP/ neutral crown ether]Cl2 [2]pseudorotaxanes
A 2:1 mixture of CD3OD:CDCl3 was used as the solvent mixture for NMR solutions for
[CpBP/wheel]Cl2 [2]pseudorotaxanes.
Solutions of 3.56(±0.01) x 10-3 M of the axle and wheel components were prepared by
dissolving 1.000(±0.001) mg of [CpBP]Cl2, 1.146(±0.001) mg of BPP34C10,
1.359(±0.001) mg of BN38C10 and 1.172(±0.001) mg of BN32C8, respectively in
600(±1) μL of the NMR solvent mixture.
The solutions of 3.56(±0.01) x 10-3 M of [CpBP/wheel]Cl2 [2]pseudorotaxanes were
prepared by mixing 1.000(±0.001) mg of [CpBP]Cl2 together with either 1.146(±0.001)
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mg of BPP34C10 or 1.359(±0.001) mg of BN32C8 or 1.172(±0.001) mg of BN38C10 in
600(±1) μL of the NMR solvent mixture.

2.4.3. [C4BP/ neutral crown ether][PF6]2 [2]pseudorotaxanes
A 1:1 mixture of d-acetone:CDCl3 was used as a solvent mixture for NMR solutions.
The 4.0(±0.4) x 10-3 M [C4BP][PF6]2, BPP34C10 and [BPP34C10/C4BP][PF6]2
[2]pseudorotaxane solutions were prepared by dissolving 1.5(± 0.1) mg [C4BP][PF6]2,
1.1(±0.1)

mg

of

BPP34C10

and

2.6(±0.1)

mg

of

[BPP34C10/C4BP][PF6]2

[2]pseudorotaxane crystals, respectively, in 500(+ 1) L of the NMR solvent mixture.
The 3.7(±0.3) x 10-3 M [C4BP][PF6]2 and BN38C10 solutions were prepared by
dissolving 1.5(+ 0.1) mg of [C4BP][PF6]2, 1.4(± 0.1) mg BN38C10, respectively in 600(±
1) L of the NMR solvent mixture. The 3.7(±0.1) x 10-3 M [C4BP/BN38C8][PF6]2
[2]pseudorotaxane solution was prepared by dissolving 1.4(± 0.1) mg of [C4BP][PF6]2
and 1.5(± 0.1) mg of BN38C10 in 600(± 1) L of the NMR solvent mixture.
The 3.7(± 0.3) x 10-3 M [C4BP][PF6]2 and BN32C8 were prepared by dissolving 1.5(±
0.1) mg of [C4BP][PF6]2, 1.2(± 0.1) mg of BN38C10, respectively in 600(± 1) L of the
NMR solvent mixture. The 3.7(±0.1) x 10-3 M [C4BP/BN32C8][PF6]2 [2]pseudorotaxane
solution was prepared by dissolving 1.5(± 0.1) mg of [C4BP][PF6]2 and 1.2(± 0.1) mg of
BN32C8, respectively, in 600(± 1) L of the NMR solvent mixture.
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2.4.4. [4,4′-bipyridinium axle/ DSBPP34C10] [2]pseudorotaxanes
The solutions of 3.69(±0.01) mM of [C4BP][PF6]2, [C4BP/ syn- and anti-DSBPP34C10]
[2]pseudorotaxanes

and

[TBA]2DSBPP34C10

were

prepared

by

dissolving

1.500(±0.001) mg, 2.398(±0.001) mg and 2.616(±0.001) mg, respectively, in 600(±1) L
of a 1:1 mixture of d6-acetone and CD3OD.
The solutions of 6.90(±0.01) mM of [PyBP/syn- and anti-DSBPP34C10], [PyBP/synDSBPP34C10] and [PyBP/anti-DSBPP34C10] pseudorotaxanes were prepared by
dissolving 3.500(±0.001) mg of [2]pseudorotaxane crystals in 500(±1) L of CD3OD.
The solutions of 6.90(±0.01) mM [PyBP][NO3]2 and [TBA]2DSBPP34C10 were prepared
by dissolving 1.516(±0.001) mg of [PyBP][NO3]2 and 4.100(±0.001) mg of
[TBA]2DSBPP34C10, respectively, in 500(±1) L of CD3OD.
The solutions of 5.34(±0.01) mM of [CpBP/ syn- and anti-DSBPP34C10] was prepared
by dissolving 1.500(±0.001) mg of [CpBP]Cl2 and 3.780(±0.001) mg of syn- and anti[TBA]2DSBPP34C10 in 600(±1) L of CD3OD. The standard solutions of 5.34(±0.01)
mM syn- and anti-[TBA]2DSBPP34C10 and [CpBP]Cl2 were prepared by dissolving
3.780(±0.001) mg and 1.500(±0.001) mg, respectively, in 600(±1) L of CD3OD.

2.5. Axle-to-wheel molar ratios of pseudorotaxanes
The Job’s plot method118 was employed to determine the axle:wheel stoichiometry in
pseudorotaxane solutions using UV-Visible spectroscopy or 1H-NMR spectroscopy.
Equimolar standard solutions of the axle and the wheel were prepared. In the case of
UV-Vis spectroscopic method, as shown in Table 2.1, the standard solutions were mixed
using a micropipette to obtain the different molar ratios of wheel:axle in a final volume of
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3.00(± 0.1) mL. The absorbance of each solution was measured at its max. The plot of
absorbance at max vs. mole fraction was used to obtain the stoichiometry between the
wheel and the axle.

Sample
number

Wheel:axle
molar ratio

1
2
3
4
5
6
7
8
9
10
11

10:0
9:1
8:2
7:3
6:4
5:5
4:6
3:7
2:8
1:9
0:10

Volume
of axle/
mL
3.00
2.70
2.40
2.10
1.80
1.50
1.20
0.90
0.60
0.30
0.00

Volume
of wheel /
mL
0.00
0.30
0.60
0.90
1.20
1.50
1.80
2.10
2.40
2.70
3.00

Conentration of
axle/
(± 0.1) x 10-4 M
10
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0

Concentration of
wheel/
(± 0.1) x 10-4 M
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0

Table 2.1: Solutions preparation for molar ratio measurements of pseudorotaxanes by
UV-Vis spectroscopic method.

In the case of the 1H-NMR method, the standard solutions of the axle and the wheel were
mixed using a micropipette according to Table 2.2 to obtain the different molar ratios of
the axle and the wheel in the total volume of 600(±1) l to determine the stoichiometry.
The concentration of the axle and the wheel solutions were identical. 1H-NMR spectra of
each sample were taken at room temperature.
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Sample number

Axle:wheel ratio

1
2
3
4
5
6
7

6:0
5:1
4:2
3:3
2:4
1:5
0:6

Volume of axle
solution/ l
600
500
400
300
200
100
0

Volume of wheel
solution/ l
0
100
200
300
400
500
600

Table 2.2: Solution preparation for molar ratio measurements of pseudorotaxanes by 1HNMR spectroscopic method.

UV-Visible spectroscopy was used to determine the molar ratios of all pseudorotaxanes
except [PyBP/BPP34C10][NO3]2 and [CpBP/BPP34C10]Cl2. 1H-NMR spectroscopy was
used

to

determine

the

molar

ratio

of

[PyBP/BPP34C10][NO3]2

and

[CpBP/BPP34C10]Cl2.
A 1:1 mixture of CH3OH:CHCl3 was used as the solvent for [PyBP/wheel][NO3]2 and
[CpBP/wheel]Cl2 [2]pseudorotaxanes, while a 1:1 mixture of CH3CN:CHCl3 was used
for [C4BP/wheel][PF6]2 [2]pseudorotaxanes. All [axle/DSBPP34C10] [2]pseudorotaxane
solutions were prepared in milli-Q H2O. In the case of the determination of the molar
ratio of [C4BP]2+ and [TBA]2DSBPP34C10 pseudorotaxanes, [C4BP]Br2 was used
instead [C4BP][PF6]2 due to solubility problems.
For UV-Vis spectra, standard solutions of 1.00(± 0.01) x 10-3 M [PyBP][NO3]2,
[CpBP]Cl2,

[C4BP][PF6]2,

[C4BP]Br2,

BPP34C10,

BN38C10,

BN32C8

and

[TBA]2DSBPP34C10 were prepared in 25.00(± 0.03) mL volumetric flasks, by
dissolving 10.910(± 0.001) mg, 11.701(± 0.001) mg, 16.951(± 0.001) mg, 13.703(±
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0.001) mg, 13.436(± 0.001) mg 15.907(± 0.001) mg, 13.715(± 0.001) mg and 29.479(±
0.001) mg, respectively.
For 1H–NMR spectra, standard solutions of 2.00(±0.02) x 10-3 M [PyBP][NO3]2,
[CpBP]Cl2 and BPP34C10 were prepared by dissolving 1.832(±0.001) mg, 2.055(±0.001)
mg and 2.252(±0.001) mg, respectively in 2.10(±0.02) mL of a 1:1 mixture of
CDCl3:CD3OD.

2.6. Binding constant measurements
The Benensi-Hilderbrand method119 was used to obtain the association constant between
the axle and the wheel of [2]pseudorotaxanes using UV-Visible spectroscopy or 1H-NMR
spectroscopy. Spectroscopic method and the solvent selection were similar to the section
2.5 unless otherwise mentioned.

2.6.1. [PyBP/neutral crown ether][NO3]2 [2]pseudorotoxanes
For NMR spectra, the standard solution of 2.00(±0.01) mM [PyBP][NO3]2 was prepared
by dissolving 3.053(±0.001) mg in the total volume of 3.50(±0.03)

mL while the

standard solutions of 5.00(±0.03) mM BPP34C10 were prepared by dissolving
4.022(±0.001) mg in the total volume of 1.50(±0.01) mL of the deuterated solvent
mixture. The standard [PyBP][NO3]2 solution was titrated with the standard BPP34C10
solution to obtain the final axle:wheel ratio of 1:5. After each addition, 1H-NMR spectra
were recorded.
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For UV-Vis spectra, standard solutions of 0.50(± 0.01) x 10-3 M and 1.00(± 0.01) x 10-3
M [PyBP][NO3]2 were prepared in 10.00(± 0.02) mL volumetric flasks by dissolving
2.182(± 0.001) mg and 4.363(± 0.001) mg of [PyBP][NO3]2, respectively.
The standard [PyBP/BN38C10][NO3]2 and [PyBP/BN32C8][NO3]2 [2]pseudorotaxane
solutions was prepared to obtain a 1:10 axle:wheel ratio by dissolving 7.953(±0.001) mg
of BN38C10 and 6.858(±0.001) mg of BN32C8 in 2.50(±0.01) mL of standard 0.50(±
0.01) x 10-3 M and 1.00(± 0.01) x 10-3 M [PyBP][NO3]2 solutions, respectively.
The volume of 2.00(±0.01) mL of standard [PyBP][NO3]2 solution was transferred to a
cuvette and titrated with the standard pseudorotaxane solution up to a wheel:axle ratio of
5:1 in the total volume of 4.00(±0.03) mL.
2.6.2. [CpBP/neutral crown ether]Cl2 [2]pseudorotoxanes
The dilution method120,121 was used to determine the binding constants of
[CpBP/BN38C10]Cl2 and [CpBP/BN38C10]Cl2 [2]pseudorotaxanes.
The standard solution of 3.00(±0.01) x 10-3 M [CpBP]Cl2 was prepared by dissolving
5.140(±0.001) mg in the total volume of 3.50(±0.03) mL while the standard solutions of
7.50(±0.01) x 10-3 M BPP34C10 were prepared by dissolving 6.033(±0.001) mg in the
total volume of 1.50(±0.01) mL of CD3OD.

The standard [CpBP]Cl2 solution was

titrated with standard BPP34C10 solution to obtain a final axle:wheel ratio of 1:5. After
each addition, 1H-NMR spectra were recorded.
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The standard solution of 3.00(±0.01) x 10-3 M [CpBP/BN38C10]Cl2 [2]pseudorotaxane
solutions were prepared by dissolving 14.042(±0.001) mg of [CpBP]Cl2 and
19.089(±0.001) mg of BN38C10 in a 10.00(±0.02) mL volumetric flask.
The standard solution of 1.50(±0.01) x 10-3 M [CpBP/BN32C8]Cl2 [2]pseudorotaxane
solutions were prepared by dissolving 7.021(+0.001) mg of [CpBP]Cl2 and 8.229(±0.001)
mg of BN32C8 in a 10.00(±0.02) mL volumetric flask.
The standard solution of pseudorotaxanes were transferred to a cuvette and diluted with a
1:1 mixture of CH3OH:CHCl3 by successive addition of 125 L to obtain the final
volume of 4.00(±0.03) mL. After each addition absorbance at max was measured using a
UV-Vis spectrometer.
2.6.3. [C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes
A standard solution of 1.0(±0.1) x 10-3 M [C4BP][PF6]2 was prepared in 10.00(± 0.02)
mL volumetric flasks by dissolving 6.8(± 0.1) mg of [C4BP][PF6]2 in a 1:1 mixture of
CH3CN:CHCl3.
The standard [C4BP/wheel][PF6]2 pseudorotaxane solutions were prepared to obtain
1.0(± 0.1) x 10-3 M [C4BP][PF6]2 concentration and 10.0(± 0.1) x 10-3 M wheel
concentration in the same solution by dissolving 13.4(±0.1) mg of BPP34C10, 15.9(±
0.1) mg of BN38C10, 13.7(± 0.1) mg of BN32C8, respectively in 2.50(± 0.01) mL of
standard [C4BP][PF6]2 solution.
The volume of 2.00(+0.01) mL standard [C4BP][PF6]2 solution was transferred to a
cuvette and titrated with standard pseudorotaxane solution up to a wheel:axle ratio of
5:1 in a total volume of 4.00(±0.03) mL.
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2.6.4. [4,4′-bipyridinium axle/DSBPP34C10] [2]pseudorotaxanes
The dilution method was used to determine the binding constant and extinction
coefficient of [axle/DSBPP34C10] [2]pseudorotaxanes.120,121 Water was used as the
solvent.
The 3.0(± 0.1) x 10-3 M solutions of the axle and the wheel were prepared in 5.00(±0.01)
mL volumetric flasks. The UV-visible spectrum of each solution was recorded and the
max was determined. The solutions were diluted by adding 200 L of the solution at a
time and the new absorbance was measured at the max. The dilution followed by
absorbance measurements were carried out to obtain 12 data points.

2.7. Electrochemistry
A composite electrode system containing two platinum wires (0.04 mm) as working and
counter electrodes and a silver wire as a quasi-reference electrode was used. It was
polished using 0.05 m Al2O3 on a felted surface.

Tetrabutylammonium

hexafluorophosphate (TBAPF6, 0.1 M) was used as a supporting electrolyte unless
otherwise mentioned. The sample solutions were degassed by purging purified nitrogen
and kept under an inert atmosphere throughout the measurements. Ferrocene was used as
an internal standard. Potential values were reported versus the ferrocene/ferrocenium
(Fc/Fc+) redox couple.

The volume of 2.00 (± 0.01) mL of standard solution was

transferred to a shell vial which contains 77.5(± 0.1) mg of TBAPF6 (supporting
electrolyte) and few crystals of ferrocene (reference). Solvent-saturated N2 was purged
through the electrochemical solution over 30 min. This procedure was followed for all
standard solutions prior to the electrochemical measurements.
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2.7.1. [PyBP/neutral crown ether][PF6]2 pseudorotaxanes
The standard solutions of the axle, wheel and [PyBP/wheel][PF6]2 [2]pseudorotaxane
were prepared in a 1:1 mixture of CH3CN:CH2Cl2.
The standard solutions of 0.50(± 0.01) x 10-3 M [PyBP][PF6]2, BPP34C10, BN38C10 and
BN32C8 were prepared in 10.00(±0.02) mL volumetric flasks by dissolving
3.010(±0.001) mg, 2.683(±0.001) mg, 3.181(±0.001) mg and 2.743(±0.001) mg,
respectively.
The standard solutions of 0.50(± 0.01) x 10-3 M [PyBP/wheel][PF6]2 [2]pseudorotaxanes
were prepared by 3.010(±0.001) mg of [PyBP][NO3]2 together with 2.683(±0.001) mg of
BPP34C10, 3.181(±0.001) mg of BN38C10 and 2.743(±0.001) mg of BN32C8 in 10.00
mL volumetric flasks.
2.7.2. [CpBP/neutral crown ether]Cl2 [2]pseudorotaxanes
Tetrabutylammonium chloride (TBACl) (55.6 mg, 0.1 M) was used as the supporting
electrolyte. The standard solutions of the axle, wheel and [CpBP/wheel]Cl2
[2]pseudorotaxane were prepared in a 2:1 mixture of CH3OH:CH2Cl2.
The standard solutions of 1.00(± 0.01) x 10-3 M [CpBP]Cl2, BPP34C10, BN38C10 and
BN32C8 were prepared in 10.00(±0.02) mL volumetric flasks by dissolving
4.681(±0.001) mg, 5.366(±0.001) mg, 6.362(±0.001) mg and 5.486(±0.001) mg
respectively.
The standard solutions of 1.00(± 0.01) x 10-3 M [CpBP/wheel]Cl2 pseudorotaxanes were
prepared by dissolving 4.681(±0.001) mg of [CpBP]Cl2 together with 5.366(±0.001) mg
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of BPP34C10 or 6.362(±0.001) mg of BN38C10 or 5.486(±0.001) mg of BN32C8 in
10.00(± 0.02) mL volumetric flasks.
2.7.3. [C4BP/ neutral crown ether][PF6]2 pseudorotaxanes
A 1:2 mixture of CH3CN:CH2Cl2 were used as the solvent mixture for the axle, wheel and
[C4BP/wheel][PF6]2 [2]pseudorotaxane solutions.
The standard solutions of 1.0(± 0.1) x 10-3 M [C4BP][PF6]2, BPP34C10, BN38C10 and
BN32C10 were prepared in 10.00(± 0.02) mL volumetric flasks by dissolving 6.7(± 0.1)
mg, 5.3(± 0.1) mg, 6.3(± 0.1) mg and 5.4(± 0.1) mg, respectively.
The standard solution of 1.0(± 0.1) x 10-3 M [C4BP/BPP34C10][PF6]2 [2]pseudorotaxane
was prepared in 10.00(± 0.02) mL volumetric flask by dissolving 6.7(± 0.1) mg of
[C4BP][PF6]2 and 5.3(± 0.1) mg of BPP34C10.
2.7.4. [4,4′-bipyridinium axle/DSBPP34C10] [2]pseudorotaxanes
The standard solutions of 0.50(± 0.01) x 10-3 M [PyBP/syn-DSBPP34C10] and
[PyBP/anti-DSBPP34C10] were prepared in a 10.00(± 0.02) mL volumetric flask by
dissolving 5.032(± 0.001) mg in a 2:1 mixture of CH3OH:CH3CN.
The standard solutions of 1.00(± 0.01) x 10-3 M [CpBP/syn- and anti-DSBPP34C10]
were prepared in a 10.00(± 0.02) mL volumetric flask by dissolving 10.904(±0.001) mg
of [CpBP/syn- and anti- DSBPP34C10] crystals in a 2:1 mixture of CH3OH:CH2Cl2.
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2.8. Metal binding studies of [PyBP/neutral crown ether]2+ by UV-Vis spectroscopy
Standard solutions of 2.00(± 0.01) x 10–3 mM [PyBP][NO3]2, BPP34C10, BN38C10 and
BN32C8 were prepared in 5.00(±0.01)

mL volumetric flasks by dissolving

4.361(±0.001) mg, 5.366(±0.001) mg, 6.363(±0.001) mg and 5.486(±0.001) mg,
respectively. Standard solutions of 4.00(± 0.01) x 10–3 mM ZnCl2, ZnBr2, ZnI2, CdCl2,
CdBr2, CdI2, HgCl2, HgBr2 and HgI2 were prepared in 10.00(±0.02) mL volumetric flasks
by dissolving 5.464(±0.001) mg, 9.008(±0.001) mg, 12.767(±0.001) mg, 9.133(±0.001)
mg, 10.888(±0.001) mg, 14.650(±0.001) mg, 10.860(±0.001) mg, 14.416(±0.001) mg and
18.176(±0.001) mg, respectively.
Standard solutions of 4.00(± 0.01) x 10–3 mM ZnCl2/KCl, ZnBr2/KBr and ZnI2/KI were
prepared by adding 5.452(±0.001) mg of KCl, 9.008(±0.001) mg of KBr, 12.767(±0.001)
mg of KI in standard solutions of 4.00(± 0.01) x 10–3 mM ZnCl2, ZnBr2 and ZnI2,
respectively. As shown in Table 2.3, standard solutions were mixed and UV-Vis spectra
of each solution were recorded.
Volume of
[PyBP]2+
solution/ mL
1.00
1.00
1.00
1.00

Volume of the
crown ether
solution/ mL
1.00
1.00
1.00
1.00

Volume of
MX2 or
MX2/KX / mL
0.25
0.50
0.75
1.00

Volume of the
solvent/ mL

Pseudorotaxane:
M2+ ratio

0.75
0.50
0.25
0.00

1:1
1:2
1:3
1:4

Table 2.3: Solution preparation for the metal binding studies.

2.9. Metal binding studies of [PyBP/neutral crown ether]2+ by 1H-NMR spectroscopy
All pseudorotaxane solutions were prepared in a 1:1 mixture of CH3OH:CH2Cl2 while all
MX2/KX (1/1) (M = Zn(II), Cd(II), Hg(II), X = Cl¯, Br¯, I¯) solutions were prepared in
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CH3OH. Always a solution of MX2/KX (1/1) was layered over a solution of
pseudorotaxane. Each pseudorotaxane layer consisted of a 1:1 mixture of [PyBP][NO3]2
axle (2.5 mg, 0.0057 mmol) and crown ether (BPP34C10 (3.1 mg, 0.0057 mmol) or
BN38C10 (3.6 mg, 0.0057 mmol) or BN32C8 (3.2 mg, 0.0057 mmol)). The MX2/KX
(1/1) layer consisted of two molar equivalents of pseudorotaxanes.
After one week, the resulting solution and crystals/precipitate were separated by
decanting the solution. Crystals or precipitates were washed with a 3:1 mixture of
CH3OH and CH2Cl2 and dried under air. The decanted solution was evaporated. 1H-NMR
spectra of evaporated solution and dried crystal/precipitates were recorded in DMSO-d6.
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2.10. Crystallographic data
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm‒3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

BN32C8

[PyBP][PF6]2

[C4BP][PF6]2

C32H36O8
548.61
Triclinic
Pī
7.4523(3)
8.8380(3)
10.7212(5)
84.569(2)
77.234(2)
83.613(2)
682.61(5)
1
1.335
0.095
9470/ 3269
2461
1.153
0.0429, 0.1458

C20H16F12N4P2
602.31
Monoclinic
Pī
8.2362(3)
10.3486(3)
14.9607(4)
110.227(1)
105.969(1)
90.024(1)
1143.87(6)
2
1.749
0.307
12590/ 5545
1989
0.609
0.0528, 0.1140

C22H30F12N2O4P2
676.42
Orthorhombic
Pbca
12.7649(2)
14.3247(2)
15.5038(2)
90.00
90.00
90.00
2834.92(7)
4
1.585
0.265
45964/ 4333
2286
1.742
0.0871, 0.2767

[PyBP/BPP34C10][NO3]2
[PyBP/BN38C10][SbF6]2
6CH3OH
C54H80N6O22
C56H60F12N4O10Sb2
1165.24
1420.62
Triclinic
Monoclinic
P21/n
Pī
12.213(1)
10.3855(1)
14.899(2)
24.9720(2)
17.192(2)
11.6137(1)
89.846(2)
90
70.310(2)
109.275
86.037(2)
90
2937.7(6)
2843.14(4)
2
2
1.317
1.6593
0.102
1.051
23489/ 11982
44789/ 8249
7105
6065
0.953
0.790036
0.035196, 0.0605
0.0799, 0.2142

Table 2.4 continued.
[PyBP/BN32C8][SbF6]2
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm–3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

C52H52F12N4O8Sb2
1332.51
Triclinic
Pī
10.3857(1)
10.4595(1)
13.6142(2)
103.848(1)
96.698(1)
111.089(1)
1305.75(3)
1
1.6944
1.135
35411/ 7609
4965
1.348642
0.078269,0.2295

[PyBP/(DB24C8)2][NO3]2
H2O
C68H82N6O23
1351.41
Triclinic
Pī
14.610(2)
16.579(2)
20.410(3)
110.930(2)
99.577(2)
102.447(2)
4345.4(1)
2
1.031
0.134
36399/ 18681
9640
0.980
0.0820, 0.2413

[CpBP-2H+/BPP34C10]

[CpBP-2H+/BN32C8]

C52H56N2O14
933.01
Triclinic
Pī
12.927(2)
12.934(2)
23.159(4)
78.533(2)
84.806(3)
72.774(2)
3622.5(1)
3
1.248
0.094
29287/ 15504
8179
0.952
0.0657, 0.1551

C56H52N2O12
945.02
Monoclinic
P2(1)/n
14.787(3)
19.130(4)
22.707(5)
90.00
98.202(4)
90.00
6358(2)
10
1.272
0.095
43083/ 11152
7250
1.061
0.1627, 0.4180

Table 2.4 continued.
[C4BP/BPP34C10][PF6]2
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm‒3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

C50H70F12N2O14P2
1213.02
Triclinic
Pī
10.5908(2)
11.5200(3)
13.0613(5)
102.140(2)
101.609(2)
109.620(1)
1402.07(7)
1
1.437
0.182
78662/ 8541
7109
1.271
0.0435, 0.1537

[PyBP/syn-DSBPP34C10]
4CH3OH
C52H70N4O20S2
1135.24
Monoclinic
P2(1)/c
19.636(2)
17.557(2)
15.764(2)
90.00
99.144(2)
90.00
5365.3(1)
4
1.405
0.181
37482/ 11636
6747
1.086
0.1539, 0.2504

[PyBP/anti-DSBPP34C10]
4CH3OH
C52H70N4O20S2
1135.24
Triclinic

[CpBP/anti-DSBPP34C10]
4CH3OH
C56H70N2O24S2
1218.38
Triclinic

Pī

Pī

8.5780(2)
12.9550(2)
13.1558(3)
81.374(1)
71.058(1)
85.470(1)
1366.45(5)
1
1.380
0.178
38258/ 8317
6577
1.035
0.0544, 0.1461

12.3174(2)
16.0382(2)
16.8376(2)
74.166(1)
70.057(1)
85.460(1)
3007.79(7)
2
1.192
0.158
16070/ 10099
896
1.467
0.0862, 0.2458

Table 2.4 continued.
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm‒3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

[C4BP/anti-DSBPP34C10]

[C4BP/syn-DSBPP34C10]

[PyBP/BN38C10](ZnCl3)2

C50H68N2O20S2
1081.18
Monoclinic
Pn

C52H80N2O24S2
1181.30
Triclinic

15.7889(15)
8.3821(8)
23.226(2)
90.00
107.124(2)
90.00
2937.6(5)
2
1.222
0.161
23934/ 12447
9140
1.031
0.0714, 0.1973

12.844(4)
14.902(4)
15.770(5)
83.125(5)
85.321(5)
76.012(5)
2903.6(2)
2
1.351
0.174
24432 /12437
8603
1.070
0.0542, 0.1454

C56H60Cl6N4O10Zn2
1292.52
Monoclinic
P21/n
17.5218(8)
16.1106(7)
20.7074(9)
90.00
100.232(3)
90.00
5752.5(4)
4
1.492
1.173
82404/ 16811
6195
0.937
0.0697, 0.1214

Pī

[PyBP/BN32C8](ZnCl3)2
2CH3OH
C54H60Cl6N4O10Zn2
1268.50
Monoclinic
P21/c
8.5117(3)
15.9674(5)
20.4293(6)
90
97.588(2)
90
2752.23(2)
2
1.531
1.224
90784/ 8046
5921
1.058
0.0518, 0.1497

Table 2.4 continued.
[PyBP/BN38C10](ZnBr3)2
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm‒3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

C56H60Br6N4O10Zn2
1559.28
Monoclinic
P21/n
17.5924(2)
16.3095(2)
21.2570(2)
90.00
100.799(1)
90.00
5991.1(1)
4
1.729
4.861
162070/ 17520
11007
1.041
0.0470, 0.0947

[PyBP/BN32C8](ZnBr3)2
CH3OH
C53H56Br6N4O9Zn2
1503.22
Monoclinic
P21/c
8.4959(1)
16.3216(2)
20.7112(3)
90.00
97.903(1)
90.00
2844.68(6)
2
1.755
5.114
40093/8294
3319
0.966
0.1362, 0.0703

[PyBP/BPP34C10][CdBr4]

[PyBP/BN38C10][CdBr4]

C48H56Br4CdN4O10
1281.01
Orthorhombic
Pbca

C56H60Br4CdN4O10
1381.12
Monoclinic

18.9050(2)
17.3064(1)
31.5699(3)
90.00
90.00
90.00
10328.9(1)
8
1.838
3.587
171593/15776
9854
0.908 (1.061486)
0.0467, 0.1216

11.1323(2)
20.1613(3)
28.3599(5)
91.835(1)
100.902(1)
92.955(1)
6236.3(2)
4
1.635
3.101
174034/37707
15215
1.053
0.0843/ 0.1982

Pī

Table 2.4 continued.
[PyBP/BPP34C10][CdI4]
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm‒3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

C48H56CdI4N4O10
1468.97
Orthorhombic
Pbca
18.7667(2)
18.3528(2)
31.9417(4)
90.00
90.00
90.00
11001.4(2)
8
1.774
2.697
104749/16836
8139
1.016
0.0820, 0.1412

2([PyBP/BN38C10][CdI4])
CHCl3∙4CH3OH
C117H137Cd2Cl3I8N8O24
3385.70
Monoclinic

[PyBP/BN32C8](CdI3)2
2CH3OH
C54H60Cd2I6N4O10
1911.26
Monoclinic

[PyBP/BN38C10](Hg2Cl6)2
PyBP∙2CH3OH
C78H84Cl12Hg4N8O12
2553.29
Triclinic

Pī

Pī

Pī

11.5238(4)
13.9373(4)
20.2886(7)
86.472(2)
88.951(2)
76.119(2)
3157.39(18)
1
1.781
2.426
83396/ 15025
7194
0.822
0.0859, 0.2105

9.8786(2)
16.8160(3)
20.8803(3)
98.642(1)
102.633(1)
105.02(1)
3189.3(1)
2
1.990
3.625
102629/ 18525
7402
0.985
0.0730, 0.1363

10.8869(1)
14.7822(1)
15.3243(1)
112.373(1)
100.917(1)
103.572(1)
2107.60(3)
1
2.012
7.707
57233/ 12266
7828
1.022
0.0432, 0.0655

Table 2.4 continued.
[PyBP/BN32C8][Hg2Cl6]
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm‒3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

C52H52Cl6Hg2N4O8
1474.86
Triclinic

[PyBP/BN38C10] (Hg2Br6)2
PyBP∙CH3OH
C77 H80 Br12 Hg4 N8 O11
3054.77
Monoclinic

[PyBP/BN32C8][Hg2Br6]

[PyBP/BN38C10][Hg2I6]

C52 H52 Br6 Hg2 N4O8
1741.62
Monoclinic

C59H72Hg2I6N4O13
2207.79
Monoclinic

Pī

Pī

Pī

Pī

9.7025(2)
11.5838(3)
12.6269(3)
98.550(1)
103.965(1)
101.351(1)
1321.26(5)
1
1.854
6.164
57649/7696
6137
1.038
0.0426, 0.0986

10.9943(2)
15.1689(2)
15.5408(3)
111.580(1)
101.951(1)
104.728(1)
2196.86(7)
1
2.309
12.484
61152/ 12778
7328
1.066
1.066/ 0.0584

9.8203(1)
11.5983(2)
12.8782(2)
94.835(1)
106.333(1)
103.139(1)
1353.42(3)
1
2.137
10.150
58173/7890
7162
0.770
0.0239, 0.0862

11.3555(2)
12.1082(2)
14.2423(3)
103.372(1)
97.008(1)
115.665(1)
1661.16(5)
1
2.207
7.465
94488/ 10141
9381
1.009
0.0302, 0.1145

Table 2.4 continued.
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Formula
Fw
cryst syst
space group
a/Å
b/Å
c/Å
deg
deg
deg
V/ Å3
Z
Dcalc/g cm‒3
/mm-1
reflns collected/unique
obsd reflns [I > 2
GOF (on F2)
R(F), Rw(F) [I > 2

[PyBP/BN32C10][Hg2I6]

Cu(Pyacac)2∙2CHCl3

Cu(Pyacac)2

C52 H52 Hg2 I6 N4 O8
2023.56
Monoclinic

C22H22Cl6CuN2O4
654.69
Monoclinic
P21/n
7.5930(1)
10.2106(2)
16.4980(2)
90
98.950(1)
90
1263.50(3)
2
1.7207
1.533
18514/
4018
3233
0.879021
0.034356/ 0.1257

C20H20CuN2O4
415.94
Monoclinic
P21/n
7.5845(1)
14.2341(2)
11.0903(2)
90
96.340(1)
90
1189.97(3)
2
1.1607
0.940
17497/ 3609
2789
3.064404
0.135611/ 0.4094

Pī
10.039(1)
11.7664(12)
13.0968(13)
93.757(6)
106.866(6)
105.202(7)
1411.8(2)
1
2.380
8.765
39316/8564
5312
1.058
0.0840, 0.2520

Table 2.4: Crystallographic data of starting materials, ligands and their supramolecules.

[Cu(Phacac)2]2
[diaza-18-crown-6]
C48H52Cu2N2O12
976.02
Triclinic
P

[Cu(L1)][PF6]2
C40H34CuF12N4O2P2
956.19
Triclinic
P

12.1642(1)
19.2773(3)
21.2499(2)
112.581(1)
105.852(1)
96.121(1)
4298.65(9)
4
1.039
0.549
138525/ 24971
17104
0.892
0.0442/ 0.1197

9.0642(1)
11.0157(1)
19.9613(2)
78.810(1)
88.689(1)
88.511(1)
1954.23(3)
2
1.625
0.741
43463/ 9290
6601
1.034
0.0587/ 0.1412

CHAPTER 3

RESULTS AND DISCUSSION
3.1. Characterization of pseudorotaxanes
3.1.1. UV-visible spectroscopic studies
[PyBP][NO3]2, [CpBP]Cl2 and [C4BP]Br2 axles are very slightly yellow in color while
[C4BP][PF6]2 axle, BPP34C10, BN38C10, BN32C8 and [TBA]2DSBPP34C10 crown
ethers are colorless in the solution regardless of the solvent. Upon mixing the solutions of
the axle and the wheel, colored pseudorotaxane solutions formed instantaneously.
In [4,4′-bipyridinium/aromatic crown ether] [2]pseudorotaxanes,

the -electron rich

wheel interacts with the -electron deficient axle via CT interaction to form a colored
host-guest complex.

The color of [2]pseudorotaxanes depends on the energy gap

between the highest occupied molecular orbital (HOMO) of the donor unit (crown ethers)
and the lowest unoccupied molecular orbital (LUMO) of the acceptor unit (4,4′bipyridinium core).122 Therefore, using different crown ethers with the same axle
produces a series of colors due to the change in the HOMO energy level while the LUMO
energy level remains constant. Table 3.1 summarizes the absorbance maxima of the
pseudorotaxane solutions studied.
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Axle
Wheel
[PyBP][NO3]2 BPP34C10
BN38C10
BN32C8
[CpBP]Cl2
BPP34C10
BN38C10
BN32C8
[C4BP][PF6]2 BPP34C10
BN38C10
BN32C8
[C4BP][PF6]2 [TBA]2DSBPP34C10
[PyBP][NO3]2
[CyBP]Cl2

Solvent
CH3OH: CHCl3 = 1:1

CH3OH: CHCl3 = 1:1

Acetone: CH2Cl2 = 2:1

CH3OH

max/ nm
495
590
610
484
556
585
451
503
501
393
440
440

Table 3.1: Absorption spectral data for [2]pseudorotaxanes.

3.1.1.1. [PyBP/neutral crown ether][NO3]2 [2]pseudorotaxanes
A mixture of [PyBP][NO3]2 axle with crown ethers, BPP34C10, BN38C10 or BN32C8 in
a 1:1 mixture of CH3OH and CHCl3 produced red, purple and blue colored solutions with
absorption maxima at 495, 590 and 610 nm, respectively (Figure 3.1).
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a)

1.00

b)

B4
rot
[PyBP/BPP34C10][NO
3]2
N4
rot
[PyBP/BN38C10][NO
3]2
[PyBP/BN32C8][NO
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rot
3]2
[PyBP][NO3]2
PyBP
BPP34C10
B4
BN38C10
N3
BN32C8
N4

0.90

Absorbance

0.80
0.70
0.60
0.50
0.40
0.30
0.20
0.10
0.00
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Wavelength/ nm

Figure 3.1: a) Pseudorotaxane solutions; b) UV-Visible spectra of [PyBP/neutral crown
ether][NO3]2 [2]pseudorotaxanes (in a 1:1 mixture of CH3OH and CHCl3).
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3.1.1.2. [CpBP/neutral crown ether]Cl2 [2]pseudorotaxanes
Upon mixing a solution of [CpBP]Cl2 axle in a 1:1 mixture of CH3OH and CHCl3 with
solutions of crown ethers, BPP34C10, BN38C10 or BN32C8 in the same solvent mixture
produced red, purple and blue colored solutions with absorption maxima at 484, 556 and
585 nm, respectively (Figure 3.2).

a)
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1.00

b)

B4[CpBP/BPP34C10]Cl2
N4[CpBP/BN38C10]Cl2
N3[CpBP/BN32C8]Cl2
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[CpBP]Cl2
B4BPP34C10
N4BN38C10
N3BN32C8

0.90
0.80

Absorbance
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0.60
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0.40
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0.10
0.00
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550
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750
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Wavelength/ nm

Figure 3.2: a) Pseudorotaxane solutions; b) UV-Visible spectra of [CpBP/neutral crown
ether]Cl2 [2]pseudorotaxanes (in a 1:1 mixture of CH3OH and CHCl3).

3.1.1.3. [C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes
Addition of the axle solution to a BPP34C10 wheel solution (2:1 mixture of acetone and
CH2Cl2) instantaneously produced a light orange colored solution with absorption
maximum at 451nm, while both BN38C10 or BN32C8 wheel solutions produced light
magenta colored solutions with absorption maxima at 503 and 501 nm, respectively
(Figure 3.3).
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0.7
[C4BP/BN38C10][PF6]2
(8)_14f
[C4BP/BN32C8][PF6]2
(8)_14g
[C4BP/BPP34C10][PF6]2
(8)_14e
BN38C10
(8)_14c
BN32C8
(8)_14d
BPP34C10
(8)_14b
[C4BP][PF6]2
(8)_14a

Absorbance

0.6
0.5
0.4
0.3
0.2
0.1
0
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450

550

650

750

Wavelength/ nm

Figure 3.3: UV-Visible spectra of [C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes
(in a 1:1 mixture of acetone and CH2Cl2).
3.1.1.4. [DSBPP34C10/axle] [2]pseudorotaxanes
Both [PyBP][NO3]2 and [CpBP]Cl2 instantaneously produced maroon–red solutions with
the wheel in CH3OH, which show absorption maxima at 440 nm, while [C4BP]Br2
produces an orange solution with absorption maximum at 393 nm (Figure 3.4).
0.49

[CpBP/syn- and anti-DSBPP34C10]
7_23_6
[PyBP/syn- and anti-DSBPP34C10]
7_20_6
[C4BP/syn- and anti-DSBPP34C10]
7_25_5
[CpBP]Cl2
7_23_11
[PyBP][NO3]2
7_20_11
[C4BP][PF6]2
7_25_11
syn- and anti-DSBPP34C10
7_20_1

Absorbance

0.39
0.29
0.19
0.09
-0.01
350

450

550

650

750

Wavelength/ nm

Figure 3.4: UV-Visible spectra of [axle/DSDBPP34C10] [2]pseudorotaxanes (in
CH3OH).
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In the case of the pseudorotaxanes discussed in Section 3.1.1., the CT transitions between
the -electron rich wheel and the -electron deficient axle, and similar color changes
were observed. [4,4′-bipyridinium/BPP34C10]2+ [2]pseudorotaxane analogs with
benzyl123 or methyl21 instead of pyridyl, 4-carboxyphenyl or 3-(carboethoxy)propyl
groups show max values at 450 nm and 436 nm, respectively (in acetone). These slight
changes are attributed to the change in LUMO level of the axle due to different
substituent groups and the polarity of the medium (solvent).
The absorbance maxima of both [C4BP/BN38C10]2+ and [C4BP/BN38C10]2+
[2]pseudorotaxane systems lie in the same region as similar [4,4′-bipyridinium/
binaphtho] chromophores (501 nm).105 Compared to the [C4BP]2+ axle, aromatic
substitutents – pyridyl and 4-carboxyphenyl – at the two ends of the [PyBP]2+ and
[CpBP]2+ axles shift the absorption band to higher wavelengths by means of reducing the
HOMO-LUMO energy gap of the naphthalene donor group and the 4,4′-bipyridinium
core acceptor of pseudorotaxanes.
The absorption maxima of [4,4′-bipyridinium/DSBPP34C10] [2]pseudorotaxanes appear
in a lower wavelength region than those of [4,4′-bipyridinium/BPP34C10]2+, even in
highly polar solvents, such as water or CH3OH. This difference is attributed to the
decrease in the HOMO energy level of the [DSBPP34C10]2–, compared to BPP34C10
which results in an increase in the HOMO-LUMO energy gap.

99

3.1.2. 1H-NMR spectroscopic studies
1

H–NMR spectra of the individual axle, individual wheel, equimolar mixture of the two

or crystals of [2]pseudorotaxanes were recorded in the same deuterated solvent/solvent
mixtures at room temperature. The peaks of both the axle and the wheel shift from their
original chemical shift value upon pseudorotaxane formation. The 1H–NMR spectra of
the [2]pseudorotaxanes discussed below show only a single set of resonances, even after
the addition of excess axle or wheel. This observation revealed that [2]pseudorotaxanes
undergo a fast exchange equilibrium with their individual axle and wheel components on
the NMR time scale. The relative chemical shift of the individual components of the
[2]pseudorotaxane depends on the  stacking, C–H···O hydrogen bonds and N···O–
electrostatic interactions involved in [2]pseudorotaxanes.

3.1.2.1. [PyBP/neutral crown ether][NO3]2 [2]pseudorotaxanes
The 1H–NMR spectra of [PyBP/neutral crown ether] pseudorotaxanes were recorded in a
1:1 mixture of CD3OD and CDCl3. The upfield shifts of the axle protons in the  = 8.28–
9.82 ppm region and the downfield shifts of neutral crown ether peaks in the  = 6.71–
8.01 ppm region are a result of pseudorotaxane formation (Table 3.2). A representative
example of stacked 1H-NMR spectra of the axle, [2]pseudorotaxane and the wheel is
shown below (Figure 3.5). Proton assignments are given in Figure 3.6.
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Figure 3.5: 1H-NMR spectra (400 MHz) of 3.88 mM solutions of [PyBP][NO3]2 (blue),
BPP34C10 (red), and [PyBP/BPP34C10][NO3]2 (green) in a 1:1 mixture of CH3OH and
CHCl3 at 25 ◦C.

3.1.2.2. [CpBP/neutral crown ether][NO3]2 [2]pseudorotaxanes
The 1H–NMR spectra of [CpBP/neutral crown ether] pseudorotaxanes were recorded in a
2:1 mixture of CD3OD and CDCl3. Similarly to the chemical shift changes of the
[PyBP]2+ pseudorotaxanes, the NMR peaks of the [CpBP]2+ axle in the  = 7.98–9.56
ppm region shifted upfield, while the ones of the wheel in the  = 6.72–7.71 ppm region
shifted downfield due to pseudorotaxane formation (Table 3.3).

3.1.2.3. [C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes
The 1H–NMR spectra of [C4BP/neutral crown ether] pseudorotaxanes were recorded in a
2:1 mixture of acetone–d6 and CDCl3.

The significant upfield shifts of the NMR
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resonances of the [C4BP]2+ axle in the  = 8.77–9.38 ppm region (Ha and Hb protons) and
the downfield shifts of the wheel peaks in the  = 6.72–7.72 ppm region (Hh, Hi and Hj
protons) are an indication of the interaction between the 4,4′–bipyridinium core of the
[C4BP]2+ axle and the neutral crown ether wheels (Table 3.4).

3.1.2.4. [axle/DSBPP34C10] [2]pseudorotaxanes
The 1H–NMR spectra of [C4BP/DSBPP34C10] pseudorotaxanes were recorded in a 2:1
mixture of acetone-d6:CDCl3, while the ones of the [PyBP/DSBPP34C10] and the
[CpBP/DSBPP34C10] [2]pseudorotaxanes were recorded in CD3OD (Table 3.5 and 3.6).
Since a mixture of syn– and anti– isomers of DSBPP34C10 were used, two distinct sets
of aromatic peaks were observed in the aromatic region of the crown ethers (but only one
set in the aliphatic region). Similar to the previous [2]pseudorotaxanes, with neutral
crown ethers, the peaks of the axle shifted upfield, while the peaks of the crown ether
peaks shifted downfield.

Figure 3.6: Proton assignment of axles and wheels.

102

In the case of the [2]pseudorotaxanes discussed above,  stacking interactions between
the 4,4′–bipyridinium core and aromatic rings (bis-phenyl or bis-naphtho) of the crown
ethers shield the axle protons. As a result, the axle protons shift upfield, while the crown
ether peaks shift downfield.
The Hd protons of the [PyBP]2+ and [CpBP]2+ axles and the Ha protons of the [C4BP]2+
axle of the [2]pseudorotaxanes show the largest chemical shift change among the
different protons of those pseudorotaxanes. The magnitude of the chemical shift change
of [bis-naphtho crown ether/4,4′-bipyridinium]2+ [2]pseudorotaxanes is larger than the
[bis-p-phenylene/4,4′-bipyridinium]2+ [2]pseudorotaxanes.
In the case of the [PyBP/neutral crown ether]2+ [2]pseudorotaxanes, the chemical shift of
Hd

proton

increases

as

follows:

[PyBP/BPP34C10][NO3]2

(0.49)

<

[PyBP/BN38C10][NO3]2 (0.70) < [PyBP/BN328][NO3]2 (0.77). The magnitude of the
chemical shift change of the Hd proton in each [2]pseudorotaxane system is given within
parentheses and they are correlated to the association constant measurements discussed in
Section 3.1.4. As with the [PyBP/neutral crown ether]2+ [2]pseudorotaxanes, the same
correlation of the chemical shift change and the binding constant values were observed
for all other [2]pseudorotaxanes studied here.
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Compound
[PyBP][NO3]2

CD3OD:CDCl3 = 1:1

[PyBP/BPP34C10][NO3]2

CD3OD:CDCl3 = 1:1

[PyBP/BN38C10][NO3]2

CD3OD:CDCl3 = 1:1

[PyBP/BN32C8][NO3]2

CD3OD:CDCl3 = 1:1

Compound

() for Hb /ppm

Solvent

Solvent

() for Ha /ppm

() for Hd /ppm

() for Hc /ppm

9.82

9.30

9.17

8.28

(d, J = 5.16 Hz, 4H)

(d, J = 3.64 Hz, 4H)

(d, J = 4.67 Hz, 4H)

(d, J = 3.24 Hz, 4H)

9.47 (-0.35)

9.02 (-0.28)

8.68 (-0.49)

8.06 (-0.22)

(d, J = 6.96 Hz, 4H)

(d, J = 5.12 Hz, 4H)

(d, J = 6.96 Hz, 4H)

(d, J = 6.20 Hz, 4H)

9.58 (-0.24)

9.35 (+0.05)

8.47 (-0.70)

8.39 (+0.11)

(d, J = 6.96 Hz, 4H)

(d, J = 6.24 Hz, 4H)

(d, J = 6.96 Hz, 4H)

(d, J = 6.24 Hz, 4H)

9.43 (-0.39)

9.34 (+0.04)

8.40 (-0.77)

8.29 (+0.01)

(d, J = 6.60 Hz, 4H)

(d, J = 5.88 Hz, 4H)

(d, J = 6.96 Hz, 4H)

(d, J = 6.24 Hz, 4H)

() for Hh /ppm

() for Hi /ppm

() for Hj /ppm

() for Hk /ppm

() for Hl /ppm

() for Hm /ppm

() for Hn
/ppm
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BPP34C10

[PyBP/BPP34C10][NO3]2
BN38C10

CD3OD:CDCl3 = 1:1

CD3OD:CDCl3 = 1:1

CD3OD:CDCl3 = 1:1

[PyBP/BN38C10][NO3]2

CD3OD:CDCl3 = 1:1

BN32C8

CD3OD:CDCl3 = 1:1

[PyBP/BN32C8][NO3]2

CD3OD:CDCl3 = 1:1

6.71

3.94

3.80

(s, 8H)

(m, 8H)

(m, 8H)

6.55 (-0.16)

3.84 (-0.10)

3.74 (-0.06)

(m,8H)

(m, 8H)

(m, 8H)

3.67
(m, 16H)
3.61 (-0.06)
(s, 16H)

8.01

7.45

6.76

4.22

4.15

(d, J = 8.84 Hz, 4H)

(d, J = 8.06 Hz, 4H)

(d, J = 7.72 Hz, 4H)

(d, J = 3.12 Hz, 8H)

(d, J = 3.30 Hz, 8H)

4.01

7.76 (-0.25)

7.40 (-0.05)

6.74 (-0.02)

4.28 (+0.06)

4.19 (+0.04)

(d, J = 8.08 Hz, 4H)

(d, J = 8.06 Hz, 4H)

(d, J = 7.72 Hz, 4H)

(d, J = 4.22 Hz, 8H)

(d, J = 4.04 Hz, 8H)

7.84

7.24

6.81

4.39

4.21

4.09

(d, J = 8.44 Hz, 4H)

(d, J = 8.06 Hz, 4H)

(d, J = 7.68 Hz, 4H)

(t, J = 4.76 Hz, 8H)

(t, J = 4.76 Hz, 8H)

(s, 8H)

7.63(-0.21)

7.20 (-0.04)

6.78(-0.03)

4.37 (-0.02)

4.23 (+0.02)

4.13 (+0.04)

(d, J = 8.44 Hz, 4H)

(d, J = 8.06 Hz, 4H)

(d, J = 7.72 Hz, 4H)

(d, J = 4.40 Hz, 8H)

(d, J = 4.20 Hz, 8H)

(s, 8H)

(m, 16H)
4.01 (0.00)
(m, 16H)

Table 3.2: 1H-NMR chemical shifts and chemical shift changes for the [PyBP][NO3]2 axle and it’s corresponding [2]pseudorotaxanes
(top) and wheels and their [2]pseudorotaxanes (bottom), which undergo fast exchange on the NMR time scale.

Compound
[CpBP]Cl2

[CpBP/BPP34C10]Cl2

[CpBP /BN38C10]·Cl2
[CpBP /BN32C8]Cl2

Compound

Solvent
CD3OD:CDCl3 = 2:1

CD3OD:CDCl3 = 2:1

CD3OD:CDCl3 = 2:1

CD3OD:CDCl3 = 2:1

Solvent

() for Hb /ppm

() for Ha /ppm

() for Hd /ppm

() for Hc /ppm

9.56

8.95

8.39

7.98

(d, J = 5.48 Hz, 4H)

(d, J = 5.48 Hz, 4H)

(d, J = 8.04 Hz, 4H)

(d, J = 8.04 Hz, 4H)

9.48 (-0.08)

8.70 (-0.25)

8.40 (+0.01)

8.04 (+0.06)

(d, J = 6.60 Hz, 4H)

(d, J = 5.84 Hz, 4H)

(d, J = 8.40 Hz, 4H)

(d, J = 8.04 Hz, 4H)

9.32 (-0.24)

8.44 (-0.51)

8.26 (-0.13)

8.07 (+0.09)

(d, J = 5.12 Hz, 4H)

( d, J = 8.44 Hz, 4H)

(s, 4H)

( d, J = 8.04 Hz, 4H)

9.23 (-0.33)

8.44 (-0.51)

(-0.39) 8.00 (+0.02)

(s, 4H)

(d, J = 8.04 Hz, 4H)

(d, J = 8.04 Hz, 8H)

() for Hh /ppm

() for Hi /ppm

() for Hj /ppm

6.72

3.94

3.81

(s, 8H)

(m, 8H)

(m, 8H)

6.54 (-0.18)

3.83 (-0.11)

3.73 (-0.09)

(s, 8H)

(m, 8H)

(m, 8H)

7.71

7.15

6.48

3.98

3.89

(d, J = 8.44 Hz, 4H)

(t, J = 8.06 Hz, 4H)

(d, J = 7.72 Hz, 4H)

(m, 8H)

(m, 8H)

7.41 (-0.30)

7.08 (-0.07)

6.46 (-0.02)

3.91 (-0.07)

3.85 (-0.04)

( d, J = 8.40 Hz, 4H)

( t, J = 8.06 Hz, 4H)

( t, J = 7.72 Hz, 4H)

(m, 8H)

(m, 8H)

7.52

6.94

6.54

4.09

3.91

3.79

(d, J = 8.44 Hz, 4H)

(t, J = 8.04 Hz, 4H)

(d, J = 7.68 Hz, 4H)

(m, 8H)

(m, 8H)

(m, 8H)

7.24 (-0.28)

6.89 (-0.05)

6.49 (-0.05)

4.05 (-0.04)

3.94 (+0.03)

3.84 (+0.05)

(s, 4H)

(t, J = 7.88 Hz, 4H)

(s, 4H)

(s, 8H)

(s, 8H)

(s, 8H)

() for

() for Hl

Hk /ppm
CD3OD:CDCl3 = 2:1

[CpBP/BPP34C10]Cl2

CD3OD:CDCl3 = 2:1

BN38C10

CD3OD:CDCl3 = 2:1

[CpBP /BN38C10]Cl2

CD3OD:CDCl3 = 2:1

BN32C8

CD3OD:CDCl3 = 2:1

[CpBP /BN32C8]Cl2

CD3OD:CDCl3 = 2:1
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BPP34C10

/ppm

() for

() for Hk

Hj /ppm

/ppm

3.68
(m, 16H)
3.59 (-0.09)
(m, 16H)
3.72
(m, 16H)
3.70 (-0.02)
(m, 16H)

Table 3.3: 1H-NMR chemical shifts and chemical shift changes for the [CpBP]Cl2 axle and it’s corresponding [2]pseudorotaxanes (top)
and wheels and their [2]pseudorotaxanes (bottom), which undergo fast exchange on the NMR time scale.

Compound
[C4BP][PF6]2

[C4BP/BPP34C10][PF6]2

[C4BP/BN38C10][PF6]2

[C4BP/BN32C8][PF6]2

Compound

BPP34C10
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[C4BP/BPP34C10][PF6]2

BN38C10

[C4BP/BN38C10][PF6]2

BN32C8

[C4BP/BN32C8][PF6]2

Solvent

() for Hb /ppm

() for Ha /ppm

() for Hc /ppm

() for Hf /ppm

() for He/ppm

() for Hd /ppm

() for Hg /ppm

Acetone-d6:

9.38

8.77

4.98

4.06

2.52

2.44

1.18

CDCl3 = 2:1

(d, J = 7.00 Hz, 4H)

(d, J = 6.20 Hz, 4H)

(t, J = 7.40 Hz, 4H)

(q, J = 7.10 Hz, 4H)

(t, J = 7.10 Hz, 4H)

(q, J = 7.10 Hz, 4H)

(t, J = 7.30 Hz, 6H)

Acetone-d6:

9.26 (-0.12)

8.50 (-0.27)

4.95 (-0.03)

4.10 (+0.04)

2.56 (+0.04)

2.47 (+0.03)

1.20 (+0.02)

CDCl3 = 2:1

(d, J = 6.60 Hz, 4H)

(d, J = 6.60 Hz, 4H)

(t, J = 7.50 Hz, 4H)

(q, J = 7.20 Hz, 4H)

(t, J = 7.30 Hz, 4H)

(m, 4H)

(t, J = 7.10 Hz, 6H)

Acetone-d6:

9.05 (-0.33)

7.99 (-0.78)

4.93 (-0.05)

4.13 (+0.07)

2.60 (+0.08)

2.46 (+0.02)

1.22 (+0.04)

CDCl3 = 2:1

(d, J = 6.20 Hz, 4H)

(s, 4H)

(t, J = 7.40 Hz, 4H)

(q, J = 7.20 Hz, 4H)

(t, J = 7.30 Hz, 4H)

(m, 4H)

(t, J = 7.10 Hz, 6H)

Acetone-d6:

9.13 (-0.25)

8.16 (-0.61)

4.90 (-0.08)

4.12 (–0.06)

2.56 (+0.04)

2.48 (+0.04)

1.21 (+0.03)

CDCl3 = 2:1

(s, 4H)

(s, 4H)

(s, 4H)

(m, 4H)

(t, J = 7.30 Hz, 4H)

(m, 4H)

(t, J = 7.10 Hz, 6H)

() for Hh /ppm

Solvent

() for Hi /ppm

() for Hj /ppm

() for Hk /ppm

() for Hl /ppm

() for

() for

Hm /ppm

Hn/ppm

Acetone-d6:

6.72

3.94

3.77

CDCl3 = 2:1

(s, 8H)

(m, 8H)

(m, 8H)

3.62

Acetone-d6:

6.49 (–0.23)

3.79 (–0.15)

3.74 (–0.03)

CDCl3 = 2:1

(m,8H)

(m, 8H)

(m, 8H)

Acetone-d6:

7.72

7.15

6.52

4.04

3.90

CDCl3 = 2:1

(d, J = 8.40 Hz, 4H)

(t, J = 8.10 Hz, 4H)

(d, J = 7.70 Hz, 4H)

(t, J = 4.60 Hz, 8H)

(t, J = 4.40 Hz, 8H)

Acetone-d6:

7.22 (–0.50)

7.05 (–0.10)

6.54 (+0.02)

3.99 (–0.05)

3.90 (0.00)

CDCl3 = 2:1

(d, J = 8.08 Hz, 4H)

(t, J = 8.10 Hz, 4H)

(d, J = 7.70 Hz, 4H)

(d, J = 4.40 Hz, 8H)

(d, J = 4.00 Hz, 8H)

Acetone-d6:

7.55

6.93

6.59

4.12

3.88

3.73

CDCl3 = 2:1

(d, J = 8.40 Hz, 4H)

(t, J = 8.10 Hz, 4H)

(d, J = 7.70 Hz, 4H)

(t, J = 4.80 Hz, 8H)

(t, J = 4.80 Hz, 8H)

(s, 8H)

Acetone-d6:

7.30 (–0.25)

6.94 (–0.01)

6.60 (+0.01)

4.12 (0.00)

3.95 (–0.07)

3.85 (+0.08)

CDCl3 = 2:1

(s, 4H)

(t, J = 8.10 Hz, 4H)

(d, J = 7.70 Hz, 4H)

(d, J = 4.40 Hz, 8H)

(d, J = 4.00 Hz, 8H)

(s, 8H)

(m, 16H)
3.73 (+0.11)
(s, 16H)
3.70
(m, 16H)
3.80 (–0.10)
(s, 16H)

Table 3.4: 1H–NMR chemical shifts and chemical shift changes for the [C4BP][PF6]2 axle and it’s corresponding [2]pseudorotaxanes
(top) and wheels and their [2]pseudorotaxanes (bottom), which undergo fast exchange on the NMR time scale.

Compound

Solvent

Aromatic protons (Hh, Hi and Hj)
() for Hh

Aliphatic protons ( Hk, Hl, Hm and Hn)

() for Hi /ppm

() for Hj /ppm

() for Hk /ppm

/ppm

() for

() for Hm /ppm

() for Hn

Hl /ppm





/ppm

syn- and anti-

Acetone-d6:

7.40

6.96

6.83

4.12

3.96

3.80

3.74

3.66

3.60

[TBA]2DSBPP34C10

CD3OD = 2:1

(d+d, J =

(d+d, J = 8.80 Hz,

(dd+dd, J = 3.28,

(t, J = 5.32 Hz,

(m, 4H)

(m, 4H)

(m, 4H)

(m, 4H)

(m, 12H)

3.14 Hz, 2H)

2H)

8.80 Hz, 2H)

4H)

[C4BP/ syn- and antiDSBPP34C10]
syn- and anti-

Acetone-d6:
CD3OD = 2:1

6.75

CD3OD

7.41

7.00

6.87

4.15

3.98

3.86

3.79

3.71

3.65

(d+d, J =

(d+d, J = 2.38 Hz,

(dd+dd, J = 3.32,

(t, J = 5.14 Hz,

(m, 4H)

(t, J = 5.12 Hz, 4H)

(m, 4H)

(m, 4H)

(m, 12H)

3.14 Hz, 2H)

2H)

6.40 Hz, 2H)

4H)

6.98

6.44

6.36

3.60

3.54

3.48

(d, J = 3.28

(dd, J = 9.34 Hz,

(dd, J = 3.30 Hz,

(m, 8H)

(m, 8H)

(m, 16H)

Hz, 2H)

2H)

2H)

6.80

6.44

6.23

3.81

3.75

3.70

3.67

(d, J= 2.92

(dd, J = 9.34 Hz,

(dd, J = 2.92 Hz,

(t, J =3.48 Hz, 8H)

(m, 8H)

(m, 8H)

(m, 8H)

Hz, 2H)

2H)

2H)

6.93

6.49

6.37

3.83

3.77

3.70

3.59

3.53

3.46

(d+d, J =

(d+d, J = 2.38 Hz,

(dd+dd, J = 3.32,

(m, 4H)

(m, 4H)

(m,8H)

(m, 4H)

(m, 8H)

(m, 4H)

3.14 Hz, 2H)

2H)

6.40 Hz, 2H)

[TBA]2DSBPP34C10
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[PyBP/ syn- and

CD3OD

anti-DSBPP34C10]

[CpBP/ syn- and
anti- DSBPP34C10]

CD3OD

(s, 2H)

6.23

3.74

3.71

(s, 4H)

(m, 24H)

(d, J = 4.04 Hz, 8H)

Table 3.5: 1H-NMR chemical shifts and chemical shift changes for the syn- and anti- [TBA]2DSBPP34C10 wheels and their
corresponding [2]pseudorotaxanes.

() for Hf

() for He

() for Hg

/ppm

/ppm

/ppm

() for Hb /ppm

() for Ha /ppm

() for Hd /ppm

() for Hc /ppm

Acetone-d6:

9.33

8.73

2.38

4.87

4.06

2.51

1.17

CD3OD = 2:1

(d, J = 6.96 Hz, 4H)

(d, J = 6.96 Hz, 4H)

(m, 4H)

(t, J = 7.32 Hz, 4H)

(q, J = 7.20 Hz, 4H)

(t, J = 7.16 Hz, 4H)

(t, J = 7.14 Hz, 6H)

[C4BP/syn- and

Acetone-d6:

9.05 (–0.28)

2.45 (+0.07)

4.84 (–0.03)

4.12 (+0.06)

2.59 (+0.08)

1.22 (+0.05)

anti-DSBPP34C10]

CD3OD = 2:1

(d, J = 6.60 Hz, 4H)

(m, 4H)

(t, J = 7.70 Hz, 4H)

(q, J = 7.20 Hz, 4H)

(t, J = 7.52 Hz, 4H)

t, J = 7.14 Hz, 6H)

[PyBP][NO3]2

CD3OD

9.68

9.06

8.98

8.07

(d, J = 6.94 Hz, 4H)

(d, J = 4.76 Hz, 4H)

(d, J = 6.96 Hz, 4H)

(d, J = 6.24 Hz, 4H)

9.46 (–0.22)

9.04 (–0.02)

8.41 (–0.57)

8.32 (+0.25)

(d, J = 6.60 Hz, 4H)

(d, J = 5.12 Hz, 4H)

(d, J = 6.24 Hz, 4H)

(d, J = 4.76 Hz, 4H)

9.62

8.95

8.38

8.01

(d, J = 6.96 Hz, 4H)

(d, J = 6.96 Hz, 4H)

(d, J = 8.40 Hz, 4H)

(d, J = 8.40 Hz, 4H)

9.43 (-0.19)

8.35 (-0.60)

8.40 (+0.02)

8.30 (+0.29)

(d, J = 6.96 Hz, 4H)

(d, J = 6.96 Hz, 4H)

(d, J = 8.76 Hz, 4H)

(d, J = 8.30 Hz, 4H)

Compound
[C4BP][PF6]2

[PyBP/ syn- and

Solvent

CD3OD

anti-DSBPP34C10]
[CpBP]Cl2

[CpBP/ syn- and
anti-DSBPP34C10]

CD3OD

CD3OD

8.10 (–0.63)
(d, J = 6.60 Hz, 4H)
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Table 3.6: 1H-NMR chemical shifts and chemical shift changes for the [axle/syn- and anti-DSBPP34C10] pseudorotaxane with the
axle, which undergo fast exchange on the NMR time scale.

3.1.3. Axle-to-wheel molar ratio of pseudorotaxanes
The Job’s plot method118 is commonly used in determination of reaction stoichiometries.
It can also be used to determine the molar ratio between the axle and the wheel
components of the pseudorotaxane. In solution, ‘a’ number of moles of axles undergo
self assembly with ‘b’ number of moles of wheels to yield [a+b]pseudorotaxanes
(Equation 1):
aAxle

+ bWheel

[a+b]Pseudorotaxane

(1)

Pseudorotaxane solutions were prepared by mixing different volumes of the axle and the
wheel so that the total number of moles of the axle and the wheel, [Axle]o+[Wheel]o = M,
remain constant, while [Axle]o/[Wheel]o varies (where [Axle]o and [Wheel]o are initial
concentrations of the axle and the wheel, respectively). Monitoring the change of a
physical or chemical property which is proportional to the concentration of
pseudorotaxanes allows us to construct a plot of [pseudorotaxane] against
[Wheel]/([Wheel]+[Axle]) or [Axle]/([Wheel]+[Axle]). This plot shows that the
concentration of the pseudorotaxane has a maximum for the axle to wheel molar ratio
which is equal to a/b. In the case of UV-Vis spectroscopic method, the absorbance of the
pseudorotaxane solution is proportional to the pseudorotaxane concentration while the
product of chemical shift change and initial concentration of the axle or wheel of the
pseudorotaxane solution is proportional to the pseudorotaxane in the NMR spectroscopic
method.124,125
The UV–visible spectroscopic method has been used for all pseudorotaxanes except
[PyBP/BPP34C10][NO3]2 and [CpBP/BPP34C10]Cl2, because the absorbance that arises
from axles and pseudorotaxanes appeared at similar wavelength. Therefore, the NMR
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spectroscopic

method

was

employed

for

[PyBP/BPP34C10][NO3]2

and

[CpBP/BPP34C10]Cl2 pseudorotaxanes.
Representative Job’s plots for each pseudorotaxane system are shown in Figure 3.7; all

[BN38C10]o x /(mM.ppm)

[PyBP][NO3]2]o x /(M.ppm)

other Job’s plots are shown in Appendix B.

A

0.03

0.02

0.01

0.00
0.00

0.25
0.50
0.75
1.00
([PyBP][NO3]2)o/
(([PyBP][NO3]2)o+ [BPP34C10]o)

0.02
0.01
0.00
0.00

0.25
0.50
0.75
1.00
[BPP34C10]o/
(([CpBP]Cl2)o + [BPP34C10]o))

0.25
Absorbance at 460 nm

0.020
Absorbance at 445 nm

B

0.03

C
0.015
0.010
0.005
0.000
0.00

0.20
0.15
0.10
0.05
0.00
0.00

0.50
1.00
Molar fraction of BPP34C10

D

0.50
1.00
Molar fraction of [PyBP][NO3]2

Figure 3.7: Job’s plots of A) [PyBP/BPP34C10][NO3]2, B) [CpBP/BPP34C10]Cl2, C)
[C4BP/BPP34C10][PF6]2 and D) [PyBP/DSBPP34C10] [2]pseudorotaxanes.

Figure 3.7a and b show the maxima of (chemical shift change x [axle or wheel]), while
Figure 3.7c and d show the highest absorbance (at their max) at 1:1 molar ratio of
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axle:wheel. It indicates that in pseudorotaxanes the axle and the wheel form a 1:1
complex.
Table 3.7 summarizes the axle-to-wheel molar ratios and solvents for all pseudorotaxanes
studied. The pseudorotaxanes that consist of a 4,4′-bipyridinium core and bis-naphtho or
bis-p-phenylene crown ethers show 1:1 complexation in solution. In contrast, the
pseudorotaxanes with 4,4′-bipyridinium axles and dibenzo-24-crown-8 (DB24C8) show a
1:2 axle:wheel ratio both in solution126 and in the solid state (discussed in Section 3.1.5).
Axle
[C4BP][PF6]2

[PyBP][NO3]2

[CpBP]Cl2

[C4BP][PF6]2
[PyBP][NO3]2
[CpBP]Cl2

Wheel

Solvent/ solvent
mixture
BPP34C10
CH3CN: CHCl3 = 1:1
BN38C10
CH3CN: CHCl3 = 1:1
BN32C8
CH3CN: CHCl3 = 1:1
BPP34C10
CD3OD: CDCl3 = 1:1
BN38C10
CH3OH: CHCl3 = 1:1
BN32C8
CH3OH: CHCl3 = 1:1
BPP34C10
CD3OD: CDCl3 = 1:1
BN38C10
CH3OH: CHCl3 = 1:1
BN32C8
CH3OH: CHCl3 = 1:1
DSBPP34C10 CH3OH
CH3OH
CH3OH

Table 3.7: Axle: wheel molar ratios of pseudorotaxanes.
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Axle: Wheel
molar ratio
1:1
1:1
1:1
1:1
1:1
1:1
1:1
1:1
1:1
1:1
1:1
1:1

3.1.4. Association constant studies
The Benesi-Hildebrand method119 or the dilution method120,121 was employed to
determine the association constant of [2]pseudorotaxanes. UV–Visible spectroscopy or
1

H–NMR spectroscopy techniques were used to collect the data.

3.1.4.1. Benesi-Hildebrand method using UV-vis spectroscopy
In solution, the axle and the wheel undergo an equilibrium process to form
[2]pseudorotaxane (Equation 2):
Axle

+ Wheel

Ka

Pseudorotaxane

(2)

where Ka is the equilibrium constant. Then, Ka can be written as:
(3)

(4)
where

is the concentration of the [2]pseudorotaxane,

of the axle and
When

is the initial concentration

is the initial concentration of the wheel.
,

and and

, equation (4) can be rearranged

as:
(5)
The plot of

When

vs

gives a straight line with a slope of

and

and an intercept of .

, equation (4) can be rearranged as:
(6)
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The plot of

vs

gives a straight line with a slope of

Association

constants

and

molar

extinction

and an intercept of .

coefficients

for

the

different

pseudorotaxanes were determined using equation (6).

1.1.4.2. Benesi-Hildebrand method using 1H–NMR spectroscopy
The NMR version of the Benesi-Hildebrand method was independently derived by
Norman C. Li 127 and Alan L. Ahsbaugh 128. Gibson and coworkers 129 used this method
to determine association constants of pseudorotaxanes. The [2]pseudorotaxane
equilibrium represented by equation (2) depends on the association constant K a and
the rate of the threading–dethreading process. The following equations are derived for
the [2]pseudorotaxane which undergoes a fast equilibrium process on NMR time scale
and shows only one set of time averaged peaks of the axle, the wheel and the
[2]pseudorotaxane. Under these circumstances, the observed chemical shift

of

any species present in the mixture is the weight average of the characteristic
freequencies of the free and complexed molecules.
(7)
(8)
where XA and XP are molar fractions of the free axle and the pseudorotaxane.

where

is the chemical shift of the free guest,

complexed guest and

is the chemical shift of the fully

is the time averaged chemical shift of the titrant.
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When

, equation (9) can be obtained after a number of refinement steps:
(9)

The concentration of the guest can be obtained as:
(10)

The double reciprocal plot of

vs

gives a straight line with a slope of

and an intercept of .

1.1.4.3. Dilution method by UV-vis spectroscopy
The dilution method was originally developed by Ray130 and adopted by Stoddart120 for
pseudorotaxanes. A 1:1 complexation of the axle and the wheel is essential when using
this method, as well as equimolar solution of the axle and the wheel. Sequential dilution
followed by the recording of optical absorption spectra is involved in this method.
(11)
(12)
where CT is the total concentration of the axle or the wheel in the solution.
When the equilibrium concentration of the pseudorotaxane is

, equation (2) can be

rearranged as:
(13)
The measured total absorbance

of the pseudorotaxane solution at a particular

wavelength is the sum of the absorbance of the free axle, free wheel and the
[2]pseudorotaxane.
(14)
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where

is the absorbance of the [2]pseudorotaxane,

uncomplexed wheel and

is the absorbance of the

is the absorbance of the uncomplexed axle. Assuming that

all species obey the Beer-Lambert law:
(15)
where,

,

and

are molar extinction coefficients of the pseudorotaxane, the axle

and the wheel, respectively.

Crown ethers show no absorbance at the max of the

pseudorotaxane. Therefore,
and equation (13) can be rearranged as:

(16)

For convenience,

and

. Then equation (18) can be

written as:

(17)

By combining equations (15) and (19), equation (20) can be obtained:

(18)

The plot of

vs

gives a straight line with a slope of

Association

constants

and

molar

extinction

coefficients

pseudorotaxanes were determined using equation (18).
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and an intercept of .
for

the

different

3.1.4.4. [PyBP/neutral crown ether][NO3]2 [2]pseudorotaxanes
Since the [PyBP][NO3]2 axle has a low solubility in a 1:1 mixture of CH3OH and CHCl3
compared to the neutral crown ethers, the axle solution was always titrated with the
[2]pseudorotaxane solution. The [PyBP/BN32C10]2+ [2]pseudorotaxane shows the
highest association constant compared to the other two [2]pseudorotaxanes (Table 3.8).
[2]Pseudorotaxane

[PyBP/BPP34C10][NO3]2
[PyBP/BN38C10][NO3]2
[PyBP/BN32C8][NO3]2

Solvent mixture

Association
constant/ M–1

Molar extinction
coefficient/
Lmol–1cm–1

CD3OD: CDCl3
(1/1)
CH3OH: CHCl3
(1/1)
CH3OH: CHCl3
(1/1)

1.69 (±0.23) x 102

–

4.20 (± 0.20) x 102 7.90 (± 0.40) х 102
8.70 (± 0.70) х 102 1.20 (± 0.10) х 103

Table 3.8: Association constants and molar extinction coefficients of [PyBP/neutral
crown ether][NO3]2 [2]pseudorotaxanes.
The Benesi-Hildebrand plots of [PyBP/BPP34C10]2+ [2]pseudorotaxanes are shown in
Figure 3.8A. (See Appendix B for all other Benesi-Hildebrand plots.)
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80
-10

K = 1.69 (± 0.23) x
R² = 0.9986

M-1

A)

-50

B)

60

(1/) / ppm-1

(1/) / ppm-1

-30

102

-70
-90

K = 1.62 (± 0.49) x 102 M-1
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Figure 3.8: Benesi-Hildebrand plots of A) [PyBP/BPP34C10][NO3]2, B)
[CpBP/BPP34C10]Cl2, C) [C4BP/BPP34C10][PF6]2 and D) [PyBP/DSBPP34C10]
[2]pseudorotaxanes

3.1.4.5. [CpBP/neutral crown ether]Cl2 [2]pseudorotaxanes
The [CpBP]Cl2 axle was titrated with BPP34C10 in pure CD3OD since both compounds
are soluble in CH3OH. Since the BN38C10 and BN32C8 crown ethers are not soluble in
pure CH3OH, a 1:1 mixture of CH3OH and CHCl3 was used as the solvent in this case.
Because the axle and the wheel have low solubility, in the CH3OH:CHCl3 mixture, the
dilution method was employed instead of the Benesi-Hildebrand method to prevent the
precipitation at higher concentrations.
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The association constant values of [CpBP/neutral crown ether]Cl2 show the same trend as
the ones of the [PyBP/neutral crown ether][NO3]2 [2]pseudorotaxanes (Table 3.9). The
Benesi-Hildebrand plot of [CpBP/BPP34C10]2+ [2]pseudorotaxanes are shown in Figure
3.8B.
[2]pseudorotaxane

Solvent mixture

[CpBP/BPP34C10]Cl2
[CpBP/BN38C10]Cl2
[CpBP/BN32C8]Cl2

CD3OD
CH3OH:CHCl3 (1/1)
CH3OH:CHCl3 (1/1)

Association
constant/ M–1
1.62 (±0.49) x 102
4.80 (± 0.20) x 102
9.70 (± 0.70) х 102

Molar extinction
coefficient/ Lmol–1cm–1
–
7.00 (± 0.30) х 102
1.04 (± 0.11) x 103

Table 3.9: Association constants and molar extinction coefficient values of
[CpBP/neutral crown ether]Cl2 [2]pseudorotaxanes.

3.1.4.6 [C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes
The axle solution was titrated with the [2]pseudorotaxane solution which has the same
axle concentration and 10 times higher wheel concentration. Constant axle concentration
was maintained throughout the titration and a 1:5 ratio of axle:wheel was obtained at the
end.
Among the [C4BP/ neutral crown ethers][PF6]2 pseudorotaxanes, the association constant
decreases

in

the

order:

[C4BP/BN32C8][PF6]2

>

[C4BP/BN38C10][PF6]2

>

[C4BP/BPP34C10][PF6]2. These results reveal that the bis-naphtho crown ethers bind
stronger than the bis-p-phenylene crown ether, BPP34C10 (Table 3.10). The BenesiHildebrand plots of [C4BP/BPP34C10]2+ [2]pseudorotaxanes are shown in Figure 3.8C.
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[2]pseudorotaxane

Solvent mixture

[C4BP/BPP34C10][PF6]2
[C4BP/BN38C10][PF6]2
[C4BP/BN32C8][PF6]2

CH3CN:CHCl3 (1/1)
CH3CN:CHCl3 (1/1)
CH3CN:CHCl3 (1/1)

Association
constant/ M–1
1.0 (±0.2) x 102
2.4 (±0.3) x 102
1.7 (±0.3) x 102

Molar extinction
coefficient/ Lmol–1cm–1
6.3 (±0.8) x 102
1.0 (±0.1) x 102
1.3 (±0.1) x 103

Table 3.10: Association constants and molar extinction coefficients of [C4BP/neutral
crown ether][PF6]2 [2]pseudorotaxanes.

3.1.4.7. [syn- and anti-DSBPP34C10/axle] [2]pseudorotaxanes
The interactions between sulphonated crown ethers and positively charged axles are
complicated in less polar solvents by ion-pairing effects.8 Even though non-covalent
interactions are less prominent in highly polar solvents, the TBA salt of syn- and antiDSBPP34C10 crown ethers forms [2]pseudorotaxanes with 4,4′-bipyridinium-based axles
even in pure water. Association constant measurements of [syn- and antiDSBPP34C10/axle] [2]pseudorotaxanes were carried out in water. [Syn- and antiDSBPP34C10/axle] [2]pseudorotaxanes show stronger interactions compared to the nonsulphonated analog of the crown ether (Table 3.11). Benesi-Hildebrand plots of
[PyBP/BPP34C10]2+ [2]pseudorotaxanes are shown in Figure 3.8A. Loeb,8 Fitzmaurice7
and coworkers have shown that addition of an anionic group such as SO3¯ or CO2¯
increases the association with a di-cationic axle. This significant change in the
association constants is a result of electrostatic ion-ion interactions in addition to
hydrogen bonds, ion-dipole interactions and  stacking between the axle and the wheel
components of [2]pseudorotaxanes.
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Axle

Ka of [axle/BPP34C10]
[2]pseudorotaxane / M–1

Ka of [axle/syn- and
anti-DSBPP34C10]
[2]pseudorotaxane
in H2O/ M–1

[C4BP][PF6]2

1.0 (±0.2) x 102
in CH3CN:CHCl3 (1/1)
1.69 (±0.23) x 102
in CH3OH:CHCl3 (1/1)
1.62 (±0.49) x 102
in CH3OH:CHCl3 (1/1)

7.39 (± 0.91) x 102

Molar extinction coefficient of
[axle/syn- and antiDSBPP34C10]
[2]pseudorotaxane in H2O/
Lmol–1cm–1
4.20 (± 0.42) x 102

2.63 (± 0.23) x 103

1.82 (± 0.03) x 102

1.34 (± 0.07) x 103

1.87 (± 0.12) x 102

[PyBP][NO3]2
[CpBP]Cl2

Table 3.11: Association constants and molar extinction coefficients of [syn- and antiDSBPP34C10/axle] [2]pseudorotaxanes compared to their non-sulphonated analogs.

In the case of the [4,4′–bipyridinium/neutral crown ether] [2]pseudorotaxanes, the [4,4′–
bipyridinium/binaphtho] [2]pseudorotaxanes show stronger association than the [4,4′bipyridinium/bis-p-phenylene] [2]pseudorotaxanes, due to stronger  interactions
between the naphtho groups of the wheel and the 4,4′-bipyridinium core of the axle.
Table 3.10 shows a comparison of the association constants of [4,4′–bipyridinium/
BPP34C10] and [4,4′-bipyridinium/DSBPP34C10] [2]pseudorotaxanes. By introducing
two negative charges on the wheel, a tenfold increase of the association constant was
observed, even in a highly polar aqueous medium. This is a consequence of the strong
electrostatic interaction between the (+2) positively charged axle and the (–2) negatively
charged wheel.
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3.1.5. Electrochemistry studies
The pseudorotaxanes discussed in this section exhibit interesting electrochemical
behavior due to the redox-active character of the 4,4′-bipyridinium core of the axle. The
electrochemistry of viologens (diquaternized form of 4,4′-bipyridine: disubsituted-4,4′bipyridinium salts)

is well understood and is comprised of two consecutive single

electron reductions (Figure 3.9).131,132

Figure 3.9: Three common redox forms of viologens: V2+, bipyridinium dication; V+●,
bipyridinium radical cation; Vo, di-reduced bipyridinium compound.

Electrochemistry studies of [2]pseudorotaxanes provide the half–wave reduction potential
of the axle and the oxidation potential of the wheel, which are measures of the strength of
inter-component interactions. Upon complexation of crown ethers with 4,4′bipyridinium-containing axles, the reduction potential of the viologen moiety shifts
towards more negative values, revealing that the presence of the crown ether facilitates
the reduction. The stronger the inter-component interactions, the larger the shift of the
reduction potential.
The cyclic voltammograms of the [4,4′-bipyridinium/crown ether]2+ [2]pseudorotaxanes
show two reductions for the axle and an oxidation for the crown ether. The first and
second reduction potentials are related to radical cation V+∙ and di-reduced V0 formation,
respectively (Figure 3.10).
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V+ •

Vo

Figure 3.10: Electrochemical reduction and dissociation of [4,4′-bipyridinium/crown
ether] [2]pseudorotaxanes.

3.1.5.1. [PyBP/neutral crown ether][PF6]2 [2]pseudorotaxanes
The cyclic voltagrams of [PyBP][PF6]2, crown ethers and its [2]pseudorotaxanes show
two reversible reduction peaks for the 4,4′-bipyridinium core of the axle (Figure 3.11).
The reduction potentials of pure [PyBP][PF6]2 axle appear at –481 mV and –720 mV. The
half-wave reduction potentials of the viologen moieties of [2]pseudorotaxanes shifted to
less negative values compared to those of the pure axle. This may be due to the low
[2]pseudorotaxane percentage in the solution at low concentration (0.5 mM). However,
the reduction potential values (Table 3.12) decrease in the order [PyBP/BPP34C10][PF6]4
> [PyBP/BN38C10][PF6]4 > [PyBP/BN32C8][PF6]4, which correlates with the
association constant values discussed in Section 3.1.4.1.
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Figure 3.11: Overlaid cyclic voltammograms of [PyBP][PF6]2
[PyBP/BN38C10][PF6]2 (red) and [PyBP/BN32C8][PF6]2 (blue).

Axle

wheel

[PyBP][PF6]2
[PyBP][PF6]2 BPP34C10
[PyBP][PF6]2 BN38C10
[PyBP][PF6]2 BN32C8

[2]pseudorotaxane

[PyBP/BPP34C10][ PF6]2
[PyBP/BN38C10][ PF6]2
[PyBP/BN32C10][ PF6]2

V2+/V+•
potential/ mV
– 481
– 453
– 465
– 475

(black),

V+•/Vo potential/
mV
– 720
– 693
– 694
– 698

Table 3.12: Reduction potentials of [PyBP][PF6]2 and [PyBP/neutral crown ether][PF6]2
[2]pseudorotaxanes.
3.1.5.2. [CpBP/neutral crown ether]Cl2 [2]pseudorotaxanes
The cyclic voltammogram of [CpBP/neutral crown ether]Cl2 shows that as expected, the
first and the second reduction potential of the axle in [2]pseudorotaxanes shifted towards
more negative values compared to the pure axle (–535 mV and –957 mV).
[CpBP/BN32C8]Cl2 [2]pseudorotaxane shows the lowest reduction potentials while
[CpBP/BPP34C10]Cl2 [2]pseudorotaxane shows the highest reduction potential among
[2]pseudorotaxanes (Table 3.13), which is correlated with the association constant values
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discussed in Section 3.1.4.2. Interestingly, the second oxidation peak of the
[2]pseudorotaxanes (Figure 3.12a-c) is sharp which reveals the strong adsorption of the
fully reduced species on the electrode surface.133
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Figure 3.12: Overlaid cyclic voltammograms of A) [CpBP/BPP34C10]Cl2
[2]pseudorotaxanes (golden brown) B) [CpBP/BN38C10]Cl2 [2]pseudorotaxanes
(brownish red), C) [CpBP/BN32C8]Cl2 pseudorotaxane (magenta) and D) [CpBP/synand anti- DSBP34C10] (black), with [CpBP]Cl2 (blue).

Axle

wheel

[2]pseudorotaxane

V2+/V+•
potential/ mV

V+•/Vo potential/
mV

[CpBP]Cl2
[CpBP]Cl2
[CpBP]Cl2
[CpBP]Cl2

–
BPP34C10
BN38C10
BN32C8

–
[CpBP/BPP34C10]Cl2
[CpBP/BN38C10]Cl2
[CpBP/BN32C10]Cl2

– 535
– 543.5
– 543.5
– 561.5

– 957
– 959
– 960
– 989

Table 3.13: Reduction potentials of [CpBP]Cl2 and [CpBP/neutral crown ether]Cl2
[2]pseudorotaxanes.
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As shown in Figure 3.12d, the second oxidation peak of the [CpBP/syn- and antiDSBPP34C10] [2]pseudorotaxanes is not easily recognizable as [CpBP/neutral crown
ether]Cl2 [2]pseudorotaxanes.

3.1.5.3. [C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes
As expected, the reduction potentials of the axle shift towards more negative values in
[2]pseudorotaxanes, while the oxidation potentials of the crown ethers shift towards less
positive values. The oxidation/reduction potential values (Table 3.14) decrease in the
order [C4BP/BPP34C10][PF6]4 > [C4BP/BN38C10][PF6]4 > [C4BP/BN32C8][PF6]4,
which correlates with the association constant values discussed in Section 3.1.4.3.
Axle

wheel

[2]pseudorotaxane

[C4BP][PF6]2
[C4BP][PF6]2
[C4BP][PF6]2
[C4BP][PF6]2

–
BPP34C10
BN38C10
BN32C8

–
[C4BP/BPP34C10][ PF6]2
[C4BP/BN38C10][ PF6]2
[C4BP/BN32C10][ PF6]2

V2+/V+•
potential/ mV
–760
–842
–853
–869

V+•/Vo
potential/ mV
– 1200
– 960
– 972
– 991

Table 3.14: Oxidation/reduction potentials of [C4BP][PF6]2, crown ethers and
[C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes.
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3.1.6. Crystallographic studies
A number of pseudorotaxane crystals suitable for X-ray diffraction analysis were grown
at –20 ºC, for the following reasons: at low temperatures, 1) the equilibrium between
individual components and pseudorotaxanes shifts to more pseudorotaxane formation,
yielding a higher percentage of pseudorotaxane in the solution, and 2) the rate of the
solution diffusion and crystal growing process becomes slower, which results in higher
quality crystals.
3.1.6.1. [PyBP/neutral crown ether]2+ [2]pseudorotaxanes
X-ray

quality,

maroon-red,

single

crystals

of

[PyBP/BPP34C10][NO3]2

[2]pseudorotaxane were grown by diffusing iPr2O into a [2]pseudorotaxane solution in
CH3OH. All attempts to obtain X-ray quality single crystals of [PyBP/bis-naphtho crown
ether][NO3]2 [2]pseudorotaxanes at –20 ºC or room temperature yielded light yellow
precipitates of [PyBP][NO3]2 and colorless crystals of the respective crown ethers.
Fortunately,

layering

a

solution

of

[PyBP/bis-naphtho

crown

ether][NO3]2

[2]pseudorotaxanes in a 1:1 mixture of CH3OH:CH3Cl with methanolic solution of either
NH4PF6 or KSbF6 yielded X-ray quality crystals of [PyBP/bis-naphtho crown ether]2+
[2]pseudorotaxanes as PF6¯ or SbF6¯ salt. Apparently, the exchange of the smaller NO3¯
ions to larger PF6¯ or SbF6¯ ions facilitates the crystal packing and the crystallization
process.
Crystal structures of all [PyBP/bis-p-phenylene or bis-naphtho neutral crown ether]2+
[2]pseudorotaxanes indicate a 1:1 complexation of the axle and the wheel in the solid
state.

In contrast,

1:2

complexation ratio of axle:wheel

was

observed in

[PyBP/(DB24C8)2][NO3]2 pseudorotaxanes in the solid state (Figure 3.13). The same 1:2
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complexation behavior of the DB24C8 crown ether with 4,4′-bipyridinium cations
bearing different aliphatic and aromatic substituents was reported by Nikitin et. al.126

a)

b)

c)

d)

Figure 3.13: Thermal ellipsoid plots of a) [PyBP/BPP34C10][NO3]2 (50
[PyBP/BN32C8][SbF6]2 (50 %), c) [PyBP/BN38C10][SbF6]2 (30 %)
[PyBP/DB24C8][NO3]2 (30 %) [2]pseudorotaxanes. Hydrogen atoms and
molecules omitted for clarity. Color code: C, gray; N, blue; O, red; Sb, bluish
green.

%), b)
and d)
solvent
gray; F,

In the crystal structures of [PyBP/neutral crown ether]2+ [2]pseudorotaxanes,

the

pseudorotaxane units lie on inversion centers except for [PyBP/BPP34C10][NO3]2. The
4,4′-bipyridinium core of the axle is symmetrically located between the two aromatic
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groups of bis-naphtho crown ethers, but it is asymmetrically located in bis-p-phenyl
crown ethers. The centroid–centroid distances ( stacking interactions) between the
aromatic rings of the crown ethers and the 4,4′-bipyridinium core of the axle are 3.630–
3.714 Å, 3.371(2) Å and 3.294(2) Å for [PyBP/BPP34C10]2+, [PyBP/BN38C10]2+ and
[PyBP/BN32C8]2+, respectively. Multiple C–H∙∙∙O hydrogen bonds with C–H∙∙∙O angle
larger than 120˚ and H∙∙∙O distances of 2.527(2)–2.693(2) Å, 2.438(2)–2.694(2) Å and
2.291(5)–2.979(5) Å were observed in [PyBP/BPP34C10]2+, [PyBP/BN38C10]2+ and
[PyBP/BPP32C8]2+, respectively (Table 3.15 shows the summary of hydrogen bonding
data of [PyBP/dis-naphtho crown ether]2+ [2]pseudorotaxanes). All [2]pseudorotaxane
crystal structures show similar terminal N∙∙∙N distances within the axle. The shortest
N∙∙∙N distance, 15.405(4) Å, was observed in [PyBP/BPP34C10]2+, while the longest
N∙∙∙N distance, 15.421(4) Å was observed in [PyBP/BN38C10]2+. The N∙∙∙N distance in
[PyBP/BN32C8]2+ is 15.414(7) Å. In all three crystal structures, the four aromatic groups
of the axle are arranged in a non-planar geometry. Crystal structures of [PyBP/bisnaphtho crown ether]2+ [2]pseudorotaxanes show linear axle and co-planar 4,4′bipyridinium core. The axle in [PyBP/BPP34C10]2+ is non-linear and the 4,4′bipyridinium core is non-planar, with an inter-planar angle of 18.58º. The two terminal
pyridine groups are rotated in the same direction by 39.47–39.88º, 47.98(9)º and
43.39(19)º degrees in [PyBP/BPP34C10]2+, [PyBP/BN32C8]2+ and [PyBP/BN34C10]2+,
respectively. Two nitrate ions found in the crystal structure of [PyBP/BPP34C10] 2+
counter balance the two positive charges of the [2]pseudorotaxane unit. In the case of
[PyBP/naphtho crown ether]2+ [2]pseudorotaxanes, two SbF6¯ anions are responsible for
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charge balance. No solvent molecules were incorporated in any of these crystal
structures.
Pseudorotaxane
[PyBP/BN38C10]2+
[PyBP/BN32C8]2+

C-H∙∙∙A
C-H/(Å)
C2 H2 O2 0.931(5)
C6 H6 O3 0.930(4)
C6 H6 O4 0.930(4)
C6 H6 O3
0.89(6)
C6 H6 O2
0.89(6)
C2 H2 O3
0.78(7)

H∙∙∙O/(Å)
2.692(4)
2.438(3)
3.072(3)
2.558(4)
2.291(5)
2.979(5)

C∙∙∙O/(Å)
3.567(4)
3.332(3)
3.716(3)
3.303(7)
3.078(7)
3.798(7)

C-H∙∙∙O/°
156.7(3)
161.1(3)
127.9(3)
136.7(3)
141.9(4)
147.5(4)

Table 3.15: Summary of hydrogen bonding data of [PyBP/bis-naphtho crown ether]2+
[2]pseudorotaxanes.

In the case of [PyBP/(DB24C8)2][NO3]2 [3]pseudorotaxane, a linear, non-planar axle
with non co-planar aromatic groups was observed. The terminal pyridine groups of the
axle are rotated by 69.27º and 22.09º degrees in the same direction, while the two
aromatic rings of the 4,4′-bipyridinium core of the axle are rotated by 47.25º degrees to
facilitate the formation of stronger  interactions between the axle and the wheel. In
each [3]pseudorotaxane unit, two threaded crown ether molecules are packed in

a

horseshoe shape (Figure 3.13.d) around the axle. The angles between the corresponding
aromatic ring of the axle and the crown ether lie within 23.35–28.99º degrees. The
centroid–centroid distances, 4.133–4.422 Å, are longer than those of the other three
[2]pseudorotaxanes with a [PyBP]2+ axle. A terminal N∙∙∙N distance of 15.319(4) Å was
observed. Similar to the other [PyBP/neutral crown ether]2+ [2]pseudorotaxanes
explained above, [PyBP/DB24C8]2+ [3]pseudorotaxanes show C–H∙∙∙O hydrogen
bonding with C–H∙∙∙O angel greater than 120˚ and H∙∙∙O distances ranging from 2.086(2)
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to 2.860(2) Å. Two nitrate ions balance the (+2) positive charge of the [3]pseudorotaxane
unit. One CHCl3 molecule was also found in the asymmetric unit of the crystal structure.

3.1.6.2. [CpBP/neutral crown ether]2+ [2]pseudorotaxanes
From the [CpBP/neutral crown ether]2+ [2]pseudorotaxanes, [CpBP–2H+/BPP34C10] and
[CpBP–2H+/BN32C8] crystallized as X-ray quality single crystals, while all the crystal
growing attempts of [CpBP/BN38C10]2+ yielded either a blue or a light yellow
precipitate ([CpBP]Cl2), and colorless crystals of BN38C10. Interestingly, the axle was
deprotonated in both crystal structures during [2]pseudorotaxane crystallization. The
crystal structures of [CpBP/BPP34C10]2+ and [CpBP/BN32C8]2+ confirm the 1:1
complexation of the axle to the wheel in the solid state (Figure 3.14).
The asymmetric unit of the [CpBP–2H+/BPP34C10] [2]pseudorotaxane consists of two
[2]pseudorotaxanes sitting on inversion centers. In the case of [CpBP–2H+/BN32C8], the
[2]pseudorotaxane unit does not lie on an inversion center. The  separations between
the aromatic rings of the crown ethers and the 4,4′-bipyridinium core of the axle range
from 3.468 to 3.730 Å in [CpBP–2H+/BPP34C10], while in [CpBP–2H+/BN32C8], they
range from 3.217 to 3.436 Å. The C–H∙∙∙O hydrogen bondings with C–H∙∙∙O angle
greater than 120˚ and H∙∙∙O distance range from 2.231(2) to 2.988(2) and 2.270(5) to
2.390(5) Å were observed in [CpBP–2H+/BPP34C10] and [CpBP–2H+/BN32C8],
respectively. A planar 4,4′-bipyridinium core was observed in the crystal structure of
[CpBP–2H+/BPP34C10], while the two pyridinium planes are rotated by 12.80º degrees
in [CpBP–2H+/BN32C8]. The axle is slightly curved in both crystal structures. The 4carboxyphenyl substituents at the two ends of the 4,4′-bipyridinium core are rotated in the
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same direction by 49.67º and 50.23º degrees in the two [2]pseudorotaxane units of
[CpBP–2H+/BPP34C10]. In the case of [CpBP–2H+/BN32C8], the terminal substituent
groups are rotated in opposite direction by 52.37º and 48.03º degrees. The carboxylate
groups at the two ends of the axle render the [CpBP]2+ axle longer than the [PyBP]2+ axle.
The C∙∙∙C distances between the two terminal COO¯ groups are 18.354(4) and 18.713(5)
Å in the two [CpBP–2H+/BPP34C10] units, respectively, and 18.23(1) Å in [CpBP–
2H+/BN32C8]. CH3OH solvent molecules were observed in both crystal structures. In
[CpBP–2H+/BPP34C10], an additional crown ether molecule was also found in the
asymmetric unit.

a)

b)

Figure 3.14: Thermal ellipsoid plots (50%) of a) [CpBP–2H+/BPP34C10] and b) [CpBP–
2H+/BN32C8] [2]pseudorotaxanes. Hydrogen atoms and solvent molecules omitted for
clarity. Color code: C, gray; N, blue; O, red.

3.1.6.3. [C4BP/neutral crown ether]2+ [2]pseudorotaxanes
[C4BP][PF6]2 is soluble in acetone and acetonitrile, while all neutral crown ethers are
soluble in CHCl3 and CH2Cl2. Therefore, initial crystal growing attempts were carried out
in a 1:1 mixture of acetone or acetonitrile and CHCl3 or CH2Cl2. Crystals of
[C4BP/BPP34C10][PF6]2

were

thus

obtained,

while

attempts

to

crystallize

[C4BP/BN38C10]2+ and [C4BP/BN32C8]2+ yielded elongated hexagonal, very light blue
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crystals of [C4BP][PF6]2 and cubic or elongated crystals of BN32C8 and BN38C10,
respectively.
The crystal structure of [C4BP/BPP34C10][PF6]2 shows 1:1 complexation of the axle and
the wheel in the solid state (Figure 1.15). The [2]pseudorotaxane unit is located on an
inversion center. The planar 4,4′-bipyridinium core of the axle is symmetrically located
between the two phenyl rings of the crown ether, with  stacking distances of 3.556(1)
Å. A summary of hydrogen bonding data of [C4BP/BPP34C10]2+ is shown in Table 3.16.
The aliphatic substituent groups at the two ends of the 4,4′-bipyridinium core are
arranged in a way that maximizes the hydrogen bond formation. The terminal C∙∙∙C
distance of the axle molecule is 16.252(3) Å. Two PF6¯ counterions balance the positive
charge of the [2]pseudorotaxane unit.

a)

b)

16.252(3) Å

Figure 3.15: a) Thermal ellipsoid plots of [C4BP/BPP34C10][PF6]2 (50%)
[2]pseudorotaxanes and b) ball-and-stick representation showing the terminal C∙∙∙C
distance of the axle. Hydrogen atoms are omitted for clarity. Color code: C, gray; N,
blue; O, red; P, purple; F, green.
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C-H∙∙∙A
O1 H24 C24
O2 H14A C14
O2 H13B C13
O3 H5A C5
O4 H7 C7
O5 H6A C6
O5 H7 C7
O5 H5A C5
O7 H6A C6
O4 H5A C5

C-H/(Å)
0.930(1)
0.970(1)
0.970(1)
0.970(2)
0.930(1)
0.970(1)
0.930(1)
0.970(2)
0.970(1)
0.970(2)

Table 3.16: Summary
pseudorotaxanes.

of

H∙∙∙O/(Å)
2.8937(8)
3.093(1)
2.447(1)
3.172(1)
2.896(1)
2.786(1)
2.9328(8)
3.123(1)
2.5124(9)
2.414(1)

hydrogen

bonding

C∙∙∙O/(Å)
3.722(1)
3.723(2)
3.318(2)
3.798(2)
3.560(2)
3.533(2)
3.765(1)
3.618(2)
3.321(2)
3.380(2)

data

of

C-H∙∙∙A/°
149.00(9)
124.05(8)
149.20(8)
123.80(8)
129.41(9)
134.34(8)
149.65(9)
113.33(8)
140.83(8)
173.83(8)
[C4BP/BPP34C10] 2+

3.1.6.4. [axle/DSBPP34C10] [2]pseudorotaxanes
The [Axle/DSBPP34C10] [2]pseudorotaxanes show 1:1 complexation of the axle and the
wheel in the solid state (Figure 3.16–3.18). iPr2O vapor diffusion or layering over a
methanolic solution of syn and anti mixture of [PyBP/DSBPP34C10] yields [PyBP/syn–
DSBPP34C10] as maroon–red colored crystals within one day at room temperature, or
within 3–4 days at –20 ºC. The orange colored [PyBP/anti-DSBPP34C10]
[2]pseudorotaxane crystallizes slower than [PyBP/syn-DSBPP34C10]. It takes one week
at room temperature and 2-3 weeks at –20 ºC freezer to crystallize. The different color of
the crystals and the different crystal growing rate facilitate the separation of the two
different isomers of [PyBP/DSBPP34C10].
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a)

b)

Figure 3.16: Thermal ellipsoid plots of a) [PyBP/anti-DSBPP34C10] (50%) and
[PyBP/anti-DSBPP34C10] (30%) [2]pseudorotaxanes. Solvent molecules and hydrogen
atoms are omitted for clarity. Color code: C, gray; N, blue; O, red; S, yellow.

In the crystal structures of the syn and anti isomers of [PyBP/DSBPP34C10], only the
[2]pseudorotaxane unit of [PyBP/anti-DSBPP34C10] lies on the inversion center of the
unit cell. These crystal structures show shorter  stacking distances, 3.525–3.657 Å
and 3.582 Å, respectively, compared to the non-sulphonated [2]pseudorotaxane analog,
[PyBP/BPP34C10]2+ (3.630-3.714 Å). Linear, non-planar axle structures were observed
in both crystal structures. The 4,4′-bipyridinium core of the axle in

[PyBP/anti-

DSBPP34C10] is planar, while the two pyridinium planes are rotated by 7.45º degrees in
[PyBP/syn-DSBPP34C10]. The terminal pyridine groups of the axle in [PyBP/antiDSBPP34C10] are rotated by 54.05º degrees in a same direction, while they are rotated
by 43.29º and 47.51º in [PyBP/anti-DSBPP34C10]. The C–H∙∙∙O hydrogen bonds with
C–H∙∙∙O angle greater than 120˚ and H∙∙∙O distances from 2.299(5)–2.811(6) Å and
2.598(2)–2.711(1) Å were observed in syn and anti isomers, respectively. The terminal
N∙∙∙N distance of the axle (15.400(5) and 15.414(2) Å in the syn and anti isomers,
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respectively) is similar to those in [PyBP/BPP34C10]2+. CH3OH molecules were found in
both crystal structures.
The [CpBP–2H+/anti-DSBPP34C10] [2]pseudorotaxane crystallizes very easily as
maroon-red cubes from a concentrated pseudorotaxane solution in methanol at room
temperature, without iPr2O or Et2O diffusion. All attempts to crystallize [CpBP–2H+/synDSBPP34C10] yielded a microcrystalline material not suited for the single crystal X-ray
diffraction analysis.

Figure 3.17: Thermal ellipsoid plot of [CpBP/anti-DSBPP34C10] (30%). Solvent
molecules and hydrogen atoms omitted for clarity. Color code: C, gray; N, blue; O, red;
S, yellow.

The asymmetric unit of [CpBP/anti-DSBPP34C10] consists of two [2]pseudorotaxane
units lying on inversion centers. The planar 4,4′-bipyridinium core forms  stacking
interactions (3.561–3.636 Å) with the sulphonated phenyl rings of the crown ether. The
terminal pyridine groups of the axle molecule are rotated by 38.59º and 72.04º degrees in
the same direction, in the two [2]pseudorotaxane units. The terminal C∙∙∙C distances
between the two terminal COO¯ units are 18.319(2) and 18.418 (2). Five CH3OH
molecules are found in the asymmetric unit.
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Both syn- and anti-DSBPP34C10 crystallize as orange X-ray quality crystals with
[C4BP][PF6]2, which were difficult to distinguish by the naked eye. Similarly to the in
non-sulphonated analog, both syn and anti [C4BP/DSBPP34C10] crystal structures show
 interactions between the aromatic rings of the axle and the wheel, which range from
3.625 to 3.724 Å and 3.546 to 3.559 Å, respectively. Both isomers of
[C4BP/DSBPP34C10] show a large number of C–H∙∙∙O hydrogen bonds between the axle
and the wheel compared to the non-sulphonated analog, [C4BP/BPP34C10]2+. The SO3¯
groups of the crown ether form addition hydrogen bonds with the 4,4′-bipyridinium core,
as well as with the aliphatic chain of the axle. C–H∙∙∙O hydrogen bonds with C–H∙∙∙O
angle greater than 120˚ and H∙∙∙O distances ranging from 2.510(4) to 2.723(4) Å and
2.441(2) to 2.654(2) Å were observed in [C4BP/anti-DSBPP34C10] and [C4BP/synDSBPP34C10], respectively. The terminal C∙∙∙C distance of the axle shows a dramatic
difference compared to the axle in the non-sulphonated pseudorotaxane analogue (Figure
3.3.15b). It is 23.229(7) Å in [C4BP/syn-DSBPP34C10] [2]pseudorotaxanes which is
larger than that of the [C4BP/anti-DSBPP34C10] [2]pseudorotaxanes, 21.34(1) Å (Figure
3.18.b). Both crystal structures show a non-planar 4,4′-bipyridinium core with 22.36º and
1.62º degrees rotation. Two CH3OH and two water molecules were found in the
asymmetric unit of [C4BP/syn-DSBPP34C10].
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a)

b)

c)
22.229 Å

21.34 Å

Figure 3.18: Thermal ellipsoid plots of a) [C4BP/syn-DSBPP34C10] (50%), b)
[C4BP/anti-DSBPP34C10] (30%) and c) end-end distances of the axles in the two
[2]pseudorotaxane isomers. Solvent molecules and hydrogen atoms omitted for clarity.
Color code: C, gray; N, blue; O, red; S, yellow.
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3.2. Temperature sensing behavior of [2]pseudorotaxanes
The results discussed in this section were published as “Single color pseudorotaxane
based temperature sensing” in New J. Chem. 2010, 34, 2097–2100101 and are reproduced
by permission of The RSC on behalf of the Centre National de la Recherche Scientifique
(CNRS) and the RSC.

In solution, the wheel and the axle components of the pseudorotaxanes undergo a
threading/dethreading equilibrium process. At different temperatures, pseudorotaxane
solutions show different color intensities depending on the actual amount of
[2]pseudorotaxane. At higher temperatures, the axle dissociates from the wheel, resulting
in a lower percentage of [2]pseudorotaxane in solution and a lower color intensity. At
lower temperatures, the pseudorotaxane formation equilibrium shifts towards a higher
percentage of [2]pseudorotaxane and more intensely colored solutions (Figure 3.19).

Figure 3.19: Temperature dependent association and dissociation of individual
components of pseudorotaxanes.

This observation prompted us to carry out VT UV-Vis spectroscopic studies, to
understand the temperature sensing behavior of pseudorotaxanes in solution. The
colorless axle, [C4BP][PF6]2 and colorless aromatic wheels, BPP34C10, BN38C10 and
BN28C8 (Figure 3.20) were used in the VT UV-Visible spectroscopic studies.
138

Figure 3.20: Schematics of the axle and wheels used in the VT UV-Vis studies.

3.2.1. Variable temperature UV-visible spectroscopic studies
As discussed in Section 3.1.1.3, [C4BP/BPP34C10]2+ [2]pseudorotaxane shows a CT
band in the visible region of the UV-Visible spectrum (max = 451 nm in a 2:1 mixture of
acetone:CH2Cl2). Since the axle and wheel are colorless in solution, they did not show
any absorbance within the visible region of the electronic spectra. The electronic spectra
of [C4BP/neutral crown ether]2+ [2]pseudorotaxanes were recorded over a 100 oC
temperature window ranging from 223 K (–50 °C) to 323 K (+50 °C) (Figure 3.21A).
The absorbance of the [2]pseudorotaxane solution increases when temperature decreases,
with no change in the max value. The other two [2]pseudorotaxane systems,
[C4BP/BN38C10]2+ and [C4BP/BN32C8]2+ also show the same behavior and their
electronic spectra are shown in Figure 3.21.B and C. The reversible and continuous
change of the absorbance value of [2]pseudorotaxanes with temperatures is an indication
of the equilibrium between [2]pseudorotaxanes and their individual components in
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solution. Interestingly, the color of [C4BP/BPP34C10][PF6]2 crystals is lost at 107–109
°C, before its melting point at 191–193 °C.
The plot of the variation of the extinction coefficient of each [2]pseudorotaxane solution
as a function of temperature (Figure 3.21.D. – calibration plot) shows that the extinction
coefficient is inversely proportional to the temperature of the [2]pseudorotaxanes studied.
Therefore, the temperature sensing behavior of [2]pseudorotaxanes could be used to
measure temperature. The calibration plot can be used as scale for colorimetric
thermometers.

Thermochromic pigments based on liquid crystals have been used in most known
colorimetric thermometers. The color change in liquid crystals,134 as in most inorganic135
and organic136 thermochromic compounds, occurs at specific temperatures over a very
narrow range. Only a few examples of individual chemical systems are known today
where the color change spans a large temperature range.137–140 In these systems, the
temperature dependent color change often involves a shift in the absorption maximum.
For application purposes, such as in microfluidic devices141–143 and other complex
systems, where conventional thermometers are inappropriate, it would be advantageous
to have a colorimetric thermometer that can be read at a single wavelength.
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Figure 3.21: Temperature-dependent optical absorption spectra of 1.0(± 0.1) mM
solutions of A) [C4BP/BPP34C10]2+, B) [C4BP/BN38C10]2+ and C) [C4BP/BN32C8]2+
[2]pseudorotaxanes in a 2:1 mixture of (CH3)2CO and CH2Cl2, recorded over a 100 oC
temperature window. D) Plot of the extinction coefficients of [C4BP/neutral crown
ether]2+ [2]pseudorotaxanes as a function of temperature.

By analyzing the temperature dependent absorption spectra, the thermodynamic
parameters of [2]pseudorotaxanes used in this study were calculated.
(19)
(20)
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are the Gibbs’ free energy change, enthalpy and entropy for

where

pseudorotaxane formation, respectively.

is the universal gas constant and

is the

temperature in K.
The equilibrium constant of pseudorotaxanes which show 1:1 axle:wheel complexation is
shown by equation (3) in Section 3.1.4:

According to the Beer-Lambert law, A

.

, then equation (3) can be written as:
(21)

where

is the absorbance of the pseudorotaxane as a function of temperature and

is the

extinction coefficient of the [2]pseudorotaxane, which is obtained from the BenesiHildebrand analysis explained in Section 3.1.4.
Ka values as a function of temperature were obtained using equation (22).
(22)

The slope and the intercept of the plot of

vs 1/T gives

respectively; the entropy and enthalpy values calculated using the
(Figure 3.22) are tabulated in Table 3.17.
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and

,

vs 1/T plot
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Figure 3.22: Plot
[2]pseudorotaxanes.

Wheel
component
BPP34C10
BN38C10
BN32C8

of

Ka*
(102M-1)
1.0 (±0.2)
2.4 (±0.3)
1.7 (±0.3)

lnKa

versus

1/T


(103 M-1 cm-1)
0.63 (±0.08)
1.0 (±0.1)
1.3 (±0.1)

for

[C4BP/neutral

H
(kcal/mol)
–11 (±0.2)
–8.1 (±0.2)
–7.1 (±0.2)

S
(cal/mol K)
–26 (±1)
–16 (±1)
–13 (±1)

crown

ether]2+

G**
(kcal/mol)
–3.2 (±0.1)
–3.4 (±0.1)
–3.2 (±0.1)

Table 3.17: Thermodynamic parameters of the formation of [C4BP/neutral crown
ether]2+ [2]pseudorotaxanes studied using 1.0 (±0.1) mM [2]pseudorotaxanes in a 2:1
mixture of (CH3)2CO and CH2Cl2.
The thermodynamic parameters obtained are consistent with reported values for similar
systems.24,144 Pseudorotaxane formation from its components in the [C4BP/neutral crown
ether]2+ systems is barrierless and is driven by entropy, with higher temperatures favoring
dissociation. It is important to note that a temperature-dependent color intensity change
would not be observable in the case of related rotaxanes, where dissociation of the wheel
from the axle is prevented by bulky stoppers.
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3.3. Metal-organic (pseudo)rotaxanes
Part of this section was published in Inorg. Chem., 2012, 51, 3156-3160145 and is
reproduced with permission. Copyright 2012 American Chemical Society.
After complete characterization of [2]pseudorotaxanes in the solid state as well as in
solution,

the

metal

binding

properties

of

[PyBP/neutral

crown

ether]2+

[2]pseudorotaxanes were studied. In the solid state, MX2 ( M = Zn2+, Cd2+, Hg2+; X =
Cl¯, Br¯ and I¯ ) binding properties of [PyBP/neutral crown ether]2+ [2]pseudorotaxanes
were studied by using single crystal X-ray diffraction, while the solution state studies
were carried out using UV-Vis and 1H-NMR spectroscopy.

3.3.1. X-ray diffraction studies
3.3.1.1. Crystal growing
Metal-organic (pseudo)rotaxane crystals suitable for X-ray diffraction were obtained by
layering a solution of (+2) charged [2]pseudorotaxanes with a solution of neutral metal
halides, MX2 (M = Zn2+, Cd2+, Hg2+; X = Cl¯, Br¯, I¯) at room temperature. All
[PyBP/BN38C10][NO3]2 and [PyBP/BN32C8][NO3]2 pseudorotaxane solutions were
prepared in

CH3OH

and CHCl3

mixtures,

while

[PyBP/BPP34C10][NO3]2

pseudorotaxane and metal halide solutions were prepared in CH3OH. After slow mixing
of

the

layers

containing

[2]pseudorotaxane

[PyBP/BN38C10][NO3]2

or

[PyBP/BN32C8][NO3]2 and metal halide, the final solution contained a 3:1 mixture of
CH3OH and CHCl3. During crystal growing, the neutral metal salts were transformed
into singly charged anionic species of MX3¯ (M = Zn2+, Cd2+, X = Cl¯, Br¯) or doubly
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charged anionic species of CdBr42¯ or M2X62¯ (M = Hg2+, X = Cl¯, Br¯, I¯ ) by anion
scrambling.

3.3.1.2. Zinc metal-organic rotaxanes
From the fifteen X-ray quality metal-organic (pseudo)rotaxane crystals, four were
obtained

from

ZnX2

[PyBP/BN32C8][NO3]2.

(X

=
In

Cl¯,
the

Br¯)
case

and
of

[PyBP/BN38C10][NO3]2
[PyBP/BN38C10][NO3]2

or
and

[PyBP/BN32C8][NO3]2, two ZnCl3¯ or ZnBr3¯ anions bind to the two ends of (+2)
charged, ditopic [2]pseudorotaxanes to form the dizwitterionic metal-organic rotaxanes
[PyBP/BN38C10](ZnX3)2

and

[PyBP/BN32C8](ZnX3)2,

regardless

of

the

metal/pseudorotaxane ratio in the layered solutions. The iso-structural crystals of
[PyBP/BN38C10](ZnX3)2 and [PyBP/BN32C8](ZnX3)2 (X = Cl¯, Br¯), respectively,
show that neutral zinc halides of ZnCl2 and ZnBr2 were transformed into singly charged
ZnCl3¯ and ZnBr3¯ anions, respectively, during crystallization.
Since

BPP34C10

is

soluble

in

CH3OH,

crystal

growing

attempts

of

[PyBP/BPP34C10][NO3]2 with ZnX2 (X = Cl¯, Br¯) were carried out either in CH3OH
or CH3OH/CHCl3 mixtures. In both cases, [PyBP][NO3]2 precipitated as a light yellow
powder, while BPP34C10 crystallized as colorless prisms. This observation indicates
that the dissociation of the axle from the wheel occurs during the slow mixing of the
pseudorotaxane and metal halide containing layers regardless of the solvent.
To force the pseudorotaxane equilibrium towards more pseudorotaxane formation and to
facilitate the formation of the MX3¯ anions, the following two strategies were employed
one at a time or as a combination of both. Since [PyBP/BPP34C10][NO3]2 has a lower

145

association constant than [PyBP/BN38C10][NO3]2 or [PyBP/BN32C8][NO3]2, a 10-fold
excess of BPP34C10 was used to force the threading-dethreading equilibrium towards
more pseudorotaxane formation. In this attempt, only the crown ether crystallized and
the color of the solution turned from red to light yellow (the color of the axle). The use of
a MX2/KX (1:1) mixture and a pseudorotaxane/(MX2/KX) ratio of 1:2 facilitates the
formation of the MX3¯ ions and provides the optimum stoichiometry required for metalpseudorotaxane formation (equation 25). In this attempt, the axle precipitated due to the
higher ionic strength generated by KX. Upon using a [PyBP][NO3]2:BPP34C10:ZnX2:KX
ratio of 1/10/2/2 (employing both strategies at the same time), the axle precipitated and
the wheel crystallized alone. These results show that during slow mixing of the metal
halide solution and the [2]pseudorotaxane solution, the [PyBP/BPP34C10][NO3]2
[2]pseudorotaxane equilibrium shifts toward dissociation regardless of the axle/wheel or
pseudorotaxane/metal ion ratio.
[PyBP/BPP34C10][NO3]2 + [ZnX2/KX]  [PyBP/BPP34C10]( ZnX2)3 + 2KNO3

(23)

The same strategy was employed in an attempt to obtain metal-organic rotaxanes with
ZnI2 and [2]pseudorotaxanes in CH3OH/CHCl3 mixtures. During slow mixing of the
[2]pseudorotaxane and metal halide containing layers, the [PyBP]2+ axle crystallized as
the dizwitterionic [PyBP](ZnI3)2 (Figure 3.23). Again, the [2]pseudorotaxane formation
equilibrium shifted towards dissociation.

Figure 3.23: Crystal structure (ball and stick representation) of [PyBP](ZnI3)2. Solvent
molecules are omitted for clarity. Color code: Zn, magenta; I, purple; N, blue; C, black;
H, white.
146

3.3.1.3. Cadmium metal organic rotaxanes
Five single crystals suitable for X-ray diffraction studies were obtained with
[PyBP/BPP34C10][NO3]2,

[PyBP/BN38C10][NO3]2

or

[PyBP/BN32C8][NO3]2

[2]pseudorotaxanes and cadmium halides (Br¯ or I¯). The only structure showing
pseudorotaxane-metal binding is metal pseudorotaxane binding behavior was observed
with [PyBP/BN38C10][NO3]2 and cadmium iodide. Its binding pattern is similar to the
zinc-bound rotaxanes: one unit of ditopic [PyBP/BN32C8]2+ [2]pseudorotaxane binds to
two singly charged CdBr3¯ anions to yield a dizwitterionic metal-organic rotaxane.145
The crystal structure shows that neutral CdI2 was converted into singly charged anionic
species of CdI3¯ during self assembly. In the other four structures, doubly charged
CdX42¯ anions act as counter ions for the (+2) charged [2]pseudorotaxane units, without
metal-pseudorotaxane binding. During the initial preparation of metal-pseudorotaxane
crystals, significant amounts of [PyBP][CdI4] crystals (Figure 3.24) were isolated from
each

vial.

This

observation

indicates

that

the

equilibrium

between

each

[2]pseudorotaxane and its individual components shifts towards dissociation due to the
crystallization of [PyBP][CdI4] .
[PyBP][NO3] + neutral crown ether

[PyBP/neutral crown ether][NO3]2

[PyBP]2+ + 2 CdI2

[PyBP][CdI4]

+ Cd2+

(24)
(25)

Figure 3.24: Crystal structure (ball and stick representation) of [PyBP][CdI4]. Solvent
molecules are omitted for clarity. Color code: Cd, green; I, purple; N, blue; C, black; H,
white.
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3.3.1.4. Mercury metal-organic rotaxanes
Six X-ray quality crystals were obtained with the combination of [PyBP/BN38C10] 2+ and
[PyBP/BN32C8]2+ [2]pseudorotaxanes and mercury halides. Crystal structures show that
rearrangement of mercury halides for the anion formation is slightly different from zinc
and cadmium halides. The neutral mercury halides underwent not only anion scrambling
but also dimerization to form doubly charged anionic species of Hg2X62¯ (X = Cl¯, Br¯,
I¯), which have two bridging halide ions connecting two mercury ions. Two anions of
doubly charged Hg2X62¯ (X = Cl¯, Br¯) bind to the two ends of the ditopic axle of
[PyBP/BN38C10][NO3]2 [2]pseudorotaxanes to yield two negatively charged metalorganic rotaxanes, while the corresponding analog of the [PyBP/BN38C10]2+
[2]pseudorotaxanes

show

metal-pseudorotaxane

non-binding

behavior.

[PyBP/BN38C10]2+ and [PyBP/BN32C8]2+ [2]pseudorotaxanes crystallize with Hg2I62¯
in which both structures Hg2I62¯ behaves as a counter ion in crystallization with doubly
charged pseudorotaxanes. It shows similar behavior to the CdX42¯ anion in the
[2]pseudorotaxane crystal structure. The [PyBP/BPP34C10]2+ [2]pseudorotaxane did not
crystallize as metal-organic (pseudo)rotaxane with mercury halides.

3.3.2. Crystallographic description
3.3.2.1. Zinc metal-organic rotaxanes
The asymmetric units of [PyBP/BN38C10](ZnCl3)2 and [PyBP/BN38C10](ZnBr3)2
consist

of

two

metal-organic

rotaxane

(MOR)

units,

while

the

ones

of

[PyBP/BN32C8](ZnCl3)2 and [PyBP/BN32C8](ZnBr3)2 consist of only one (Figure 3.25).
In all four cases, the pseudorotaxane units are located on inversion centers. The 4,4′-
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bipyridinium core of the axle interacts with the two naphthalene rings of the crown ether
via  stacking. [PyBP/BN32C8](ZnCl3)2 and [PyBP/BN32C8](ZnBr3)2 show 
stacking distances of 3.375(3) Å and 3.414(3) Å, while [PyBP/BN38C10](ZnCl3)2 and
[PyBP/BN38C10](ZnBr3)2 show  stacking distances ranging from 3.293(2) to
3.679(3) and 3.345(2) to 3.668(2)Å, respectively. The multiple C–H∙∙∙O hydrogen bonds
ranging from 3.057(5) to 3.496(6) Å contribute to the association between the axle and
the wheel of the [2]pseudorotaxane units. Planar 4,4′-bipyridinium cores and linear
[PyBP]2+ axles were observed in all four crystal structures. The terminal N∙∙∙N distances
of the axles of the four [2]pseudorotaxanes are similar. Identical N∙∙∙N distances,
15.437(3) Å and 15.437(9) Å were observed in [PyBP/BN32C8](ZnCl3)2 and
[PyBP/BN32C8](ZnBr3)2, respectively. The terminal N∙∙∙N distances of the two axles in
the asymmetric unit of [PyBP/BN38C10](ZnCl3)2 and [PyBP/BN38C10](ZnBr3)2 are
15.417(8) and 15.432(7) Å, and 15.378(4) and 15.403(6) Å, respectively. The two
terminal pyridine units of [PyBP/BN32C8](ZnCl3)2 and [PyBP/BN32C8](ZnBr3)2 were
rotated relative to the 4,4′-bipyridinium core by 23.65 and 29.6(2)˚ in the same direction.
In the case of [PyBP/BN38C10](ZnCl3)2, the terminal pyridine rings of the two
pseudorotaxane units in the asymmetric unit one rotated by 26.8(2)˚ and 43.01(2)˚ in
opposite directions while in [PyBP/BN38C10](ZnBr3)2 They are rotated by 27.19(17)˚
and 45.64(17)˚ in the same direction. In all four structures, distorted tetrahedral
coordination geometry of zinc ion was observed. The Zn–N distances of MORs derived
from [PyBP/BN38C10]2+ (2.083(2)–2.088(1) Å) were smaller than those of derived from
[PyBP/BN32C8]2+ (2.095(5)–2.107(3) Å). Methanol molecules were found only in the
crystal structure of [PyBP/BN32C8](ZnBr3)2.
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a)

b)

c)

d)

Figure 3.25: Thermal ellipsoid plot (30 %) of a) [PyBP/BN38C10](ZnCl3)2, b)
[PyBP/BN32C8](ZnCl3)2,
c)
(40
%)
[PyBP/BN38C10](ZnBr3)2
and
d)
[PyBP/BN32C8](ZnBr3)2. Hydrogen atoms and solvent molecules are omitted for clarity.
Color code: Zn, magenta; Cl, green; Br, orange; O, red; N, blue; C, black.

3.2.2.2. Cadmium metal-organic rotaxanes
In the cadmium metal-organic rotaxane crystal structures, the [2]pseudorotaxane units are
not located on inversion centers except for [PyBP/BN38C10][CdI4]2. The  stacking
interactions between the 4,4′-bipyridinium core of the axle and the bis-naphtho rings of
the wheel are 3.421(1) Å. The  stacking interactions range from 3.451(2) to
3.479(3)Å, 3.549(2) to 3.664(2) Å, 3.433(4) to 3.607(1) Å and 3.249(3) to 3.215(4) Å in
[PyBP/BPP34C10][CdBr4], [PyBP/BPP34C10][CdI4], [PyBP/BN38C10][CdBr4] and
[PyBP/BN32C8][CdI4], respectively. The [PyBP]2+ axles are linear in all structures
except for [PyBP/BN32C8](CdI3)2 (Figure 3.26).
A

co-planar

4,4′-bipyridinium

core

was

only

observed

in

the

case

of

[PyBP/BN38C10][CdI4]. The two pyridinium rings of the 4,4′-bipyridinium core of
[PyBP/BPP34C10]2+ are rotated by 14.11(16)º and 19.88º in [PyBP/BPP34C10][CdBr4]
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and [PyBP/BPP34C10][CdI4], respectively. These angles are more than twice as large as
those in [PyBP/BN38C10][CdBr4] (6.26º and 7.11º). The angle between the two rings of
the 4,4′-bipyridinium core of [PyBP/BN32C8](CdI3)2 is 6.2°. This non-planarity of the
4,4′-bipyridinium core of the axle apparently leads to a better overlapping of the 
orbitals of the electron-rich crown ether and the electron-deficient axle, which leads to a
lower

energy

state

of

the

structure.

[PyBP/BPP34C10][CdBr4]

and

[PyBP/BPP34C10][CdI4] show N∙∙∙N distances of 15.462(6) and 15.45(1) Å,
respectively.

The two [PyBP/BN38C10] units in the asymmetric unit of

[PyBP/BN38C10][CdBr4] have N∙∙∙N distances of 15.36(4) and 15.43(4) Å. The
[PyBP/BN38C10][CdI4] and [PyBP/BN32C8](CdI4)

crystal structures show 15.49(1)

and 15.38(1) terminal N∙∙∙N distances, respectively. Multiple C–H∙∙∙O hydrogen bonds
between the axle and the wheel are observed in all five structures. Two CH3OH and one
CHCl3 molecule are observed in the asymmetric unit of [PyBP/BN38C10] [CdBr4].
Distorted tetrahedral geometry of cadmium ion was observed in all five structures. The
Cd−N bond lengths of 2.320(7) and 2.345(7) Å lie within the 2.266−2.421 Å range for
Cd−N distances found in complexes reported in the CSD containing the PyCdI3 unit.
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a)

b)

c)

d)

e)

Figure 3.26: Thermal ellipsoid plots (30 %) of a) [PyBP/BPP34C10][CdBr4], b)
[PyBP/BPP34C10][CdI4], c) [PyBP/BN38C10][CdBr4], d) [PyBP/BN38C10][CdI4] and
e) [PyBP/BN32C8](CdI4). Hydrogen atoms and solvent molecules omitted for clarity.
Color code: Cd, dark green; Br, orange; I, purple; O, red, N, blue; C, black.
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3.3.2.3. Mercury metal-organic rotaxanes
Only the [PyBP/BN38C10]2+ and [PyBP/BN32C8]2+ pseudorotaxanes crystallized with
mercury halides to yield X-ray quality single crystals (Figure 3.27). The mercury metalorganic rotaxanes sit on inversion centers. Linear axles with co-planar 4,4′-bipyridinium
cores were observed in all crystal structures. The terminal N∙∙∙N distances of the axles
were found to be 15.42(1), 15.49(1), 15.43(1), 15.49(1), 15.469(6) and 15.48(2) Å in
[PyBP/BN38C10](Hg2Cl6)2,
[PyBP/BN32C8][Hg2Br6],

[PyBP/BN32C8][Hg2Cl6],
[PyBP/BN38C10][Hg2I6]

[PyBP/BN38C10](Hg2Br6)2,
and

[PyBP/BN32C8][Hg2I6],

respectively. The mercury metal-organic rotaxanes derived from [PyBP/BN32C8]2+
[2]pseudorotaxanes,

[PyBP/BN32C8][Hg2Cl6],

[PyBP/BN32C8][Hg2Br6]

and

[PyBP/BN32C8][Hg2I6], show shorter  stacking distances (3.24(1), 3.283(1) and
3.298(4)Å,

respectively)

[2]pseudorotaxanes,

than

those

derived

[PyBP/BN38C10](Hg2Cl6)2,

from

[PyBP/BN38C10]2+

[PyBP/BN38C10](Hg2Br6)2

and

[PyBP/BN38C10][Hg2I6] (3.39(1), 3.460(3) and 3.730(2) Å, respectively). This
observation goes along with the higher association constant value of [PyBP/BN32C8] 2+
[2]pseudorotaxanes discussed in Section 3.1.4. The 4,4′-bipyridinium core of the axle is
planar, while the terminal pyridine group are rotated to the same direction by 38.0(1)°,
31.0(1)°, 39.3(3)°, 29.2(1)°, 36.5(2)° and 32.62(5)° in [PyBP/BN38C10](Hg2Cl6)2,
[PyBP/BN32C8][Hg2Cl6],

[PyBP/BN38C10](Hg2Br6)2,

[PyBP/BN32C8][Hg2Br6],

[PyBP/BN38C10][Hg2I6] and [PyBP/BN32C8][Hg2I6], respectively. The asymmetric
units of [PyBP/BN38C10](Hg2Cl6)2 and [PyBP/BN38C10](Hg2Cl6)2 contain an
additional axle molecule to neutralize the (–2) charge of the metal-rotaxane unit. In
addition, they contain one methanol (solvent) molecule. In all six structures, the mercury
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ion is found in the distorted tetrahedral environment. The Hg−N bond length of 2.317(4)
Å also lies within the 2.113−2.445 Å range found in other reported PyHgCl3-containing
complexes.
a)

b)

c)

d)

e)

Figure 3.27: Thermal ellipsoid plots (30 %) of a) [PyBP/BN38C10](Hg2Cl6)2, b)
[PyBP/BN32C8][Hg2Cl6], c) [PyBP/BN38C10](Hg2Br6)2, d) [PyBP/BN32C8][Hg2Br6],
e) [PyBP/BN38C10][Hg2I6] and f) [PyBP/BN32C8][Hg2I6]. Hydrogen atoms and solvent
molecules omitted for clarity. Color code: Hg, brown; Cl, green; Br, orange; I, purple; O,
red; N, blue; C, black.
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3.2.2.3.1. Blue-red dichroism
Interestingly, optical absorption micrographs of [PyBP/BN32C8][Hg2Cl6] taken under
polarized light show that the crystal drastically changes color from blue to red (and vice
versa) upon rotation around the perpendicular axis (Figure 3.28a).
a)

b)

Figure 3.28: a) Optical micrographs of the same crystal of [PyBP/BN32C8][Hg2Cl6] in
two different orientations (under Paratone-N oil) b) Columnar arrangement of the
[PyBP/BN32C8]2+ and [Hg2Cl6] 2¯ units in the crystal structure.
A closer examination of the packing diagram reveals a columnar arrangement of the
pseudorotaxane units and [Hg2Cl6]2¯ units (Figure 3.28b). A similar blue/red linear
dichroic emission from a triarylmethane dye has recently been reported.146
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3.3.3. UV-visible spectroscopic studies
Zinc halide binding studies of [PyBP/neutral crown ether]2+ [2]pseudorotaxanes were
carried out in a 1:1 mixture of CH3OH and CHCl3. Separate solutions with 1:1, 1:2, 1:3
and 1:4 [2]pseudorotaxane:ZnX2 molar ratios were prepared and the corresponding UVVisible spectra were recorded. None of the mixtures yields a precipitate.
The UV-Visible spectra of ZnCl2/[2]pseudorotaxane and ZnBr2/[2]pseudorotaxane were
similar to that of the corresponding [2]pseudorotaxane, and provide no evidence for
metal-pseudorotaxane binding (Figure 3.29a and b). The ZnI2/[2]pseudorotaxane system
shows

a

slightly

different

behavior

from

ZnCl2/[2]pseudorotaxane

and

ZnBr2/[2]pseudorotaxane. The absorbance value of ZnI2/[2]pseudorotaxane solutions
increased with the [2]pseudorotaxanes:ZnI2 molar ratio compared to the corresponding
[2]pseudorotaxane (Figure 3.29c). The increased absorbance is an indication of CT
transition between iodide ions and the [2]pseudorotaxane unit and it does not provide a
direct indication of metal-pseudorotaxane binding.
According to the solid state characterization of zinc metal-organic rotaxanes, the
[2]pseudorotaxane units are coordinated by two ZnX3¯anions. Therefore, to provide an
additional halide ion and facilitate ZnX3¯ formation, zinc halide solutions were prepared
by using equimolar amounts of ZnX2 and KX, which is expected to produce ZnX3¯ ions.
ZnX2 + KX

ZnX3¯ + K+

(26)

In all cases, the mixtures of [ZnX2/KX]/[2]pseudorotaxanes yielded a light yellow
precipitate, regardless of the [ZnX2/KX]:[2]pseudorotaxanes ratio.
CdI2

and

[2]pseudorotaxane

mixtures

show

a

behavior

similar

to

the

ZnI2/[2]pseudorotaxanes. In a similar way, mercury halide binding experiments of

156

[PyBP/ neutral crown ether]2+ [2]pseudorotaxanes were carried out. The mixtures of
[2]pseudorotaxane and HgCl2 or HgBr2 gave precipitates immediately after mixing, even
at low concentrations such as 0.66 mM for both the [2]pseudorotaxane and the mercury
halide. In the case of HgI2/[2]pseudorotaxane mixtures, no precipitation occurs and the
absorbance maxima remain constant regardless of the metal:[2]pseudorotaxane ratio
(Figure 3.29d).
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Figure 3.29: a) ZnCl2, b) ZnBr2, c) ZnI2 and d) HgI2 binding studies of
[PyBP/BPP34C10]2+ [2]pseudorotaxanes in a 1:1 mixture of CH3OH:CHCl3 using UVVisible spectroscopy. Color code: [PyBP][NO3]2 axle, blue; [PyBP/BPP34C10]2+: MX2
(M = Zn(II) or Hg(II), X = (Cl¯, Br¯, I¯)) = 1:1 (red), 1:2 (purple), 1:3 (black), 1:4
(yellow), 1:5 (green).
The UV-Visible spectra of ZnCl2, ZnBr2, ZnI2, HgI2 binding studies with [PyBP/
BN38C10]2+ and [PyBP/BN32C8]2+ [2]pseudorotaxanes are given in Appendix C.
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3.3.4. 1H-NMR spectroscopic studies
[2]Pseudorotaxanes and [MX2/KX] solutions were layered to obtain the optimum ratio of
[2]pseudorotaxane:[MX2/KX] of 1:2 at the end of the slow mixing of the two layers. All
[2]pseudorotaxane solutions were prepared in a 1:1 mixture of CH3OH:CH2Cl2, while
[MX2/KX] solutions were prepared in CH3OH to obtain a 2:1 CH3OH:CH2Cl2 ratio at the
end. Within one week, either precipitation or crystallization took place in each vial. The
solution was decanted and the precipitates/crystals as well as the residues obtained by
evaporating the decanted solutions were analyzed by 1H-NMR.
Observations of each vial and the 1H-NMR analysis results are tabulated in Tables 3.18
and 3.19, respectively.
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2+

MX2/KX
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[PyBP/BPP34C10]
solution
precipitate/crystal
Colorless
Light yellow
ZnCl2/KCl
solution
precipitate
Colorless
Light brown
ZnBr2/KBr
solution
crystalline solid
Light yellow
ZnI2/KI
Red crystals
solution
Colorless
Light yellowishCdCl2/KCl
solution
brown precipitate
Colorless
Light yellow
CdBr2/KBr
solution
precipitate
Bright yellow
CdI2/KI
Yellow crystals
solution
Light golden
Light yellow
HgCl2/KCl
brown needle
solution
shaped crystals
Colorless
HgBr2/KBr
Light yellow solid
solution
HgI2/KI

Light yellow
solution

Maroon-red
precipitate

[2]pseudorotaxane
[PyBP/BN38C10]2+
solution
precipitate/crystal
Light yellow
Light yellow
solution
precipitate
Colorless
Light yellowishsolution
green solid
Light yellow
Red crystalline
solution
aggregates
Colorless
Light yellowishsolution
brown solid
Colorless
Light yellow
solution
precipitate
Bright yellow
Yellow crystals
solution
Light golden-brown
Light yellow
needle shaped
solution
crystals
Colorless
Light yellow solid
solution
Light yellow
solution

Table 3.18: Observations of crystal growing vials after one week.

Maroon-red
precipitate

[PyBP/BN32C8]2+
solution
precipitate/crystal
Light yellow
Colorless crystals and
solution
light yellow precipitate
Light blue
Colorless crystals and
solution
light yellow precipitate
Light yellow
Dark blue precipitate
solution
Colorless
Light yellowish brown
solution
solid
Colorless
Light yellow precipitate
solution
Bright yellow
Yellow crystals
solution
Light yellow
solution

Light golden brown
needle shaped crystals

Colorless
solution

Light yellow solid

Light yellow
solution

Three different solid
aggregates, orange, red
and dark-blue

MX2/KX

2+

[PyBP/BPP34C10]
precipitate/crystal

[2]pseudorotaxane
[PyBP/BN38C10]2+
precipitate/crystal

ZnCl2/KCl

[PyBP][NO3]2

[PyBP][NO3]2

ZnBr2/KBr

[PyBP][NO3]2

[PyBP][NO3]2

ZnI2/KI

[PyBP][NO3]2

[PyBP][NO3]2

CdCl2/KCl

[PyBP][NO3]2

[PyBP][NO3]2

CdBr2/KBr [PyBP][NO3]2

[PyBP][NO3]2 and
BN38C10
[PyBP][NO3]2 and
BN38C10

CdI2/KI

[PyBP][NO3]2

HgCl2/KCl

[PyBP][NO3]2

[PyBP][NO3]2

HgBr2/KBr [PyBP][NO3]2

[PyBP][NO3]2

HgI2/KI

[PyBP][NO3]2

[PyBP][NO3]2

[PyBP/BN32C8]2+
precipitate/crystal
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8
[PyBP][NO3]2 and
BN32C8

Table 3.19: Results of NMR analysis of solids/crystals from each crystal growing vial.

According to the 1H-NMR analysis of precipitates, the following trends have been
observed. In the case of [PyBP/BPP34C10]2+ [2]pseudorotaxanes, always the axle
molecules precipitate. Both the axle and the wheel molecules precipitate in the
[PyBP/BN38C10]2+ [2]pseudorotaxanes. In [PyBP/BN32C8]2+ [2]pseudorotaxanes either
axle or both the axle and the wheel precipitate.
Since Zn2+, Cd2+ and Hg2+ are diamagnetic cationic species, peak broadening in the
NMR, an indication of presence of metal ion, cannot be observed. Even though NMR
spectra provide information about the composition of the precipitate/crystalline solid, the
presence/absence of the neutral metal halide, cationic metal ion or anionic metal halide
clusters cannot be concluded based on the NMR results.
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3.4. Isomer separation of syn- and anti-DSBPP34C10 using pseudorotaxane crystals
Crystal structures of [PyBP/neutral crown ether]2+ [2]pseudorotaxanes show that the
metal-organic (pseudo)rotaxanes always assemble so that the net charge of the entity is
zero. Reduction of the charge of the pseudorotaxanes has a potential to obtain MORFs
with higher order of dimensionalities with positively charged metal ions. Therefore to be
able to use the more common, positively charged metal ions for rotaxane framework
construction, neutral and negatively charged pseudorotaxanes were synthesized by
introducing anionic sulphonate groups to the BPP34C10 wheel component.

Neutral [2]pseudorotaxane formation
[PyBP][NO3]2 + [TBA]2DSBPP34C10  [PyBP/DSBPP34C10] + 2[TBA]NO3

(27)

Negatively charged [2]pseudorotaxane formation
[CpBP–2H+] + [TBA]2DSBPP34C10  [CpBP–2H+/DSBPP34C10]2– + 2TBA+

(28)

The acidic form of DSBPP34C10 was converted to the corresponding TBA salt
([TBA]2DABPP34C10) by reacting a colorless solution of DSBPP34C10 in methanol
with a colorless aqueous solution of TBAOH. The final solvent mixture consists of a
H2O:CH3OH in 1:10 ratio, which yields a white precipitate at room temperature.
Although the 1H–NMR spectrum of the evaporated filtrate could be assigned to the syn–
and anti– [TBA]2DSBPP34C10, the ratio between the anti– and syn– isomers is found to
be different than 1:1. Crystallization of the white precipitate as X–ray quality, prismatic,
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colorless crystals reveals that it consist of the SO2Cl derivative of anti-DSBPP34C10
(Figure 3.30).

Figure 3.30: Crystal structure of the SO2Cl derivative of anti-DSBPP34C10. Color code:
C, black; O, red; S, yellow; Cl, green.

To obtain a better percentage of anti–TBA2DSBPP34C10 in the DSBPP34C10 isomer
mixture, the reaction was carried out at 50 ºC instead of room temperature which yields
no precipitate of the SO2Cl derivative.
Fitzmaurice7 and coworkers used TBA2DSBPP34C10 in rotaxanes and pseudorotaxanes,
as a mixture of the syn- and anti- isomers. Using conventional methods, such as
recystallization, precipitation or chromatographic methods, they were unable to separate
the acid or TBA+ salt form of the syn– and anti–DSBPP34C10. We achieved the
separation of the two isomers via the [PyBP/syn- and anti-DSBPP34C10] pseudorotaxane
formation.
As explained in Section 2.2.2.11., the syn– and anti–TBA2DSBPP34C10 crown ethers
crystallize with the [PyBP][NO3]2 axle as red and orange crystals, respectively (Figure
3.31a). The red and orange crystals show different crystallization rates, which facilitates
the manual separation of the [PyBP/syn-DSBPP34C10] and [PyBP/anti-DSBPP34C10]
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crystals. The addition of HPF6 to the manually separated [2]pseudorotaxane crystals
dethreads the axle from the wheel and precipitates the [PyBP]2+ axle as its PF6¯ salt,
leaving the acid form of the crown ether in solution (Figure 3.31b). Evaporation of the
filtrate yields the acid form of pure isomers.
a)

b)

Figure 3.31: a) [2]Pseudorotaxane crystals of [PyBP/syn–DSBPP34C10] and
[PyBP/anti–DSBPP34C10] in the crystal growing vial; b) schematics of syn– and anti–
DSBPP34C10 isomer separation using [2]pseudorotaxanes.
The 1H–NMR spectra of the acidic form of the pure anti– and syn–DSBPP34C10 are
shown in Figure 3.32.
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Figure 3.32: 1H NMR of anti-DSBPP34C10 and syn-DSBPP34C10.
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3.5. Metallo-ligands for MORFs
The pseudorotaxane building blocks reported so far consist of either a) an organic axle
and an organic wheel,13,10 b) an organic axle and a hybrid organic-inorganic wheel147,148
or c) a hybrid organic-inorganic axle and an organic wheel.149 The use of both organic
axles and wheels for pseudorotaxane construction is widely explored, while studies on
the combination of organic axles/wheels and hybrid wheels/axles are yet to be performed.
Interestingly, none of the research groups have used hybrid axles or wheels for MORFs
construction yet.
An interesting organic-inorganic hybrid metallo-ligand, Cu(Pyacac)2 was synthesized and
characterized by Halliwell et. al. in 1997. Cu(Pyacac)2 is a linear, rigid ligand with two
pyridine groups at the two ends (Figure 3.33a).150 Later on, Maverick and coworkers
synthesized Cu-Cd mixed metal-organic frameworks (MMOFs).151 The reaction of
Cd(NO3)2 with Cu(Pyacac)2 yields a ladder type 1D structure (Figure 3.33.b) while the
reaction of CuCl2 and Cu(Pyacac)2 yields a square grid type 2D structure (Figure 3.33.c).
Therefore, we proposed to test whether Cu(Pyacac)2 can to form pseudorotaxanes and
ultimately MORFs.
a)

c)

b)

Figure 3.33: a) Schematic of the linear, rigid metallo-ligand, Cu(Pyacac)2; b) ladder type
1D structure and c) square grid type 2D MMOFs of Cu(Pyacac)2. Color code: C, black;
O, red; N, blue; Cd, yellow; Cu, orange. Reproduced with permission from reference 151.
Copyright 2007 American Chemical Society.
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The Cu(Pyacac)2 ligand is insoluble in common organic solvents except THF and CHCl3.
It is very slightly soluble in C2H5OH. Mixing a solution of light yellowish-green
Cu(Pyacac)2 in CHCl3 with a colorless solution of BPP34C10, BN38C10 or BN32C8 in
CHCl3 yields a solution with a similar color as that of Cu(Pyacac)2. Attempts to
crystallize pseudorotaxanes with a Cu(Pyacac)2 axle and a BPP34C10, BN38C10 or
BN32C8 wheel yielded only Cu(Pyacac)2 as green, cubic crystals (Figure 3.34 a).
a)

b)

Figure 3.34: Thermal ellipsoid plot (80 %) of Cu(Pyacac)2 (polymorph1) and b) it’s
packing diagram showing weak Cu-N coordination bonds. Solvent molecules omitted for
clarity. Color code: C, black; O, red; N, blue; Cu, light blue.

The crystal structure of Cu(Phacac)2 (polymorph 1) shows that terminal pyridine
nitrogens from two axles coordinate to the square planar Cu(II) center of another axle in
between the two, via Cu-N co-ordination bonds, resulting in a 2D sheet of
[Cu(Pyacac)2]∞. The Cu∙∙∙N distance (2.591(2)Ǻ) is longer than the usual Cu–N distance
of 2.57(1). The terminal N∙∙∙N distance is 15.128(2) Å.
From the crystal structure of Cu(Pyacac)2 it became apparent that the formation of Cu-N
coordination bonds might prevent the formation of [Cu(Pyacac)2/neutral crown ether]
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pseudorotaxanes. Therefore, for the next crystal growing attempt, a diaza crown ether
was employed instead of the aromatic crown ethers (Figure 3.35). The interior diameter
between two nitrogen atoms of diaza-18-crown-6 reported in CSD lie within 5.314(2) to
5.740(2) Å while the H∙∙∙H distance of the CH3 groups are 6.121(2). Apparently, it is
sufficiently large to allow threading of the Cu(Phacac)2 axle via slippage mechanism.152
In addition, the two N atoms located at opposite side of the macrocycle can potentiarly
coordinate to the Cu(II) ion center of the axle and lead to pseudorotaxane formation.

Figure 3.35: Schematics of the formation of the proposed [2]pseudorotaxanes of
[Cu(Pyacac)2/diaza-18-crown-6].
Attempts to grow pseudorotaxane crystals with Cu(Pyacac)2 and diaza-18-crown-6
yielded the X-ray quality, green cubic crystals of a different polymorph of Cu(Pyacac)2
(Figure 3.36). The crystal structure of the polymorph 2 indicates that the Cu-N distance
(2.438(6) Å) is slightly shorter than the corresponding one in polymorph 1. The terminal
N∙∙∙N distance is 15.213(8) Å. The shape and the size of the cavity in the polymorph 1
and polymorph 2 are different from the ones in a third, known polymorph of
Cu(Phacac)2.150
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Figure 3.36: Thermal ellipsoid plot (80 %) of Cu(Pyacac)2 (polymorph 2) and it’s
packing diagram showing long Cu-N coordination bonds. Solvent molecules omitted for
clarity. Color code: C, black; O, red; N, blue; Cu, light blue.

These results show that the pyridine nitrogen has a higher coordination affinity than the
diaza-18-crown-6 nitrogen towards the Cu(II) metal center. Since phenyl groups have no
potential to coordinate to the Cu(II) center of the another axle, the phenyl analog of the
Cu(Pyacac)2 axle, bis[3-(4-phenyl)pentane-2,4-dionato]copper(II) (Cu(Phacac)2), was
used in the next experiment (Figure 3.37).

Figure 3.37: Schematics of the formation of the proposed [2]pseudorotaxanes of
[Cu(Phacac)2/diaza-18-crown-6].
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Evaporation of a mixture of Cu(Phacac)2 and diaza-18-crown-6 in CH3OH produced Xray quality, prismatic, blue crystals. The crystal structure reveals no pseudorotaxane
formation from Cu(Phacac)2 and diaza-18-crown-6. In contrast, one molecule of diaza18-crown-6 is sandwiched between two axles, with the two N atoms of the diaza-18crown-6 coordinating to two Cu(II) centers of two axles yielding penta-coordinated
Cu(II) centers (ML3) (Figure 3.38).

Figure 3.38: Crystal structure of ML3. Color code: C, black; O, red; N, blue; Cu, light
blue.

Proposed improvements to obtain the hybrid axle containing [2]pseudorotaxanes are
described in Section 4.2.2.
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3.6. Molecularly woven materials
The L1 molecule (See Figure 1.40 in Chapter 1.2.2) was designed to have all the basic
elements required to form a double stranded, dinuclear helix with metal ions. The 2,2′bipyridinium unit is a well known chelating group. The length of the connecting
–CH2–CH2– group is long enough to allow the helical dimer formation between two L1
molecules. The rigid phenyl groups attached to the 2,2′–bipyridinium unit places the allyl
groups away from each other, preventing the intramolecular alkene metathesis reactions.
The terminal allyl groups are expected to undergo intermolecular alkene metathesis
reaction.

The multistep synthesis (see Scheme 2.6 in Chapter 2.3.1.7) of L1 started by protecting
the OH group of 4-bromophenol (compound 6). The OH group is converted into a tertbutyl dimethyl silyloxy (TBDMS) group which is not affected by lithiation reagents or by
the conditions in the next steps. The synthesis of compound 8 was carried out in a onepot, two-step reaction, comprised of lithiation followed by introduction of the SnBu3
group. Compound 10 was synthesized similarly. Both compound 8 and 10 are starting
materials for the Stille cross-coupling reaction. The palladium catalyzed cross-coupling
between compound 10 and 11 yields 3-bromo-3′-methyl-2,2′-bipyridine, compound 12.
The Stille coupling reaction between the organotin compound 8, and aromatic bromo
compound 12, yields compound 13. Lithium diisopropyl amide (LDA) was used as the
lithiation reagent in the synthesis of compound 14. LDA shows greater selectivity over
BuLi in proton abstraction vs. nucleophilic addition. Deprotection of the OTBDMS
protecting group using TBAF is a common procedure. Therefore, compound 14 was
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deprotected using TBAF. The last step of the multi-step is the attachment of the allyl
group onto compound 15.
Since L1 is soluble in CHCl3 and [Cu(CH3CN)4]PF6 is soluble in CH3CN, a mixture of
CHCl3 and CH3CN was used in crystal growing. After evaporation of the solvent, X-ray
quality single crystals were obtained. The crystal growing attempts with L1 and other
tetrahedral metal ions (Ag(I)) always yielded a white precipitate or microcrystalline
powder. 1H-NMR analysis showed that the precipitate is pure L 1.

B

A′

A

B′

Figure 3.39: Crystal structure (ball and stick representation) of the Cu(II) complex of L1.
Hydrogen and solvents omitted for clarity. Color code, C; black, O; red, N; blue, P;
purple; F; lime green, Cu(II); light blue.

The crystal structure of the Cu(II) complex of L1 (Figure 3.39) shows that L1 forms a
single stranded helical structure with Cu(II) ions. Rings A and B, and A′ and B′ show
 stacking distances 3.527(2) Å and 3.540(5) Å, respectively. The Cu(II) ion has a
distorted tetrahedral coordination geometry. The two 2,2′-bipyridinium cores are not
planar. Two PF6¯ counter ions balance the charge of the Cu(II) complex of L1.
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This crystal structure reveals that the  stacking interactions between the aromatic
rings and the freely rotating –CH2–CH2– single bond between two pyridine units of the
two 2,2′-bipyridinium groups form a mononuclear Cu(I) complex, instead of a double
stranded, dinuclear complex.. Therefore, we proposed a new multi-step synthetic route
(Scheme 5.1) to synthesize ligand L2, which has a rigid –C6H4– linker instead of –CH2–
CH2– between the two 2,2′-bipyridinium groups, and rigid 1,10-phenantholine groups
instead of the 2,2′-bipyridinium groups.
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CHAPTER 4

CONCLUSIONS
UV-Visible

spectroscopic

[2]pseudorotaxanes

studies

of

the

[4,4′-bipyridinium/crown

ether]

show the effect of the HOMO-LUMO energy gap between the

electron rich crown ether and the electron deficient 4,4′-bipyridinium axle on the energy
of the charge transfer transition and the resulting color of the pseudorotaxanes and their
stability.
The

NMR

studies

performed

on

[4,4′-bipyridinium/neutral

crown

ether]2+

pseudorotaxane solutions show that in solution the pseudorotaxane is in fast equilibrium
with its individual components.
The Job’s plots of pseudorotaxanes show that a 1:1 complexation between the axle and
the wheel of all pseudorotaxanes in solution.
The

Benesi-Hildebrand

plots

of

[4,4′-bipyridinium/neutral

crown

ether]2+

[2]pseudorotaxanes show that bis-naphtho crown ethers (BN38C10 and BN32C8) bind to
the axle molecules more strongly than the bis-p-phenyl crown ether (BPP34C10).
Attachment of two negative charges onto the crown ether was achieved by sulfonating
BPP34C10. The DSBPP34C10 crown ether binds to axles 10 times more strongly than
the non-sulphonated analog (BPP34C10) in water.
Electrochemical studies of [2]pseudorotaxanes show that the reduction potential of the
4,4′-bipyridinium core decreases and the oxidation potential of the wheel increases upon
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pseudorotaxane formation, due to the interaction of the electron-rich wheel with the
electron-deficient axle.
Crystallographic studies of pseudorotaxanes show stacking and C–H∙∙∙O hydrogen
bonding interactions in the solid state. All pseudorotaxanes except [PyBP/DB24C8]2+
show a 1:1 complexation between the axle and the wheel in the solid state.
[PyBP/DB24C8]2+ shows an axle:wheel ratio of 1:2.
We have shown that the combinations of the linear-rigid [PyBP][NO3]2 or [CpBP]Cl2
axles with BPP34C10, BN38C10, BN32C8 or DSBPP34C10 crown ethers are versatile
templating motifs for pseudorotaxane formation and are potential building blocks for the
construction of MORFs.
The interactions between the axle and the wheel at low temperatures are stronger than at
high temperatures. The stronger the interactions between the axle and the wheel, the
higher the intensity of the corresponding pseudorotaxane solution. Variable temperature
UV-vis studies of [C4BP/neutral crown ether]2+ [2]pseudorotaxanes show temperature
sensing behavior of [2]pseudorotaxanes over a 100 ºC window without changes in the
max value.
Metal binding studies of [PyBP/neutral crown ether]2+ pseudorotaxanes indicate that
they have different binding affinities towards zinc, cadmium and mercury metal halides.
Among the (+2) charged linear, rigid axle [2]pseudorotaxanes, only [PyBP/BN38C10]2+
or [PyBP/BN32C8]2+ yield dizwitterionic metal-organic rotaxanes with ZnCl2 and ZnBr2.
Two (–1) charged ZnX3¯ moieties (X= Cl¯, Br¯) bind to the two ends of the
[2]pseudorotaxanes. Attempts to grow crystals of MORFs with [PyBP/BPP34C10]2+
[2]pseudorotaxanes and ZnX2 (X= Cl¯, Br¯, I¯) yield to the separation of the individual
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components of the pseudorotaxanes. The wheel crystallizes, while the axle precipitates in
the case of ZnCl2 or ZnBr2. With ZnI2, the axle crystallizes as [PyBP](ZnI3)2 instead of
forming a metal-pseudorotaxane complex.
All (+2) charged linear, rigid axle [2]pseudorotaxanes of [PyBP/BPP34C10]2+ or
[PyBP/BN38C10]2+ crystallize with (–2) charged CdBr42¯ and CdI42¯ counter ions; only
the [PyBP/BN32C8]2+ [2]pseudorotaxane binds to two (–1) charged CdI3¯ moieties.

The [PyBP/BN32C8]2+ [2]pseudorotaxanes do not form metal-rotaxane complexes with
HgX2 (X= Cl¯, Br¯, I¯), while [PyBP/BN38C10]2+ [2]pseudorotaxanes show metalrotaxane binding with HgX2 (X = Cl¯, Br¯) but not with HgI2. During crystallization, the
neutral mercury halides convert into (–2) charged dimerized species, Hg2X62–The
pseudorotaxane unit binds to two (–2) charged Hg2X62– moieties to yield (–2) charged
metal-organic rotaxanes when X = Cl¯ and Br¯.
Metal-organic rotaxanes derived from [PyBP/BN38C10][NO3]2 and Hg2+ halides (Cl¯,
Br¯, I¯)

show blue/red dichroism due to the columnar arrangement of the

[PyBP/BN38C10]2+ pseudorotaxane units in the crystals.
To use the most common cationic metal nodes for metal binding studies,
[2]pseudorotaxanes with negatively charged DSBPP34C10 wheel was prepared.
Differences in crystallization rate and color of [PyBP/syn–DSBPP34C10] and
[PyBP/anti–DSBPP34C10] facilitate the manual separation of the two isomeric, neutral
[2]pseudorotaxane crystals. It enables the separation of pure syn and anti isomers of
DSBPP34C10, which were inseparable by conventional methods.
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The pyridine nitrogens of the metallo-ligand Cu(Pyacac)2 bind to the Cu(II) centers
instead of forming pseudorotaxanes with diaza-18-crown-6 and lead to a 2D square grid.
The shape and the size of the cavities of the 2D structure depend on the solvents used in
the crystal growing attempts. The use of Cu(Phacac)2 prevents the square grid formation
of metallo-ligand itself. Diaza-18-crown-6 forms a sandwiched structure with two
Cu(Phacac)2 metallo-ligands. The N atoms of the diaza-18-crown-6 wheel coordinate to
square planar Cu(II) centers of two adjacent axles and lead to penta-coordinated, square
pyramidal Cu(II) coordination geometries.

Ligand L1 binds to Cu(II) to form a tetrahedral mononuclear metal complex which is
driven by  interactions between the terminal phenyl group and the pyridine group of
the 2,2′-bipyridinium core.
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CHAPTER 5

FUTURE WORK
5.1. Synthesis of tetrasulphonated BN38C10
Negatively charged (–2) [2]pseudorotaxanes could be synthesized using tetrasulphonated
BN38C10 (TSBN38C10), [CpBP]Cl2 or [PyBP][NO3]2 axles (Figure 5.1). Negatively
charged pseudorotaxanes have a high potential to undergo self-assembly with positively
charged metal ions to yield neutral MORFs with different dimensionality. This approach
facilitates the elimination of counter ions from the cavity space of the MORFs.

a)

b)

Figure 5.1: Schematics of a) TSBN38C10 and b) negatively charged pseudorotaxane
formation.

5.2. Synthesis of larger diaza crown ethers and metallo-ligands with hexacoordinated
metal centers.
The crystal structure of diaza-18-crown-6 bound Cu(Phacac)2 (Figure 3.38) shows that
diaza-18-crown-6 binds to Cu(Phacac)2 from outside, instead of wrapping around it.
Apparently, even at higher temperatures (65 ˚C) the barrier for the wheel to slip onto the
axle is too high. To lower this barrier, larger wheel molecules, such as 1,13-diaza-24crown-6 or dipyrido-24-crown-8 can be used (Figure 5.2a and b). Also, bis[3177

(4-phenyl)pentane-2,4-dionato]nickel(II) (Ni(Phacac)2) can be used as the axle, since
nickel is more likely to become hexacoordinate than copper.

Figure 5.2: Schematics of a) diaza-24-crown-8, b) dipyrido-24-crown-8 and c)
Ni(Phacac)2.
5.3. Molecularly woven materials
Ligand L2 was designed to have favorable features to facilitate double stranded,
dinuclear helicate formation. The Cu complex of L1 shows that the –CH2–CH2– spacer
and the C–C single bond between the two pyridinium rings of 4,4′-bipyridine provides
enough flexibility to L1 to adopt a confirmation that leads to a helical mononuclear
complex. To impart rigidity to the structure, a m–C6H4 spacer and 1,10-phenanthroline
groups are proposed (Figure 5.3).

Figure 5.3: Schematics of L2.
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The proposed multistep synthetic route for L2 is given in Scheme 5.1

Scheme 5.1: Multi-step synthesis of ligand L2
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H-NMR and 13C-NMR spectral data of selected compounds
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H-NMR of BPP34C10 in CDCl3
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H-NMR of BN32C8 in CDCl3
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H-NMR of [CpBP]Cl2 in CD3OD
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H-NMR of compound 13 in CDCl3
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C-NMR of compound 13 in CDCl3
198

1

H-NMR of compound 14 in CDCl3
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C-NMR of compound 14 in CDCl3
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H-NMR of compound 15 in d6-DMSO
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C-NMR of compound 15 in d6-DMSO
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H-NMR of compound 16 in CDCl3
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H-NMR of compound 19 in CDCl3
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Appendix B
Molar ratio plots and Benesi-Hildebrand plots of pseudorotaxanes
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Benesi-Hildebrand plots
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[C4BP/neutral crown ether][PF6]2 [2]pseudorotaxanes
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Appendix C
Solution state metal binding studies of [PyBP/BN38C10]2+ and [PyBP/BN32C8]2+
pseudorotaxanes
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